Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,A1BG,Alpha-1B-glycoprotein,20510,132,1.60 [0.58-4.38],0.3608107559815644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AAMDC,Mth938 domain-containing protein,19922,125,1.20 [0.87-1.66],0.2689003098103719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AARSD1,Alanyl-tRNA editing protein Aarsd1,23526,149,1.26 [0.98-1.63],0.0713374070307862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABCA2,ATP-binding cassette sub-family A member 2,19790,124,0.59 [0.35-1.00],0.0482408391156495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABHD14B,Protein ABHD14B,23365,150,1.28 [1.00-1.65],0.0541691595597999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABL1,Tyrosine-protein kinase ABL1,23526,149,1.21 [0.99-1.49],0.0618717131840614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABO,Histo-blood group ABO system transferase,20513,128,0.96 [0.86-1.08],0.5034412626051716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ABRAXAS2,BRISC complex subunit Abraxas 2,19790,124,1.15 [0.89-1.49],0.2861651303984642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23083,148,0.92 [0.76-1.10],0.3568477020088916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20126,125,1.20 [0.98-1.47],0.0727284315998923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20484,132,1.20 [1.01-1.44],0.0408224712428181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACAN,Aggrecan core protein,23395,146,0.68 [0.40-1.17],0.1674243844084679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACE,Angiotensin-converting enzyme,20513,128,1.13 [0.61-2.08],0.6994541088671027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACE2,Angiotensin-converting enzyme 2,23208,146,0.86 [0.64-1.14],0.2934912132276189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACHE,Acetylcholinesterase,20023,132,0.96 [0.58-1.58],0.8605719956148937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACOT13,Acyl-coenzyme A thioesterase 13,20422,129,1.10 [0.95-1.27],0.2135369856257005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,23640,150,1.23 [0.94-1.60],0.1328442039706845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19884,122,1.35 [0.97-1.88],0.0772840617702823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACP5,Tartrate-resistant acid phosphatase type 5,23740,146,1.33 [0.85-2.06],0.2083647574063862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACP6,Lysophosphatidic acid phosphatase type 6,23818,151,0.87 [0.72-1.06],0.1784723519013758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACRBP,Acrosin-binding protein,20415,129,1.40 [1.01-1.95],0.0446707282855956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACRV1,Acrosomal protein SP-10,19884,122,1.05 [0.90-1.23],0.5360252286947809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19790,124,1.20 [0.79-1.84],0.3947289763939331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACTA2,"Actin, aortic smooth muscle",23208,146,0.95 [0.67-1.36],0.787025938336491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACTN2,Alpha-actinin-2,19790,124,0.86 [0.64-1.15],0.3176408058334322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACTN4,Alpha-actinin-4,23231,145,0.87 [0.53-1.43],0.5768603936612939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACVRL1,Serine/threonine-protein kinase receptor R3,23393,149,1.15 [0.65-2.06],0.6287442357833068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACY1,Aminoacylase-1,23640,150,0.92 [0.73-1.18],0.5198642039658339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19790,124,0.80 [0.58-1.11],0.1893998843272405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ACYP1,Acylphosphatase-1,19955,132,1.42 [1.12-1.82],0.0043592156652174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADA,Adenosine deaminase,23917,149,1.18 [0.81-1.73],0.3835435249925699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADA2,Adenosine deaminase 2,23522,146,1.39 [1.00-1.93],0.0472776615466324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19884,122,1.28 [0.78-2.11],0.3341564593469064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,23208,146,1.36 [0.85-2.18],0.1966475684211369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,23436,150,0.68 [0.46-1.02],0.0634866469259385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23917,149,0.99 [0.66-1.49],0.9627331757059944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23818,150,2.07 [1.36-3.14],0.0006806715471766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,20422,129,1.84 [1.10-3.08],0.0204977895215413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19884,122,1.35 [0.83-2.20],0.2302930065414268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23938,149,0.90 [0.49-1.66],0.7453424741707831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,23526,149,0.99 [0.69-1.40],0.9371827018822558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,23208,146,1.08 [0.70-1.66],0.7169224492848065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19884,122,1.08 [0.67-1.75],0.753890833668577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23701,148,0.75 [0.55-1.03],0.07349958695359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTSL2,ADAMTS-like protein 2,20492,132,0.71 [0.42-1.20],0.2060620835613467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTSL4,ADAMTS-like protein 4,19922,125,0.64 [0.31-1.30],0.215062035038444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADAMTSL5,ADAMTS-like protein 5,20484,132,0.79 [0.52-1.21],0.2823320241408622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23083,148,1.06 [0.70-1.61],0.7670767945266973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADD1,Alpha-adducin,20023,132,1.34 [1.06-1.70],0.0140255445455984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRB3,Adhesion G protein-coupled receptor B3,23393,149,0.83 [0.53-1.28],0.3904990484407271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRD1,Adhesion G-protein coupled receptor D1,20023,132,1.20 [0.79-1.80],0.3921295790994535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRE1,Adhesion G protein-coupled receptor E1,20422,129,1.33 [0.99-1.80],0.0573004224192899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRE2,Adhesion G protein-coupled receptor E2,23725,148,1.89 [1.16-3.08],0.0102806735061374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRE5,Adhesion G protein-coupled receptor E5,23824,148,1.82 [1.22-2.70],0.0031237625967913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRF5,Adhesion G protein-coupled receptor F5,20484,132,1.87 [1.00-3.48],0.048882332550171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRG1,Adhesion G-protein coupled receptor G1,23526,149,1.09 [0.93-1.29],0.2789558531111801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRG2,Adhesion G-protein coupled receptor G2,23640,150,1.10 [0.64-1.89],0.7247721359734083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADGRV1,Adhesion G-protein coupled receptor V1,19830,123,0.71 [0.52-0.96],0.0274344881923263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADH1B,All-trans-retinol dehydrogenase,20023,132,0.85 [0.68-1.08],0.1862170479762697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,23208,146,0.95 [0.79-1.15],0.6219856713329146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADIPOQ,Adiponectin,20510,132,1.14 [0.89-1.45],0.2979806289019112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADM,Pro-adrenomedullin,23846,151,0.92 [0.53-1.60],0.7677875151971388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ADRA2A,Alpha-2A adrenergic receptor,19790,124,1.12 [0.90-1.39],0.3280179499980643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AFAP1,Actin filament-associated protein 1,20023,132,1.08 [0.88-1.32],0.4513428429391605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AFM,Afamin,20510,132,0.45 [0.20-1.01],0.0526207042197924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AFP,Alpha-fetoprotein,23350,148,0.91 [0.72-1.14],0.4116906488538702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGBL2,Cytosolic carboxypeptidase 2,19830,123,0.87 [0.74-1.04],0.119272889141459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGER,Advanced glycosylation end product-specific receptor,23571,148,0.76 [0.53-1.09],0.1338128076564766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGR2,Anterior gradient protein 2 homolog,22947,146,1.16 [1.00-1.34],0.0522120743849065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGR3,Anterior gradient protein 3,23047,148,0.91 [0.71-1.17],0.4531740427140002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGRN,Agrin,23725,148,1.05 [0.69-1.60],0.8177707389523241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGRP,Agouti-related protein,23917,149,0.95 [0.72-1.25],0.7029940130009759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGT,Angiotensinogen,20513,128,0.73 [0.31-1.69],0.4588240023635818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AGXT,Serine--pyruvate aminotransferase,23640,150,0.97 [0.80-1.18],0.7681950144748542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHCY,Adenosylhomocysteinase,23640,150,1.09 [0.88-1.34],0.4446954768745337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHNAK,Neuroblast differentiation-associated protein AHNAK,19922,125,0.80 [0.45-1.39],0.4225577751481632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHNAK2,Protein AHNAK2,19922,125,1.02 [0.58-1.79],0.9588647525272472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,20415,129,1.14 [0.90-1.43],0.2717509707765818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHSG,Alpha-2-HS-glycoprotein,20513,128,0.70 [0.38-1.29],0.2497091907947885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AHSP,Alpha-hemoglobin-stabilizing protein,23608,147,1.17 [0.98-1.40],0.0756034323145022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIDA,"Axin interactor, dorsalization-associated protein",19939,127,1.02 [0.84-1.24],0.8434726966151971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIF1,Allograft inflammatory factor 1,23083,148,0.95 [0.72-1.25],0.7052636350132833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIF1L,Allograft inflammatory factor 1-like,19922,125,0.83 [0.57-1.19],0.3042888009249923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23493,149,1.09 [0.96-1.25],0.1942554377184789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AK1,Adenylate kinase isoenzyme 1,23640,150,1.30 [1.05-1.61],0.0178874487788115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AK2,"Adenylate kinase 2, mitochondrial",20438,131,1.06 [0.91-1.24],0.4406974753299366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKAP12,A-kinase anchor protein 12,20023,132,1.02 [0.45-2.30],0.9667393855552452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR1B1,Aldo-keto reductase family 1 member B1,23083,148,1.17 [0.97-1.42],0.1011812814185065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR1B10,Aldo-keto reductase family 1 member B10,19939,127,0.74 [0.55-1.01],0.0590176261163753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR1C4,Aldo-keto reductase family 1 member C4,23208,146,0.86 [0.62-1.17],0.3353436670013241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19884,122,1.02 [0.79-1.31],0.8952411896359596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKT1S1,Proline-rich AKT1 substrate 1,23119,148,1.20 [0.96-1.50],0.1066788501110431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKT2,RAC-beta serine/threonine-protein kinase,20447,131,1.12 [0.98-1.28],0.090323701929095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AKT3,RAC-gamma serine/threonine-protein kinase,22976,148,1.20 [0.93-1.54],0.1581709151951797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALCAM,CD166 antigen,23938,149,1.46 [0.70-3.06],0.3116851800864723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH1A1,Retinal dehydrogenase 1,23652,147,1.06 [0.81-1.39],0.6618601601146921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH2,"Aldehyde dehydrogenase, mitochondrial",20415,129,0.67 [0.43-1.05],0.0840781533097446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",23570,149,1.14 [0.93-1.39],0.1969989102707711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",20447,131,1.12 [0.80-1.59],0.504323015662329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALMS1,Alstrom syndrome protein 1,20126,125,0.61 [0.38-0.97],0.0369082300223132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALPI,Intestinal-type alkaline phosphatase,19884,122,1.04 [0.91-1.20],0.5406060264454182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ALPP,"Alkaline phosphatase, placental type",23526,149,1.00 [0.87-1.15],0.9869112529583018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMBN,Ameloblastin,23231,145,0.65 [0.35-1.21],0.1751114086390617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMBP,Protein AMBP,23810,151,1.11 [0.54-2.28],0.7696281317228152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20492,132,1.27 [0.68-2.38],0.4457377122673032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMFR,E3 ubiquitin-protein ligase AMFR,23119,148,1.03 [0.82-1.30],0.7688918298404043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMIGO1,Amphoterin-induced protein 1,19939,127,1.28 [0.98-1.68],0.0701860911908954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMIGO2,Amphoterin-induced protein 2,23526,149,2.27 [1.26-4.09],0.0062415207904689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMN,Protein amnionless,23231,145,1.07 [0.78-1.46],0.6790752708671252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMOT,Angiomotin,20023,132,1.02 [0.65-1.60],0.924787146753634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMOTL2,Angiomotin-like protein 2,20326,129,0.96 [0.67-1.37],0.8155148256098594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMPD3,AMP deaminase 3,20438,131,1.27 [1.01-1.61],0.0397890661531928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19242,119,0.79 [0.54-1.15],0.2129520492210038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMY2A,Pancreatic alpha-amylase,22762,140,0.77 [0.56-1.06],0.1100197886604169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AMY2B,Alpha-amylase 2B,22051,138,0.78 [0.57-1.07],0.1259745139828958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANG,Angiogenin,23602,148,1.22 [0.79-1.87],0.3659650854129517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPT1,Angiopoietin-1,23550,148,1.10 [0.92-1.31],0.2883559643519824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPT2,Angiopoietin-2,23846,151,1.18 [0.80-1.73],0.4076561716285339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL1,Angiopoietin-related protein 1,23268,142,0.94 [0.56-1.59],0.8200627935044469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL2,Angiopoietin-related protein 2,23644,148,1.10 [0.76-1.59],0.5989647312051467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL3,Angiopoietin-related protein 3,23680,148,0.91 [0.59-1.38],0.644194627187016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL4,Angiopoietin-related protein 4,23689,148,1.11 [0.80-1.54],0.514665533742253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANGPTL7,Angiopoietin-related protein 7,23846,151,0.91 [0.61-1.36],0.6433571712693251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANK2,Ankyrin-2,19790,124,0.97 [0.75-1.25],0.7927217877661786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19884,122,1.11 [0.90-1.38],0.3209911118429268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANKRA2,Ankyrin repeat family A protein 2,19767,126,1.05 [0.77-1.43],0.7465865454574979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANKRD54,Ankyrin repeat domain-containing protein 54,23083,148,1.15 [0.91-1.45],0.2341260508331881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19922,125,0.92 [0.57-1.49],0.7456825894675622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANPEP,Aminopeptidase N,23718,147,0.83 [0.48-1.44],0.5123299110571921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA1,Annexin A1,19920,132,1.24 [0.90-1.71],0.1948344733941448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA10,Annexin A10,23119,148,0.95 [0.79-1.14],0.5715436696403735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA11,Annexin A11,23571,149,1.20 [0.95-1.50],0.1284971097162686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA2,Annexin A2,19627,125,1.01 [0.79-1.29],0.9574584799631624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA3,Annexin A3,23818,150,1.17 [0.95-1.43],0.132732281652246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA4,Annexin A4,23538,150,1.27 [1.05-1.53],0.0149411760645673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ANXA5,Annexin A5,23035,145,1.11 [0.68-1.79],0.6837742098447336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AOC1,Amiloride-sensitive amine oxidase [copper-containing],23231,145,0.91 [0.68-1.22],0.5245637053918417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AOC3,Membrane primary amine oxidase,23752,148,1.39 [0.84-2.28],0.1997732795056426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP1G2,AP-1 complex subunit gamma-like 2,20415,129,1.17 [0.95-1.43],0.1383239492305078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP2B1,AP-2 complex subunit beta,19939,127,1.28 [0.93-1.78],0.1334452192131642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP3B1,AP-3 complex subunit beta-1,20422,129,1.17 [0.95-1.45],0.1488747973402253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AP3S2,AP-3 complex subunit sigma-2,20438,131,1.26 [0.90-1.75],0.1758889512388379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,23526,149,1.09 [0.81-1.48],0.5594595632147343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APCS,Serum amyloid P-component,20329,131,1.04 [0.62-1.76],0.8790588417609086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23781,151,1.20 [0.95-1.51],0.1193165541451596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APLP1,Amyloid-like protein 1,23640,150,0.85 [0.63-1.13],0.258080006406209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOA1,Apolipoprotein A-I,20510,132,1.11 [0.61-2.03],0.7283254132913504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOA2,Apolipoprotein A-II,20513,128,0.89 [0.63-1.26],0.5214698021005547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOA4,Apolipoprotein A-IV,20510,132,1.15 [0.72-1.82],0.558870888895588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOB,Apolipoprotein B-100,20513,128,1.39 [0.66-2.93],0.3859783683141817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOBR,Apolipoprotein B receptor,19922,125,0.97 [0.65-1.45],0.8781844138064544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOC1,Apolipoprotein C-I,20477,132,0.86 [0.55-1.35],0.5196424920765295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOD,Apolipoprotein D,19617,129,0.70 [0.43-1.15],0.1627226307687979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOE,Apolipoprotein E,20510,132,0.96 [0.74-1.25],0.773591316991614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOF,Apolipoprotein F,20513,128,0.93 [0.51-1.71],0.8237340350244311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOH,Beta-2-glycoprotein 1,23652,147,1.06 [0.71-1.57],0.7841255432441134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOL1,Apolipoprotein L1,20513,128,0.92 [0.67-1.28],0.634426784180399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APOM,Apolipoprotein M,23717,148,1.07 [0.64-1.77],0.8018952912357374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APP,Amyloid-beta precursor protein,23615,147,1.08 [0.87-1.35],0.4745108726411522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APPL2,DCC-interacting protein 13-beta,20023,132,1.06 [0.91-1.23],0.437457304439598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,APRT,Adenine phosphoribosyltransferase,23393,150,1.35 [0.98-1.85],0.0646040039061572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARAF,Serine/threonine-protein kinase A-Raf,20126,125,1.15 [0.91-1.45],0.2408015225376836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AREG,Amphiregulin,23526,149,1.30 [0.91-1.87],0.148028593553302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARF6,ADP-ribosylation factor 6,20422,129,1.10 [0.94-1.28],0.249031554392961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARFIP1,Arfaptin-1,20447,131,1.26 [1.00-1.60],0.050495322992116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARG1,Arginase-1,23479,151,1.35 [1.02-1.78],0.032945610334362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARG2,"Arginase-2, mitochondrial",20415,129,0.80 [0.51-1.26],0.3336212318714446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP1,Rho GTPase-activating protein 1,23083,148,1.24 [0.90-1.71],0.1795707173228051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP25,Rho GTPase-activating protein 25,23083,148,1.10 [0.88-1.39],0.3954735871087055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP30,Rho GTPase-activating protein 30,20126,125,0.83 [0.51-1.34],0.4492068449120641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP45,Rho GTPase-activating protein 45,20023,132,1.08 [0.88-1.32],0.4610721010955483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGAP5,Rho GTPase-activating protein 5,19767,126,0.97 [0.77-1.23],0.8135337879481969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF1,Rho guanine nucleotide exchange factor 1,20438,131,1.21 [1.00-1.46],0.0451730518672574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF10,Rho guanine nucleotide exchange factor 10,20447,131,1.07 [0.90-1.28],0.4392079622192276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF12,Rho guanine nucleotide exchange factor 12,23613,149,1.07 [0.93-1.23],0.3406782533223789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARHGEF5,Rho guanine nucleotide exchange factor 5,19830,123,1.25 [1.02-1.52],0.0320730053705339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARID3A,AT-rich interactive domain-containing protein 3A,19830,123,0.97 [0.63-1.50],0.8898865226190099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARID4B,AT-rich interactive domain-containing protein 4B,23119,148,1.24 [0.93-1.65],0.1365867811409414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARL13B,ADP-ribosylation factor-like protein 13B,19790,124,1.16 [0.92-1.47],0.2155585287452046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19790,124,1.33 [0.89-2.00],0.1692932631182787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARMCX2,Armadillo repeat-containing X-linked protein 2,19830,123,0.78 [0.54-1.12],0.1759779872550802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARNT,Aryl hydrocarbon receptor nuclear translocator,23231,145,1.15 [0.79-1.66],0.4714241625790234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19790,124,0.99 [0.71-1.39],0.9628270985958582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARSA,Arylsulfatase A,23652,147,1.24 [0.91-1.68],0.1771563432287132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARSB,Arylsulfatase B,23526,149,1.23 [0.96-1.58],0.1010966357891761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ART3,Ecto-ADP-ribosyltransferase 3,23752,148,0.95 [0.64-1.43],0.8197509557609768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ART5,Ecto-ADP-ribosyltransferase 5,19830,123,1.06 [0.82-1.38],0.6507729004409233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ARTN,Artemin,23231,145,0.77 [0.52-1.14],0.1954320318202455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASAH1,Acid ceramidase,20307,132,1.29 [0.95-1.74],0.0993146415990377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASAH2,Neutral ceramidase,23436,150,0.91 [0.70-1.17],0.4633173984736746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASGR1,Asialoglycoprotein receptor 1,23436,150,0.92 [0.57-1.50],0.7364960954947224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASGR2,Asialoglycoprotein receptor 2,20513,128,0.95 [0.50-1.81],0.886935051088203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASPN,Asporin,20484,132,0.63 [0.33-1.19],0.1531663156850473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASPSCR1,Tether containing UBX domain for GLUT4,20447,131,1.34 [1.05-1.72],0.0188692611906525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19922,125,1.03 [0.87-1.22],0.7494584657924548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ASS1,Argininosuccinate synthase,19790,124,0.95 [0.75-1.19],0.6446043354014969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATF2,Cyclic AMP-dependent transcription factor ATF-2,23119,148,1.11 [0.92-1.34],0.2750033021682392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19767,126,0.90 [0.53-1.53],0.7089147385157428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATG16L1,Autophagy-related protein 16-1,20422,129,1.17 [0.96-1.42],0.1220776696857214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATG4A,Cysteine protease ATG4A,23083,148,1.26 [1.00-1.58],0.0517240262711728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATOX1,Copper transport protein ATOX1,23701,148,1.18 [0.96-1.45],0.1189103578059927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19790,124,1.09 [0.78-1.53],0.6161407827427927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19790,124,0.94 [0.54-1.63],0.8202957065744263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19790,124,0.88 [0.54-1.42],0.5954533573788924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP1B4,Protein ATP1B4,19767,126,1.20 [0.82-1.76],0.3374218831145487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19790,124,1.08 [0.83-1.39],0.5719556339538416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19790,124,0.90 [0.62-1.31],0.581057672806079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP5IF1,"ATPase inhibitor, mitochondrial",23725,148,1.12 [0.98-1.28],0.1005861344488153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP5PO,"ATP synthase subunit O, mitochondrial",23119,148,0.94 [0.66-1.35],0.7533276672811836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6AP2,Renin receptor,23083,148,0.90 [0.61-1.33],0.6105835762100016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1D,V-type proton ATPase subunit D,23526,149,1.50 [0.99-2.27],0.0577718004069712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1F,V-type proton ATPase subunit F,23086,148,1.29 [1.06-1.58],0.0129637570417839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1G1,V-type proton ATPase subunit G 1,19922,125,1.18 [0.93-1.48],0.1659049153649129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATP6V1G2,V-type proton ATPase subunit G 2,19790,124,0.97 [0.80-1.17],0.7426908453682903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATRAID,All-trans retinoic acid-induced differentiation factor,20422,129,1.37 [0.91-2.08],0.1338567686593751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATRN,"Attractin, Isoform 2",20510,132,1.01 [0.37-2.76],0.9799979711297532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN10,Ataxin-10,23119,148,1.11 [0.90-1.36],0.3271137360947205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN2,Ataxin-2,19830,123,0.97 [0.81-1.15],0.6845907408913043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN2L,Ataxin-2-like protein,20447,131,1.21 [0.88-1.66],0.2403116226153487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ATXN3,Ataxin-3,20438,131,1.45 [1.12-1.87],0.0042829845021685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AXIN1,Axin-1,23613,149,1.04 [0.90-1.21],0.5952463176951412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AXL,Tyrosine-protein kinase receptor UFO,23752,148,1.48 [0.88-2.51],0.1391756720747513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AZI2,5-azacytidine-induced protein 2,20447,131,1.00 [0.74-1.35],0.998459592299002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,AZU1,Azurocidin,22975,142,1.21 [1.02-1.42],0.0259369854656495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B2M,Beta-2-microglobulin,20510,132,1.04 [0.61-1.76],0.8873815965486896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19790,124,2.34 [1.27-4.33],0.0066081022022412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19922,125,1.27 [0.79-2.03],0.3181715933709221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B4GALT1,"Beta-1,4-galactosyltransferase 1",23725,148,1.23 [0.73-2.08],0.4344639311911951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,B4GAT1,"Beta-1,4-glucuronyltransferase 1",23652,147,0.90 [0.49-1.63],0.7179276066088158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BABAM1,BRISC and BRCA1-A complex member 1,19884,122,1.18 [0.67-2.07],0.569425256529876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BACH1,Transcription regulator protein BACH1,23613,149,1.12 [0.92-1.36],0.2574721915399335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAG3,BAG family molecular chaperone regulator 3,23393,149,0.78 [0.56-1.08],0.1314686572457085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAG4,BAG family molecular chaperone regulator 4,19884,122,1.19 [0.86-1.65],0.2909938936881321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAG6,Large proline-rich protein BAG6,23208,146,1.20 [0.81-1.79],0.3597642245572691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23083,148,1.10 [0.88-1.37],0.4049166574160235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAMBI,BMP and activin membrane-bound inhibitor homolog,23083,148,1.48 [0.93-2.35],0.095903141516735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BANK1,B-cell scaffold protein with ankyrin repeats,23613,149,1.10 [0.96-1.26],0.1833562254582727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAP18,Chromatin complexes subunit BAP18,20438,131,1.16 [0.94-1.42],0.1595914281861558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BATF,Basic leucine zipper transcriptional factor ATF-like,19939,127,0.89 [0.71-1.13],0.3528268650128843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BAX,Apoptosis regulator BAX,23077,146,1.18 [1.01-1.38],0.0425103920657606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAM,Basal cell adhesion molecule,23652,147,1.38 [0.77-2.47],0.2788847731985724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAN,Brevican core protein,23436,150,0.75 [0.50-1.14],0.1802528998904138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20484,132,1.37 [0.83-2.27],0.2230731296722835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19830,123,1.17 [0.88-1.55],0.2731541374557853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCHE,Cholinesterase,20131,125,0.84 [0.44-1.59],0.5867278519951866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2,Apoptosis regulator Bcl-2,20422,129,1.07 [0.80-1.43],0.6313748399099828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2L1,Bcl-2-like protein 1,20438,131,1.17 [0.99-1.38],0.0727013894622338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",23613,149,1.29 [0.89-1.86],0.1779375141847645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL2L15,Bcl-2-like protein 15,19884,122,1.11 [0.84-1.47],0.4525911164822961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19767,126,0.88 [0.66-1.18],0.4008778234820637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCL7B,B-cell CLL/lymphoma 7 protein family member B,20415,129,0.97 [0.67-1.40],0.8726095672267988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BCR,Breakpoint cluster region protein,23613,149,1.10 [0.94-1.29],0.228436862569852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BDNF,Brain-derived neurotrophic factor,20492,132,1.14 [0.93-1.39],0.2148656293525851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BECN1,Beclin-1,19922,125,1.21 [0.91-1.60],0.1819489952707888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BEX3,Protein BEX3,19767,126,0.76 [0.50-1.18],0.2254909866549027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BGLAP,Osteocalcin,20492,132,0.74 [0.61-0.90],0.0020619776881274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BGN,Biglycan,23047,148,0.94 [0.82-1.06],0.2995229992675815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BHLHE40,Class E basic helix-loop-helix protein 40,19830,123,1.01 [0.79-1.29],0.9475638144371124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19790,124,1.41 [0.73-2.71],0.3079932272120056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BID,BH3-interacting domain death agonist,23613,149,1.03 [0.84-1.28],0.7564109623394384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BIN2,Bridging integrator 2,23652,147,1.08 [0.92-1.27],0.323527248695594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BIRC2,Baculoviral IAP repeat-containing protein 2,23083,148,1.26 [1.01-1.57],0.0426881846371825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLMH,Bleomycin hydrolase,23938,149,1.39 [0.89-2.18],0.1507389024502935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLNK,B-cell linker protein,19884,122,0.97 [0.62-1.50],0.8770532768290167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19830,123,0.87 [0.67-1.12],0.2793547455092545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,20438,131,1.18 [0.79-1.75],0.4244627716236261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BLVRB,Flavin reductase,23652,147,1.23 [1.00-1.51],0.0477554135968737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMP10,Bone morphogenetic protein 10,20023,132,1.74 [0.96-3.15],0.0671445483526617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMP4,Bone morphogenetic protein 4,23393,149,0.76 [0.55-1.05],0.097666946098263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMP6,Bone morphogenetic protein 6,23171,145,0.75 [0.52-1.08],0.1251535476497717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BMPER,BMP-binding endothelial regulator protein,20023,132,1.14 [0.55-2.38],0.724242176067931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20484,132,1.48 [0.97-2.27],0.0684973957868361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19884,122,1.21 [0.83-1.76],0.3210187115633149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BOC,Brother of CDO,23208,146,0.92 [0.49-1.75],0.8073572865911558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BOLA1,BolA-like protein 1,19830,123,1.02 [0.74-1.41],0.9165078203192178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BOLA2_BOLA2B,BolA-like protein 2,19922,125,1.38 [1.00-1.91],0.0496792671333216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BPIFA2,BPI fold-containing family A member 2,19251,120,1.08 [0.92-1.27],0.3222246354320212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BPIFB1,BPI fold-containing family B member 1,23602,146,0.97 [0.77-1.22],0.7870631027245527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BPIFB2,BPI fold-containing family B member 2,20447,132,1.06 [0.82-1.38],0.6528812727389023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRAP,BRCA1-associated protein,20222,129,1.08 [0.93-1.27],0.3179796869122788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRD1,Bromodomain-containing protein 1,20126,125,1.23 [0.72-2.11],0.4560461510863179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRD2,Bromodomain-containing protein 2,19830,123,1.07 [0.66-1.74],0.7785265009544303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRD3,Bromodomain-containing protein 3,19790,124,0.92 [0.62-1.35],0.6678123852079768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRDT,Bromodomain testis-specific protein,19790,124,1.01 [0.63-1.62],0.9552947302010174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRK1,Protein BRICK1,23119,148,1.18 [0.85-1.62],0.3223793002021921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRME1,Break repair meiotic recombinase recruitment factor 1,19830,123,0.97 [0.63-1.52],0.9104333488027896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BRSK2,Serine/threonine-protein kinase BRSK2,20447,131,0.80 [0.50-1.30],0.3738160916997489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BSG,Basigin,23878,149,1.21 [0.59-2.49],0.5995755694509393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BSND,Barttin,19767,126,0.77 [0.44-1.36],0.3745288276833934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23855,150,0.78 [0.61-1.00],0.0499198795805387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BST2,Bone marrow stromal antigen 2,23855,150,1.08 [0.81-1.43],0.6107321054824963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTC,Probetacellulin,23083,148,1.07 [0.89-1.30],0.4691016852272954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTD,Biotinidase,20510,132,1.28 [0.56-2.93],0.5579960326015414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTLA,B- and T-lymphocyte attenuator,19767,126,1.07 [0.90-1.27],0.4706498837587571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTN1A1,Butyrophilin subfamily 1 member A1,20376,129,1.11 [0.74-1.66],0.6219323995560513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTN2A1,Butyrophilin subfamily 2 member A1,23725,148,1.18 [0.69-2.02],0.5408881470156438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTN3A2,Butyrophilin subfamily 3 member A2,23613,149,1.47 [1.03-2.09],0.0325790951906907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,BTNL10,Butyrophilin-like protein 10,19767,126,0.86 [0.53-1.38],0.5264788333726674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C19orf12,Protein C19orf12,23119,148,0.95 [0.75-1.20],0.6496640719431679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1GALT1C1,C1GALT1-specific chaperone 1,19790,124,1.08 [0.64-1.80],0.7830152842973909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QA,Complement C1q subcomponent subunit A,23805,149,1.08 [0.56-2.08],0.8083923430310493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",20447,131,0.94 [0.72-1.22],0.6234235398058794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QL2,Complement C1q-like protein 2,19884,122,1.05 [0.70-1.56],0.8257597503862492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23752,148,1.23 [0.89-1.72],0.2122650017061133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20023,132,1.01 [0.64-1.61],0.9523632662599024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,20447,131,0.94 [0.54-1.61],0.8171401238680741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19992,132,0.91 [0.65-1.26],0.5576682032917415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1R,Complement C1r subcomponent,20510,132,0.88 [0.35-2.26],0.7958189213130745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1RL,Complement C1r subcomponent-like protein,20470,132,0.67 [0.29-1.53],0.3401811084142945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C1S,Complement C1s subcomponent,20510,132,1.00 [0.45-2.22],0.9978936567665384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C2,Complement C2,23717,148,1.21 [0.61-2.41],0.5802112694279749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C2CD2L,Phospholipid transfer protein C2CD2L,23086,148,1.11 [0.79-1.56],0.5420364779390789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C2orf69,UPF0565 protein C2orf69,19939,127,1.15 [0.90-1.47],0.26764365103658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C3,Complement C3,19466,123,0.84 [0.55-1.29],0.421556118262384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C4BPB,C4b-binding protein beta chain,23701,148,1.20 [0.82-1.76],0.3374307495519202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C5,Complement C5,20510,132,0.72 [0.23-2.28],0.5803508671388102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C7,Complement component C7,20018,130,1.55 [0.90-2.66],0.1121885895409367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C7orf50,Uncharacterized protein C7orf50,20438,131,1.11 [0.59-2.09],0.7563902035972015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C8B,Complement component C8 beta chain,20510,132,1.48 [0.85-2.57],0.1660882936732414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C9,Complement component C9,20513,128,0.80 [0.60-1.07],0.1349019328782545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,C9orf40,Uncharacterized protein C9orf40,20422,129,1.26 [1.03-1.55],0.0242735871742807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA1,Carbonic anhydrase 1,23150,144,1.24 [0.96-1.59],0.1030846988066394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA11,Carbonic anhydrase-related protein 11,23083,148,1.23 [0.83-1.83],0.2952114264580374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA12,Carbonic anhydrase 12,23526,149,1.83 [1.25-2.69],0.0019912171579272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA13,Carbonic anhydrase 13,23365,149,1.12 [0.98-1.30],0.1056052507685197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA14,Carbonic anhydrase 14,23846,151,0.74 [0.50-1.10],0.1395354112291512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA2,Carbonic anhydrase 2,23573,147,1.24 [1.01-1.52],0.043093162285294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA3,Carbonic anhydrase 3,23905,149,1.30 [1.03-1.63],0.0248660792692639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA4,Carbonic anhydrase 4,23938,149,1.69 [0.94-3.05],0.0808442690508393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA5A,"Carbonic anhydrase 5A, mitochondrial",23208,146,0.99 [0.84-1.17],0.9206151383910296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA6,Carbonic anhydrase 6,23580,146,0.93 [0.73-1.17],0.5294288177405253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA7,Carbonic anhydrase 7,20126,125,1.24 [0.79-1.95],0.3512304400720216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA8,Carbonic anhydrase-related protein,19884,122,0.80 [0.38-1.72],0.5738581067582187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CA9,Carbonic anhydrase 9,23846,151,1.38 [1.04-1.83],0.0270422890265522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CABP2,Calcium-binding protein 2,19939,127,1.21 [0.96-1.53],0.1130266513839907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19830,123,1.20 [0.72-1.99],0.4775749896777618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19790,124,1.13 [0.87-1.47],0.3458183923659618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19830,123,0.89 [0.65-1.21],0.4626747462918638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,20447,131,1.12 [0.92-1.36],0.2675046282587194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CACYBP,Calcyclin-binding protein,19991,132,1.15 [0.98-1.36],0.0903988548680609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CADPS,Calcium-dependent secretion activator 1,19939,127,0.69 [0.42-1.14],0.1508627991597619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALB1,Calbindin,23526,149,0.99 [0.71-1.36],0.9325126675845554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALB2,Calretinin,23119,148,0.80 [0.47-1.36],0.4096991084941286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCA,Calcitonin,23403,150,1.13 [0.93-1.39],0.2239175846677733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCB,Calcitonin gene-related peptide 2,20438,131,1.00 [0.65-1.53],0.9844408555694024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23775,151,0.98 [0.86-1.13],0.8264410272620306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19922,125,1.12 [0.89-1.40],0.3403289498356114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CALY,Neuron-specific vesicular protein calcyon,19790,124,1.08 [0.71-1.66],0.7191750058949269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23083,148,0.99 [0.72-1.38],0.9685851613921836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19939,127,0.90 [0.64-1.26],0.5307345189142858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,20447,131,0.99 [0.85-1.16],0.9029171612395164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CANT1,Soluble calcium-activated nucleotidase 1,23560,150,1.86 [0.91-3.78],0.087285853847249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAPG,Macrophage-capping protein,23475,151,0.99 [0.78-1.27],0.951287063403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAPN3,Calpain-3,20415,129,0.70 [0.42-1.16],0.1680398641129725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAPS,Calcyphosin,20438,131,0.95 [0.78-1.14],0.5632617334208292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CARHSP1,Calcium-regulated heat-stable protein 1,23119,148,1.14 [0.86-1.50],0.3514035833526013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASC3,Protein CASC3,19939,127,1.37 [0.95-1.98],0.0967075668628886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP1,Caspase-1,23119,148,1.04 [0.85-1.28],0.6979210908063063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP10,Caspase-10,23119,148,1.22 [1.00-1.49],0.0507288598972287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP2,Caspase-2,23613,149,1.14 [0.93-1.41],0.2093168561142506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP3,Caspase-3,23938,149,1.18 [1.00-1.39],0.0503132492758379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP4,Caspase-4,20126,125,0.99 [0.89-1.10],0.808981237704428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP7,Caspase-7,20438,131,1.15 [0.94-1.40],0.1636791701721522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP8,Caspase-8,23782,151,1.20 [0.97-1.50],0.0944163664645739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASP9,Caspase-9,19884,122,1.26 [0.98-1.62],0.0755134761138404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CASQ2,Calsequestrin-2,19790,124,0.88 [0.58-1.32],0.5256885366242255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CAT,Catalase,20216,127,1.32 [0.98-1.78],0.0637437797499642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBLIF,Cobalamin binding intrinsic factor,23609,150,1.20 [0.99-1.45],0.063771890003794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBLN1,Cerebellin-1,19830,123,0.76 [0.58-0.98],0.0349000947440529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBLN4,Cerebellin-4,23846,151,0.78 [0.49-1.23],0.2819292871141559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBS,Cystathionine beta-synthase,19922,125,0.78 [0.53-1.13],0.1870594514471007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CBX2,Chromobox protein homolog 2,19790,124,0.84 [0.51-1.39],0.502412541784941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,23436,150,1.17 [0.96-1.41],0.1137039803703911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCAR2,Cell cycle and apoptosis regulator protein 2,20438,131,0.93 [0.66-1.30],0.6714216195848988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC134,Coiled-coil domain-containing protein 134,20415,129,1.33 [0.97-1.83],0.0742500030066812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC28A,Coiled-coil domain-containing protein 28A,19939,127,0.70 [0.39-1.24],0.2236331026459401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC50,Coiled-coil domain-containing protein 50,20447,131,1.08 [0.88-1.33],0.4665661480553681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCDC80,Coiled-coil domain-containing protein 80,23640,150,0.93 [0.61-1.41],0.738730944605637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19922,125,0.89 [0.67-1.18],0.4022352898517768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL11,Eotaxin,23917,149,1.03 [0.70-1.51],0.8833138048315361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL13,C-C motif chemokine 13,23883,149,1.26 [1.03-1.55],0.0265337488608819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL14,C-C motif chemokine 14,23602,148,1.30 [0.94-1.81],0.1115707272325583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL15,C-C motif chemokine 15,23938,149,1.23 [0.89-1.68],0.209855127142239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL16,C-C motif chemokine 16,23938,149,0.97 [0.74-1.28],0.8520855799925031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL17,C-C motif chemokine 17,23565,148,1.07 [0.92-1.25],0.3917893251717763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL18,C-C motif chemokine 18,23345,148,1.08 [0.89-1.32],0.4160911526563892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL19,C-C motif chemokine 19,23855,150,0.96 [0.84-1.09],0.519739751270262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL2,C-C motif chemokine 2,23393,149,1.20 [0.92-1.57],0.1820849918054602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL20,C-C motif chemokine 20,23917,149,1.11 [0.95-1.30],0.1760368684802636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL21,C-C motif chemokine 21,23725,148,1.09 [0.76-1.58],0.6302706317519098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL22,C-C motif chemokine 22,23371,146,1.08 [0.81-1.42],0.6105735895272615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL23,C-C motif chemokine 23,23725,148,1.04 [0.73-1.46],0.8425634813982619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL24,C-C motif chemokine 24,23689,148,0.91 [0.76-1.08],0.2858420523912174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL25,C-C motif chemokine 25,23917,149,0.97 [0.72-1.31],0.8524505147003396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL26,C-C motif chemokine 26,23613,149,1.07 [0.92-1.23],0.3919388262058363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL27,C-C motif chemokine 27,23640,150,0.82 [0.65-1.03],0.0922984502592775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL28,C-C motif chemokine 28,23532,147,1.12 [0.88-1.43],0.3440983607954165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL3,C-C motif chemokine 3,23613,149,1.19 [1.00-1.41],0.0469891420460846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL4,C-C motif chemokine 4,23648,148,1.17 [0.97-1.42],0.109810548531111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL5,C-C motif chemokine 5,23752,148,1.09 [0.94-1.25],0.2421338338979947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL7,C-C motif chemokine 7,23613,149,1.16 [0.92-1.47],0.2078858185695858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCL8,C-C motif chemokine 8,23810,151,1.25 [0.98-1.59],0.0663256112432712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN1,CCN family member 1,23490,149,1.04 [0.85-1.27],0.7139603814085411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN2,CCN family member 2,23611,148,1.07 [0.83-1.38],0.6005566592268011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN3,CCN family member 3,23893,148,1.00 [0.64-1.55],0.9906104917769089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN4,CCN family member 4,23846,151,1.32 [0.93-1.87],0.1247291084402618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCN5,CCN family member 5,23652,147,1.04 [0.71-1.53],0.83669522979346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCND2,G1/S-specific cyclin-D2,20126,125,0.92 [0.58-1.44],0.7017723429987148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCNE1,G1/S-specific cyclin-E1,19884,122,0.87 [0.69-1.11],0.2657406525830612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCS,Copper chaperone for superoxide dismutase,23436,150,1.47 [1.09-1.97],0.0107826441232013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CCT5,T-complex protein 1 subunit epsilon,23083,148,1.22 [0.90-1.64],0.2002653899901208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD101,Immunoglobulin superfamily member 2,20422,129,1.09 [0.73-1.61],0.6791566655035266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD109,CD109 antigen,23652,147,1.23 [0.79-1.91],0.357302605997687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD14,Monocyte differentiation antigen CD14,23202,145,1.44 [1.02-2.05],0.0404368957848267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD160,CD160 antigen,23917,149,1.17 [0.87-1.57],0.3065329673160006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD163,Scavenger receptor cysteine-rich type 1 protein M130,23752,148,1.12 [0.80-1.57],0.4955101380114662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD164,Sialomucin core protein 24,23652,147,1.40 [0.95-2.06],0.0920472560536828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD164L2,CD164 sialomucin-like 2 protein,19939,127,0.79 [0.49-1.30],0.3564708114326724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD177,CD177 antigen,23610,147,0.96 [0.86-1.07],0.4632459162101171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD1C,T-cell surface glycoprotein CD1c,23701,148,0.76 [0.42-1.36],0.3544980076407689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD2,T-cell surface antigen CD2,19790,124,0.74 [0.44-1.25],0.2647530528500174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD200,OX-2 membrane glycoprotein,23613,149,1.25 [0.75-2.10],0.393291727059443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD200R1,Cell surface glycoprotein CD200 receptor 1,23533,149,1.08 [0.72-1.62],0.712511087205411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD207,C-type lectin domain family 4 member K,23106,148,1.14 [0.78-1.66],0.4870604060816149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD209,CD209 antigen,23707,146,0.96 [0.66-1.40],0.8183174806984022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD22,B-cell receptor CD22,23917,149,1.33 [0.97-1.84],0.0769912653044021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD226,CD226 antigen,19884,122,1.24 [0.83-1.87],0.2945465872310665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD244,Natural killer cell receptor 2B4,23917,149,1.47 [0.88-2.45],0.1373692023768865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD248,Endosialin,20492,132,0.71 [0.47-1.07],0.0983959366154105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD27,CD27 antigen,23701,148,1.28 [0.91-1.78],0.1556482050333322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD274,Programmed cell death 1 ligand 1,23436,150,1.36 [0.91-2.04],0.1323845008221516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD276,CD276 antigen,23606,148,1.06 [0.70-1.60],0.7873206240968598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD28,T-cell-specific surface glycoprotein CD28,23083,148,1.24 [0.85-1.81],0.2669947293148657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD2AP,CD2-associated protein,23640,150,1.23 [0.98-1.53],0.0711959009957101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300A,CMRF35-like molecule 8,20023,132,1.49 [0.87-2.55],0.1489620092895155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300C,CMRF35-like molecule 6,23855,150,1.32 [0.89-1.97],0.1720617485647325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300E,CMRF35-like molecule 2,23782,151,1.26 [0.90-1.76],0.1871297632385771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300LF,CMRF35-like molecule 1,23846,151,1.03 [0.82-1.31],0.7763965496571743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD300LG,CMRF35-like molecule 9,23652,147,1.28 [0.87-1.89],0.2143146722230504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD302,CD302 antigen,23526,149,1.31 [0.83-2.07],0.2482691669984799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD33,Myeloid cell surface antigen CD33,23701,148,0.91 [0.76-1.08],0.2826394395589414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD34,Hematopoietic progenitor cell antigen CD34,23783,150,1.14 [0.63-2.08],0.6622203658485798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD36,Platelet glycoprotein 4,19884,122,1.28 [0.89-1.84],0.1907402039190173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,23526,149,0.80 [0.51-1.25],0.3235491153515863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD3D,T-cell surface glycoprotein CD3 delta chain,19830,123,0.86 [0.50-1.49],0.5957052312995849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD3E,T-cell surface glycoprotein CD3 epsilon chain,20126,125,1.29 [0.89-1.86],0.1731490055885083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD3G,T-cell surface glycoprotein CD3 gamma chain,19884,122,1.05 [0.87-1.26],0.6086864133508583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD4,T-cell surface glycoprotein CD4,23575,147,1.01 [0.61-1.67],0.967718832012066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD40,Tumor necrosis factor receptor superfamily member 5,23612,148,1.31 [0.99-1.73],0.0547365208650696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD40LG,CD40 ligand,23917,149,1.21 [1.01-1.45],0.0413779327233428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD46,Membrane cofactor protein,23530,147,1.71 [1.07-2.73],0.0257234041887639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD48,CD48 antigen,23689,148,1.55 [0.97-2.47],0.0685683395796714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD5,T-cell surface glycoprotein CD5,23810,151,1.44 [1.00-2.07],0.047224252369331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD55,Complement decay-accelerating factor,22835,139,1.73 [1.04-2.88],0.0340423192261453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD58,Lymphocyte function-associated antigen 3,23561,148,1.03 [0.45-2.37],0.9367211699071591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD59,CD59 glycoprotein,22815,143,1.09 [0.57-2.08],0.8054553266022308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD5L,CD5 antigen-like,20407,132,1.09 [0.77-1.54],0.626535658817029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD6,T-cell differentiation antigen CD6,23878,149,0.96 [0.73-1.26],0.7618171958668606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD63,CD63 antigen,23393,149,1.38 [1.03-1.84],0.0315667878805635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD69,Early activation antigen CD69,23520,149,1.10 [0.93-1.30],0.267887829379157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD7,T-cell antigen CD7,19850,122,1.28 [0.88-1.86],0.2020662899420283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD70,CD70 antigen,23613,149,0.98 [0.71-1.37],0.9216649942118966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD72,B-cell differentiation antigen CD72,20023,132,1.15 [0.78-1.69],0.4918140991800434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD74,HLA class II histocompatibility antigen gamma chain,23855,150,1.25 [0.83-1.89],0.2850267212471131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD79B,B-cell antigen receptor complex-associated protein beta chain,23917,149,1.25 [0.92-1.70],0.1462823929779584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD80,T-lymphocyte activation antigen CD80,20484,132,1.50 [0.94-2.39],0.0878454434744488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD82,CD82 antigen,20126,125,0.89 [0.56-1.41],0.6277390537650658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD83,CD83 antigen,23613,149,1.22 [0.79-1.86],0.3671245456324598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD84,SLAM family member 5,23613,149,1.54 [0.98-2.42],0.0633389293670995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD86,T-lymphocyte activation antigen CD86,20422,129,1.60 [0.91-2.79],0.1001951065818623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD8A,T-cell surface glycoprotein CD8 alpha chain,23855,150,1.01 [0.76-1.34],0.9517634226001276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD93,Complement component C1q receptor,22774,141,1.19 [0.74-1.94],0.4709122022417118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD99,CD99 antigen,23652,147,1.12 [0.53-2.34],0.7682882659089099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CD99L2,CD99 antigen-like protein 2,23652,147,1.09 [0.60-1.98],0.7788130710545929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDA,Cytidine deaminase,20448,132,1.04 [0.74-1.46],0.8354353428265017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDAN1,Codanin-1,20438,131,0.90 [0.42-1.93],0.7962489465191261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC123,Cell division cycle protein 123 homolog,19767,126,1.13 [0.89-1.44],0.3157392584434023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC25A,M-phase inducer phosphatase 1,19767,126,0.66 [0.41-1.09],0.1050715443146962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC26,Anaphase-promoting complex subunit CDC26,20378,129,1.17 [0.93-1.49],0.1859091459237827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC27,Cell division cycle protein 27 homolog,23083,148,1.20 [0.96-1.50],0.1169123347622565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC37,Hsp90 co-chaperone Cdc37,23701,148,1.20 [1.01-1.42],0.0390559591431456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDC42BPB,Serine/threonine-protein kinase MRCK beta,20422,129,1.02 [0.86-1.20],0.836213530833831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDCP1,CUB domain-containing protein 1,23436,150,0.93 [0.71-1.22],0.6011126014675536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH1,Cadherin-1,22874,141,1.16 [0.82-1.65],0.4054479503041704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH15,Cadherin-15,23822,150,1.06 [0.87-1.29],0.5835207808581842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH17,Cadherin-17,23640,150,1.15 [0.94-1.40],0.1850980839143846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH2,Cadherin-2,23640,150,1.24 [0.82-1.86],0.3027637919029326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH22,Cadherin-22,20126,125,0.91 [0.48-1.71],0.7649332660885273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH23,Cadherin-23,20438,131,1.16 [0.62-2.15],0.6428425395639283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH3,Cadherin-3,23855,150,1.04 [0.70-1.55],0.8544562423379368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH4,Cadherin-4,19830,123,1.09 [0.76-1.56],0.6330794490216167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH5,Cadherin-5,23938,149,1.29 [0.81-2.07],0.282094204201531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDH6,Cadherin-6,23640,150,1.14 [0.78-1.67],0.4868233985248357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDHR1,Cadherin-related family member 1,23119,148,0.87 [0.61-1.25],0.4561927143562236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDHR2,Cadherin-related family member 2,23526,149,0.89 [0.71-1.11],0.3112620497104016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDHR5,Cadherin-related family member 5,23640,150,0.78 [0.54-1.11],0.1651857188838739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDK1,Cyclin-dependent kinase 1,19767,126,0.88 [0.55-1.41],0.5925899961744772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,20447,131,1.10 [0.84-1.43],0.4939133926474676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDKL5,Cyclin-dependent kinase-like 5,19830,123,1.01 [0.73-1.41],0.9354525856557504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDKN1A,Cyclin-dependent kinase inhibitor 1,23526,149,1.06 [0.93-1.22],0.3840289878613804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,23526,149,1.17 [1.00-1.38],0.0522928295445934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDNF,Cerebral dopamine neurotrophic factor,23526,149,0.98 [0.63-1.53],0.9343484201701592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23642,148,0.78 [0.44-1.37],0.3900955509880253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CDSN,Corneodesmosin,23848,149,0.70 [0.50-0.97],0.0342584537527236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,23666,148,1.03 [0.55-1.94],0.9193443331112306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20422,129,1.18 [0.96-1.44],0.1227774747553825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20126,125,0.80 [0.58-1.09],0.152770407385692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,20422,129,0.73 [0.48-1.11],0.1389593449701435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20126,125,1.39 [1.02-1.89],0.0381056525103528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,23613,149,1.04 [0.88-1.23],0.6362897614232388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23083,148,1.03 [0.76-1.39],0.872153653185366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22794,144,1.14 [0.90-1.46],0.2696259246100142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20492,132,1.10 [0.73-1.65],0.6434354451211863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,23208,146,1.17 [0.88-1.55],0.2897950801410536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEBPA,CCAAT/enhancer-binding protein alpha,19884,122,0.71 [0.39-1.29],0.2593726309818733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEBPB,CCAAT/enhancer-binding protein beta,23208,146,1.09 [0.75-1.58],0.6594631543527827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CELA2A,Chymotrypsin-like elastase family member 2A,20492,132,0.97 [0.75-1.26],0.8188601960889673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CELA3A,Chymotrypsin-like elastase family member 3A,23901,149,1.02 [0.80-1.30],0.8807640252761711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20023,132,0.85 [0.48-1.52],0.592286023432503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEMIP2,Cell surface hyaluronidase,19884,122,1.25 [0.79-1.99],0.3402267428325695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEND1,Cell cycle exit and neuronal differentiation protein 1,19830,123,0.89 [0.64-1.23],0.4751409842251656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CENPF,Centromere protein F,20126,125,1.24 [0.93-1.65],0.1401481525762564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CENPJ,Centromere protein J,20126,125,1.05 [0.83-1.34],0.6702840941192809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP112,Centrosomal protein of 112 kDa,19790,124,1.13 [0.81-1.58],0.4837856013812476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP152,Centrosomal protein of 152 kDa,19767,126,0.92 [0.61-1.40],0.6943944581677907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP164,Centrosomal protein of 164 kDa,23231,145,0.89 [0.68-1.17],0.4070363708232879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP170,Centrosomal protein of 170 kDa,19922,125,1.02 [0.82-1.28],0.842812957588677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP20,Centrosomal protein 20,23083,148,1.13 [0.94-1.37],0.1960338988772234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP290,Centrosomal protein of 290 kDa,20126,125,0.97 [0.69-1.36],0.8583139000921206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP350,Centrosome-associated protein 350,19767,126,1.23 [0.80-1.88],0.3459854415360067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP43,Centrosomal protein 43,23027,146,1.34 [1.10-1.64],0.0042595754318545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CEP85,Centrosomal protein of 85 kDa,23083,148,0.99 [0.79-1.24],0.9194944127154876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CERT,Ceramide transfer protein,23119,148,1.23 [0.97-1.56],0.0898654182972101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CES1,Liver carboxylesterase 1,23709,146,0.98 [0.82-1.16],0.8044039926512124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CES2,Cocaine esterase,23526,149,1.01 [0.78-1.31],0.9279476597760916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CES3,Carboxylesterase 3,23526,149,0.86 [0.69-1.08],0.1885078459218551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CETN2,Centrin-2,23119,148,1.07 [0.87-1.32],0.5209409308515771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CETN3,Centrin-3,20422,129,1.15 [0.93-1.42],0.2018729276900717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFB,Complement factor B,20156,130,1.00 [0.60-1.69],0.9866533397433384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFC1,Cryptic protein,23083,148,0.84 [0.61-1.18],0.3169522327718818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFD,Complement factor D,20510,132,0.72 [0.30-1.70],0.4532403829215832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFH,Complement factor H,19335,124,0.99 [0.46-2.10],0.9736772096620596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFHR2,Complement factor H-related protein 2,20365,132,1.28 [0.93-1.76],0.1250442288822533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFHR4,Complement factor H-related protein 4,20468,132,1.11 [0.87-1.40],0.3950095875392657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFHR5,Complement factor H-related protein 5,20253,125,1.14 [0.75-1.75],0.5343462104083815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFI,Complement factor I,20510,132,1.05 [0.45-2.47],0.908095976207246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CFP,Properdin,20510,132,0.91 [0.42-1.98],0.8131538721096407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGA,Glycoprotein hormones alpha chain,23652,147,1.00 [0.79-1.27],0.9933027568211904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20513,128,1.01 [0.64-1.60],0.9523789901497328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGN,Cingulin,19939,127,0.95 [0.59-1.50],0.8122395605195798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CGREF1,Cell growth regulator with EF hand domain protein 1,23640,150,1.08 [0.77-1.51],0.6437855796003663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23083,148,1.19 [0.94-1.51],0.1396361535381648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHAD,Chondroadherin,20023,132,0.60 [0.42-0.85],0.0039974935398065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20438,131,1.14 [0.77-1.69],0.5141622300589129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHCHD6,MICOS complex subunit MIC25,20415,129,1.10 [0.61-1.98],0.76298872150086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHEK2,Serine/threonine-protein kinase Chk2,23208,146,0.89 [0.56-1.41],0.6179916142363784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHGA,Chromogranin-A,20492,132,1.06 [0.88-1.28],0.5601712790823883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHGB,Secretogranin-1,23790,150,1.04 [0.74-1.47],0.8214603738667728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHI3L1,Chitinase-3-like protein 1,23148,145,1.09 [0.92-1.30],0.3031532488513863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHIT1,Chitotriosidase-1,23749,148,0.94 [0.87-1.01],0.1073877274624321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHL1,Neural cell adhesion molecule L1-like protein,23714,148,1.05 [0.64-1.70],0.85655303416513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHM,Rab proteins geranylgeranyltransferase component A 1,19939,127,1.24 [0.95-1.62],0.1053748671731636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHMP1A,Charged multivesicular body protein 1a,23436,150,1.26 [1.05-1.52],0.0142410713539383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHMP6,Charged multivesicular body protein 6,20484,132,1.24 [0.93-1.66],0.1412075514705491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHP1,Calcineurin B homologous protein 1,19830,123,0.84 [0.64-1.09],0.1871858968961868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHRDL1,Chordin-like protein 1,23689,148,1.07 [0.68-1.68],0.7784460060687406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHRDL2,Chordin-like protein 2,23640,150,0.78 [0.57-1.06],0.114087150395267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CHRM1,Muscarinic acetylcholine receptor M1,19939,127,1.02 [0.64-1.62],0.9240850396702508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CIAPIN1,Anamorsin,23701,148,1.25 [0.99-1.58],0.0611832716353216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CILP,Cartilage intermediate layer protein 1,20492,132,0.94 [0.70-1.28],0.7145675478334388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CINP,Cyclin-dependent kinase 2-interacting protein,20126,125,0.71 [0.45-1.14],0.1545635118958372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CIRBP,Cold-inducible RNA-binding protein,20422,129,1.16 [0.97-1.38],0.1036008405276732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CIT,Citron Rho-interacting kinase,19939,127,1.20 [0.85-1.68],0.3045034613103194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CKAP4,Cytoskeleton-associated protein 4,23801,148,1.02 [0.60-1.72],0.9475026436623614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CKB,Creatine kinase B-type,20492,132,1.34 [1.00-1.79],0.0494913389470834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",23531,148,1.05 [0.83-1.32],0.6928625539089136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLASP1,CLIP-associating protein 1,19767,126,0.97 [0.76-1.23],0.7910758269353129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLC,Galectin-10,23603,150,1.18 [0.97-1.44],0.0986282691660335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC10A,C-type lectin domain family 10 member A,23436,150,1.15 [0.77-1.71],0.492242801952499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC11A,C-type lectin domain family 11 member A,23619,147,1.07 [0.79-1.45],0.6563489686759107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC12A,C-type lectin domain family 12 member A,19884,122,1.14 [0.49-2.67],0.7633345593639471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC14A,C-type lectin domain family 14 member A,23652,147,1.30 [0.83-2.04],0.2565886336697205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC1A,C-type lectin domain family 1 member A,23208,146,0.93 [0.60-1.44],0.7403855867002701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC1B,C-type lectin domain family 1 member B,23855,150,1.09 [0.94-1.26],0.2762357376889825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC2L,C-type lectin domain family 2 member L,19939,127,1.01 [0.73-1.41],0.9486097131172966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC3B,Tetranectin,20049,129,1.08 [0.50-2.35],0.8439888237330126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4A,C-type lectin domain family 4 member A,23613,149,1.15 [0.77-1.74],0.4951388316108098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4C,C-type lectin domain family 4 member C,23613,149,1.10 [0.82-1.48],0.512797065321833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4D,C-type lectin domain family 4 member D,23613,149,0.90 [0.71-1.14],0.3923621239463092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4G,C-type lectin domain family 4 member G,23613,149,1.06 [0.69-1.64],0.7803130970403991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC4M,C-type lectin domain family 4 member M,20462,132,0.91 [0.65-1.28],0.5781171571018672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC5A,C-type lectin domain family 5 member A,23562,149,1.53 [0.96-2.43],0.0718293803868684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC6A,C-type lectin domain family 6 member A,23083,148,1.03 [0.76-1.40],0.8369696364629191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLEC7A,C-type lectin domain family 7 member A,23917,149,1.16 [0.88-1.52],0.2914622573510675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLGN,Calmegin,19939,127,0.94 [0.64-1.38],0.7480563893831069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLIC5,Chloride intracellular channel protein 5,19939,127,1.08 [0.64-1.83],0.7747878552965558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLINT1,Clathrin interactor 1,19767,126,1.14 [0.83-1.56],0.4247531630742053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLIP2,CAP-Gly domain-containing linker protein 2,23613,149,1.06 [0.93-1.20],0.4133866311569898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLMP,CXADR-like membrane protein,23846,151,1.06 [0.55-2.02],0.8676390161125409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLNS1A,Methylosome subunit pICln,19939,127,1.32 [0.85-2.06],0.2189106321556582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",23403,150,1.17 [1.00-1.35],0.0430763316266022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLPS,Colipase,23608,147,0.93 [0.76-1.14],0.473405940495383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSPN,Claspin,23086,148,1.01 [0.68-1.51],0.9546222107461276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSTN1,Calsyntenin-1,23119,148,1.02 [0.77-1.35],0.909174307912543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSTN2,Calsyntenin-2,23917,149,0.76 [0.52-1.13],0.1823043434389576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLSTN3,Calsyntenin-3,20438,131,1.00 [0.57-1.75],0.9981906503631292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLTA,Clathrin light chain A,23208,146,1.15 [0.85-1.55],0.3660593884314459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLU,Clusterin,20510,132,0.88 [0.46-1.71],0.7132098682500125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CLUL1,Clusterin-like protein 1,23597,149,0.88 [0.64-1.22],0.452865963159324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CMC1,COX assembly mitochondrial protein homolog,20484,132,1.16 [0.97-1.39],0.0970474032328834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CMIP,C-Maf-inducing protein,20415,129,1.11 [0.91-1.36],0.2911519901835224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNDP1,Beta-Ala-His dipeptidase,23752,148,1.04 [0.76-1.44],0.7944891322102438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19830,123,1.29 [1.03-1.61],0.0286080808472935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19888,125,1.24 [1.00-1.53],0.0527405321243276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNPY2,Protein canopy homolog 2,23208,146,1.00 [0.79-1.28],0.9744652166008836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNPY4,Protein canopy homolog 4,23526,149,1.20 [0.99-1.46],0.0573902064529086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNST,Consortin,23640,150,1.05 [0.92-1.21],0.4359574140368174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTF,Ciliary neurotrophic factor,19830,123,1.04 [0.63-1.72],0.8739531299005266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN1,Contactin-1,23938,149,1.27 [0.74-2.19],0.38632131594205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN2,Contactin-2,23846,151,1.10 [0.80-1.52],0.5643143526329508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN3,Contactin-3,23652,147,1.02 [0.61-1.71],0.940652050302164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN4,Contactin-4,23652,147,1.28 [0.69-2.38],0.4367946192195808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTN5,Contactin-5,23704,150,0.78 [0.52-1.16],0.2259997638584083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTNAP2,Contactin-associated protein-like 2,23613,149,1.07 [0.76-1.50],0.7002960176574609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CNTNAP4,Contactin-associated protein-like 4,19939,127,0.99 [0.84-1.16],0.872344227848789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COCH,Cochlin,20484,132,1.06 [0.74-1.52],0.7605942633214775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL15A1,Collagen alpha-1(XV) chain,20492,132,0.48 [0.26-0.89],0.0187181517560992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL18A1,Collagen alpha-1(XVIII) chain,23745,148,1.25 [0.67-2.33],0.4803749930576099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL1A1,Collagen alpha-1(I) chain,23938,149,0.51 [0.27-0.96],0.0359583925349585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL24A1,Collagen alpha-1(XXIV) chain,20422,129,0.92 [0.69-1.22],0.5686665160810628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL28A1,Collagen alpha-1(XXVIII) chain,19939,127,1.00 [0.81-1.24],0.9873779525990304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL2A1,Collagen alpha-1(II) chain,19922,125,1.20 [0.97-1.48],0.0945406356860657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL3A1,Collagen alpha-1(III) chain,20492,132,0.49 [0.24-1.00],0.050370094003425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL4A1,Collagen alpha-1(IV) chain,23640,150,1.34 [0.93-1.94],0.1110346707702257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL4A4,Collagen alpha-4(IV) chain,20094,123,1.05 [0.76-1.47],0.7624818448680499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL5A1,Collagen alpha-1(V) chain,20023,132,1.27 [0.84-1.90],0.2537396925221667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL6A3,Collagen alpha-3(VI) chain,23938,149,1.05 [0.69-1.58],0.8305119455440415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL9A1,Collagen alpha-1(IX) chain,23613,149,0.86 [0.62-1.21],0.3999854389840568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COL9A2,Collagen alpha-2(IX) chain,20126,125,1.07 [0.73-1.56],0.7357483837401536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COLEC12,Collectin-12,23606,148,1.54 [0.91-2.61],0.1059483522452316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMMD1,COMM domain-containing protein 1,19922,125,1.11 [0.84-1.48],0.4489144471729142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMMD9,COMM domain-containing protein 9,20415,129,1.24 [0.86-1.80],0.2429901789951231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMP,Cartilage oligomeric matrix protein,23411,147,0.56 [0.36-0.88],0.0109779173960977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COMT,Catechol O-methyltransferase,22947,145,1.19 [0.99-1.42],0.0569988214532171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COPB2,Coatomer subunit beta',19790,124,1.42 [1.02-1.99],0.0397064828631911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COPE,Coatomer subunit epsilon,23119,148,1.18 [0.91-1.52],0.2201015804470728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19922,125,1.00 [0.67-1.50],0.9995327018226292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CORO1A,Coronin-1A,23193,139,1.09 [0.92-1.28],0.3180619992318251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CORO6,Coronin-6,19830,123,0.99 [0.63-1.57],0.9804409195895196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",23526,149,1.24 [1.02-1.51],0.031891514234683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,COX6B1,Cytochrome c oxidase subunit 6B1,20484,132,1.56 [0.97-2.51],0.066232576318711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPA1,Carboxypeptidase A1,23938,149,0.93 [0.74-1.17],0.5459535773090858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPA2,Carboxypeptidase A2,23786,150,0.90 [0.72-1.11],0.3218299745516701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPA4,Carboxypeptidase A4,19634,131,0.71 [0.49-1.03],0.0740480198114496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPB1,Carboxypeptidase B,23938,149,0.91 [0.72-1.15],0.4312800208209493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPB2,Carboxypeptidase B2,20477,132,0.87 [0.42-1.83],0.717759792801632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPE,Carboxypeptidase E,23652,149,0.67 [0.49-0.93],0.0166554952644238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPLX2,Complexin-2,19767,126,1.27 [0.81-1.99],0.2943082599954238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPM,Carboxypeptidase M,23737,150,0.73 [0.48-1.11],0.1417964332201318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19884,122,1.37 [0.78-2.41],0.2783007002499963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPPED1,Serine/threonine-protein phosphatase CPPED1,23855,150,1.47 [1.19-1.80],0.000270816504781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPQ,Carboxypeptidase Q,20458,132,1.09 [0.69-1.73],0.698004307326415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPTP,Ceramide-1-phosphate transfer protein,19790,124,1.44 [1.01-2.07],0.0461433520831029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPVL,Probable serine carboxypeptidase CPVL,23798,151,1.32 [0.92-1.89],0.1369749380463533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPXM1,Probable carboxypeptidase X1,23701,148,1.17 [0.95-1.44],0.1321062192359178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CPXM2,Inactive carboxypeptidase-like protein X2,20484,132,0.85 [0.43-1.65],0.6213614089162012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CR1,Complement receptor type 1,20438,128,1.18 [0.73-1.91],0.4953543992034946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CR2,Complement receptor type 2,23752,148,1.45 [1.07-1.96],0.0176438263332638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23083,148,0.97 [0.81-1.15],0.6956956146935125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRADD,Death domain-containing protein CRADD,23403,150,1.27 [1.04-1.54],0.0175670970081846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CREB3,Cyclic AMP-responsive element-binding protein 3,19767,126,1.02 [0.75-1.39],0.882817932893024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CREBZF,CREB/ATF bZIP transcription factor,19767,126,1.07 [0.55-2.05],0.8489586920621226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CREG1,Protein CREG1,23324,147,0.81 [0.56-1.18],0.2821458697515906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRELD1,Protein disulfide isomerase CRELD1,20023,132,1.05 [0.66-1.65],0.8392008948622269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRELD2,Protein disulfide isomerase CRELD2,23689,148,1.23 [0.93-1.61],0.1423999148245874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRH,Corticoliberin,23046,148,0.91 [0.77-1.09],0.3126918839141603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRHBP,Corticotropin-releasing factor-binding protein,23606,148,0.77 [0.45-1.30],0.3229751118310058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRHR1,Corticotropin-releasing factor receptor 1,23208,146,1.13 [0.91-1.41],0.2695671613921084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRIM1,Cysteine-rich motor neuron 1 protein,23725,148,1.12 [0.54-2.31],0.758959617873247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRIP2,Cysteine-rich protein 2,23436,150,1.13 [0.77-1.66],0.5239256341479259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRISP2,Cysteine-rich secretory protein 2,23846,151,0.94 [0.72-1.23],0.6663890004887307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRISP3,Cysteine-rich secretory protein 3,20322,127,0.78 [0.42-1.45],0.4242238559878579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRKL,Crk-like protein,23644,148,1.10 [0.96-1.27],0.1806244093692762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRLF1,Cytokine receptor-like factor 1,23725,148,0.61 [0.34-1.09],0.094485595530704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRNN,Cornulin,22973,147,0.88 [0.71-1.10],0.2627419584732514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRTAC1,Cartilage acidic protein 1,23938,149,0.69 [0.44-1.10],0.1175357656335831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRTAM,Cytotoxic and regulatory T-cell molecule,23436,150,0.93 [0.70-1.25],0.638564344229676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRTAP,Cartilage-associated protein,19939,127,1.05 [0.75-1.47],0.7872802954155486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRX,Cone-rod homeobox protein,23208,146,1.05 [0.92-1.19],0.4485642326537861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYBB1,Beta-crystallin B1,20484,132,1.26 [0.98-1.62],0.0671395690959196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYBB2,Beta-crystallin B2,20438,131,1.29 [1.11-1.50],0.0007553191763808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYGD,Gamma-crystallin D,20438,131,1.12 [0.94-1.33],0.2065077398533188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYM,Ketimine reductase mu-crystallin,19830,123,1.02 [0.81-1.29],0.8515638568956216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CRYZL1,Quinone oxidoreductase-like protein 1,19922,125,1.16 [0.96-1.40],0.1336215883948527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSDE1,Cold shock domain-containing protein E1,19790,124,1.06 [0.93-1.22],0.369006337207978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF1,Macrophage colony-stimulating factor 1,23725,148,1.01 [0.58-1.76],0.96271476040336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF1R,Macrophage colony-stimulating factor 1 receptor,20513,128,0.91 [0.59-1.39],0.6507531644639404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF2,Granulocyte-macrophage colony-stimulating factor,19790,124,1.00 [0.62-1.60],0.9914872952591408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,23436,150,0.99 [0.78-1.25],0.9113032460125692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF2RB,Cytokine receptor common subunit beta,19884,122,1.16 [0.76-1.76],0.4893105646257708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF3,Granulocyte colony-stimulating factor,23231,145,1.03 [0.76-1.40],0.8398740813592875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSF3R,Granulocyte colony-stimulating factor receptor,19884,122,1.23 [0.71-2.14],0.456074872294681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSH1,Chorionic somatomammotropin hormone 1,20513,128,0.95 [0.53-1.70],0.8582203111207751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSNK1D,Casein kinase I isoform delta,19884,122,1.04 [0.80-1.36],0.758856750946948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSNK2A1,Casein kinase II subunit alpha,20447,131,1.57 [1.09-2.25],0.0144013626907308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSPG4,Chondroitin sulfate proteoglycan 4,20492,132,0.91 [0.55-1.52],0.7288425134612845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSPG5,Chondroitin sulfate proteoglycan 5,19830,123,0.80 [0.54-1.19],0.2706788359015618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSRP3,Cysteine and glycine-rich protein 3,19790,124,1.07 [0.91-1.27],0.3968023234176151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST1,Cystatin-SN,17816,115,1.06 [0.88-1.26],0.5554119958187055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST3,Cystatin-C,23708,148,1.28 [0.78-2.10],0.3372327786277265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST5,Cystatin-D,23143,145,0.93 [0.71-1.21],0.5829427195089696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST6,Cystatin-M,23029,143,0.80 [0.60-1.09],0.1578519836541244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CST7,Cystatin-F,23648,148,0.96 [0.81-1.13],0.59459147267425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CSTB,Cystatin-B,23332,143,1.70 [1.25-2.31],0.0006414108242057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTAG1A_CTAG1B,Cancer/testis antigen 1,20089,125,1.17 [0.85-1.61],0.3388221732023921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTBS,Di-N-acetylchitobiase,20222,125,1.02 [0.54-1.94],0.9427310654118096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTF1,Cardiotrophin-1,23208,146,1.16 [0.98-1.36],0.0819413614678072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTHRC1,Collagen triple helix repeat-containing protein 1,20492,132,0.70 [0.38-1.27],0.2404341611160788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTLA4,Cytotoxic T-lymphocyte protein 4,20492,132,1.22 [0.75-2.00],0.4276051447998928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTNNA1,Catenin alpha-1,19830,123,0.91 [0.52-1.58],0.7419487374670137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTRB1,Chymotrypsinogen B,23652,147,0.94 [0.73-1.22],0.6588026459934415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTRC,Chymotrypsin-C,23606,147,0.86 [0.69-1.07],0.1747636100693331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTRL,Chymotrypsin-like protease CTRL-1,20438,131,0.98 [0.78-1.25],0.9004527339888837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSB,Cathepsin B,23665,148,1.15 [0.87-1.51],0.3231736071443985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSC,Dipeptidyl peptidase 1,23558,148,1.14 [0.83-1.57],0.412331365007053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSD,Cathepsin D,22135,134,0.90 [0.61-1.35],0.6200132575001784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSE,Cathepsin E,20023,132,1.60 [1.18-2.18],0.0026428857811785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSF,Cathepsin F,23701,148,1.12 [0.78-1.62],0.5325189060163071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSH,Pro-cathepsin H,23121,145,0.84 [0.69-1.02],0.0816566083520803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSL,Cathepsin L1,23640,150,1.26 [0.70-2.26],0.4464787566647772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSO,Cathepsin O,23917,149,0.98 [0.61-1.57],0.9294608244732674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSS,Cathepsin S,18607,114,1.52 [0.71-3.24],0.2762145087714459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSV,Cathepsin L2,23757,151,0.88 [0.61-1.27],0.5097504728561333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CTSZ,Cathepsin Z,23680,145,1.21 [0.77-1.91],0.4066805041764213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19939,127,1.11 [0.74-1.64],0.6172790242108477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CWC15,Spliceosome-associated protein CWC15 homolog,20306,129,1.02 [0.78-1.32],0.8849342203953202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CX3CL1,Fractalkine,23436,150,1.32 [0.86-2.01],0.2012676644160976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXADR,Coxsackievirus and adenovirus receptor,23613,149,0.97 [0.71-1.32],0.8506705408819549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL1,Growth-regulated alpha protein,23574,148,1.04 [0.89-1.21],0.6289989563171331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL10,C-X-C motif chemokine 10,23725,148,1.07 [0.86-1.33],0.5339062737231803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL11,C-X-C motif chemokine 11,23855,150,1.15 [0.97-1.36],0.1145903742685826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL12,Stromal cell-derived factor 1,23231,145,1.21 [0.83-1.75],0.3157664344858327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL13,C-X-C motif chemokine 13,23855,150,0.91 [0.70-1.19],0.490494645707428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL14,C-X-C motif chemokine 14,23231,145,0.73 [0.53-0.99],0.0458483188079295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL16,C-X-C motif chemokine 16,23900,148,1.01 [0.54-1.90],0.969054775383534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL17,C-X-C motif chemokine 17,23917,149,0.88 [0.62-1.25],0.4671943723751806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL3,C-X-C motif chemokine 3,23612,148,1.09 [0.93-1.26],0.2957947642242785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL5,C-X-C motif chemokine 5,23561,150,1.13 [1.00-1.28],0.0566735057509986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL6,C-X-C motif chemokine 6,23917,149,1.18 [0.98-1.42],0.0870655926357906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL8,Interleukin-8,23478,151,1.25 [1.05-1.49],0.0102022804074059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CXCL9,C-X-C motif chemokine 9,23725,148,1.11 [0.90-1.38],0.329326554500753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYB5A,Cytochrome b5,19767,126,1.02 [0.81-1.29],0.8633258794489715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYB5R2,NADH-cytochrome b5 reductase 2,20209,129,1.16 [0.87-1.56],0.3109294964561092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19790,124,0.89 [0.71-1.12],0.3318699129032923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYTH3,Cytohesin-3,19767,126,0.87 [0.67-1.13],0.3090561516537948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,CYTL1,Cytokine-like protein 1,20492,132,1.09 [0.56-2.10],0.7976153768323818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAAM1,Disheveled-associated activator of morphogenesis 1,20023,132,1.18 [0.96-1.44],0.1108464863307928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAB2,Disabled homolog 2,23846,151,1.08 [0.95-1.23],0.2526823171733568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAG1,Dystroglycan,23725,148,1.38 [1.02-1.87],0.0346253583137175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAND5,DAN domain family member 5,19884,122,0.92 [0.68-1.25],0.6158781234318396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAPK2,Death-associated protein kinase 2,19884,122,1.25 [0.97-1.61],0.0914290167360444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,23613,149,1.12 [0.98-1.27],0.0921333277439123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DARS1,"Aspartate--tRNA ligase, cytoplasmic",23403,150,1.15 [0.94-1.41],0.1750072475576213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBH,Dopamine beta-hydroxylase,20477,128,1.18 [0.99-1.40],0.0675194588099186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBI,Acyl-CoA-binding protein,23539,146,1.17 [0.97-1.41],0.0929981204173988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBN1,Drebrin,19884,122,1.03 [0.73-1.46],0.8463106792457715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DBNL,Drebrin-like protein,23725,148,1.08 [0.93-1.27],0.3132301622430212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23701,148,1.50 [1.00-2.24],0.0484952676156138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCC,Netrin receptor DCC,19939,127,1.35 [0.73-2.49],0.3368095409556593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCDC2C,Doublecortin domain-containing protein 2C,19767,126,0.67 [0.48-0.92],0.0128759479061851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCLRE1C,Protein artemis,19767,126,0.65 [0.36-1.16],0.146132366703853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCN,Decorin,23208,146,0.73 [0.38-1.40],0.3418195405374455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTD,Deoxycytidylate deaminase,20023,132,1.14 [0.96-1.37],0.1421221016688814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTN1,Dynactin subunit 1,23846,151,1.11 [0.89-1.39],0.3398433152164127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTN2,Dynactin subunit 2,23526,149,1.02 [0.88-1.20],0.7545205374321625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTN6,Dynactin subunit 6,23119,148,1.13 [0.94-1.36],0.2001648097742312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCTPP1,dCTP pyrophosphatase 1,23640,150,0.96 [0.61-1.52],0.8604478239499225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCUN1D1,DCN1-like protein 1,19830,123,0.94 [0.74-1.21],0.6485777718857767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCUN1D2,DCN1-like protein 2,19767,126,0.96 [0.76-1.20],0.7135229497430109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DCXR,L-xylulose reductase,23701,148,1.04 [0.79-1.36],0.8022599863879664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDA1,DET1- and DDB1-associated protein 1,19790,124,0.94 [0.60-1.50],0.8082578481628505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",23526,149,1.10 [0.80-1.52],0.5644207369309544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDC,Aromatic-L-amino-acid decarboxylase,23609,150,0.84 [0.61-1.15],0.2675196567417307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDHD2,Phospholipase DDHD2,20447,131,1.15 [0.89-1.48],0.2843858063568335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDI2,Protein DDI1 homolog 2,20023,132,1.33 [1.08-1.64],0.0069008178247623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDR1,Epithelial discoidin domain-containing receptor 1,23855,150,1.40 [0.76-2.59],0.2836678457759388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDT,D-dopachrome decarboxylase,20492,132,1.38 [0.96-2.00],0.0816436387013761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX1,ATP-dependent RNA helicase DDX1,20422,129,1.19 [0.87-1.62],0.2723283518390652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX25,ATP-dependent RNA helicase DDX25,19939,127,0.95 [0.58-1.56],0.8313997177818396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX39A,ATP-dependent RNA helicase DDX39A,19884,122,1.34 [0.72-2.50],0.3550884671865236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX4,Probable ATP-dependent RNA helicase DDX4,19884,122,1.12 [0.84-1.50],0.4508317980762923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX53,Probable ATP-dependent RNA helicase DDX53,19939,127,1.05 [0.66-1.67],0.8295526094979639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DDX58,Antiviral innate immune response receptor RIG-I,23083,148,0.98 [0.75-1.26],0.8484126593404545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",23613,149,1.12 [0.96-1.30],0.1371755698001204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFA1_DEFA1B,Neutrophil defensin 1,23174,145,1.14 [0.88-1.47],0.3357662531171126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB103A_DEFB103B,Beta-defensin 103,19737,122,0.95 [0.62-1.47],0.824293127280648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB104A_DEFB104B,Beta-defensin 104,19830,123,0.82 [0.58-1.15],0.250244281955348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB116,Beta-defensin 116,19830,123,1.00 [0.79-1.27],0.9955049159698584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB118,Beta-defensin 118,19830,123,1.04 [0.77-1.39],0.8129584581236967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DEFB4A_DEFB4B,Beta-defensin 4A,23292,149,1.00 [0.91-1.11],0.9486354899139716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DENND2B,DENN domain-containing protein 2B,19790,124,1.01 [0.71-1.45],0.9440163490164069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DENR,Density-regulated protein,19884,122,1.18 [0.89-1.57],0.2485912494981788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DFFA,DNA fragmentation factor subunit alpha,23917,149,1.23 [1.00-1.51],0.0520641544124331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DGCR6,Protein DGCR6,19830,123,1.31 [0.95-1.82],0.1010985402054015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DGKA,Diacylglycerol kinase alpha,19884,122,1.39 [1.03-1.88],0.029273184114007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DGKZ,Diacylglycerol kinase zeta,23231,145,1.06 [0.70-1.58],0.7906223723744022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DHODH,Dihydroorotate dehydrogenase,19790,124,1.25 [0.91-1.72],0.1757286036397495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DHPS,Deoxyhypusine synthase,20415,129,1.15 [0.78-1.71],0.4759807883460267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,20438,131,1.12 [0.80-1.56],0.4978394485967217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DIABLO,"Diablo homolog, mitochondrial",23562,149,1.11 [0.98-1.27],0.1080453935402905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DIPK1C,Divergent protein kinase domain 1C,19939,127,0.99 [0.65-1.51],0.971763011697809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DIPK2B,Divergent protein kinase domain 2B,20023,132,0.91 [0.51-1.62],0.7445410003483619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKK1,Dickkopf-related protein 1,23855,150,1.19 [0.93-1.52],0.1597861155925585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKK3,Dickkopf-related protein 3,23938,149,1.11 [0.68-1.81],0.6673577634527298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKK4,Dickkopf-related protein 4,23393,150,1.06 [0.78-1.45],0.7025643616742442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DKKL1,Dickkopf-like protein 1,23526,149,0.92 [0.78-1.09],0.3385795840403605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLG4,Disks large homolog 4,20438,131,1.05 [0.84-1.32],0.6642478460260259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLGAP5,Disks large-associated protein 5,20447,131,0.98 [0.69-1.38],0.8955213246153284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLK1,Protein delta homolog 1,23938,149,0.90 [0.70-1.16],0.4109269263368466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLL1,Delta-like protein 1,23701,148,1.61 [1.02-2.56],0.0429964000343163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DLL4,Delta-like protein 4,19922,125,0.79 [0.58-1.08],0.1415741318432939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DMD,Dystrophin,19922,125,1.07 [0.76-1.49],0.714078421312336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DMP1,Dentin matrix acidic phosphoprotein 1,19922,125,0.79 [0.59-1.05],0.1109257993869551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJA1,DnaJ homolog subfamily A member 1,19767,126,0.64 [0.41-1.01],0.0559888535834817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJA2,DnaJ homolog subfamily A member 2,23840,148,1.14 [0.95-1.36],0.1550225728728788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJA4,DnaJ homolog subfamily A member 4,20438,131,1.16 [0.93-1.46],0.1945924119214875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB1,DnaJ homolog subfamily B member 1,23526,149,1.26 [1.06-1.49],0.008142512517561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB14,DnaJ homolog subfamily B member 14,20422,129,1.15 [0.89-1.48],0.2818163941318045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB2,DnaJ homolog subfamily B member 2,20023,132,1.51 [1.13-2.01],0.0049195701361053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB6,DnaJ homolog subfamily B member 6,19841,131,1.14 [0.93-1.39],0.2086757453255721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJB8,DnaJ homolog subfamily B member 8,23208,146,0.97 [0.74-1.28],0.8499589444687108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJC21,DnaJ homolog subfamily C member 21,20438,131,1.32 [0.90-1.94],0.1534655785786937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19922,125,1.13 [0.92-1.38],0.2324993423705991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNAJC9,DnaJ homolog subfamily C member 9,20422,129,1.36 [1.10-1.68],0.0048439543669087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNER,Delta and Notch-like epidermal growth factor-related receptor,23569,146,0.94 [0.54-1.65],0.8326827611276006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNLZ,DNL-type zinc finger protein,19830,123,1.04 [0.85-1.26],0.7188541273567742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNM1,Dynamin-1,20422,129,1.11 [0.95-1.29],0.1811541996415774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNM3,Dynamin-3,20447,131,1.31 [1.00-1.71],0.047323328370491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNMBP,Dynamin-binding protein,23436,150,0.95 [0.74-1.21],0.6629940237090272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNPEP,Aspartyl aminopeptidase,20438,131,1.02 [0.75-1.38],0.9025404413534288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,23680,148,1.41 [1.06-1.86],0.0163365237650453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOC2B,Double C2-like domain-containing protein beta,19939,127,0.98 [0.61-1.58],0.9227864398532988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOCK9,Dedicator of cytokinesis protein 9,19830,123,1.02 [0.88-1.18],0.8100249535880926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOK1,Docking protein 1,20438,131,1.07 [0.94-1.21],0.3121355445463621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DOK2,Docking protein 2,23640,150,1.08 [0.96-1.21],0.2122123757782992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPEP1,Dipeptidase 1,23403,150,0.87 [0.64-1.19],0.3906806567269598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPEP2,Dipeptidase 2,23526,149,1.68 [1.06-2.66],0.0264712244747137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP10,Inactive dipeptidyl peptidase 10,23613,149,1.14 [0.77-1.69],0.5232518702640134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP4,Dipeptidyl peptidase 4,23215,142,0.72 [0.42-1.24],0.2340856641299259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP6,Dipeptidyl aminopeptidase-like protein 6,23526,149,1.51 [0.99-2.29],0.0547492079441361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPP7,Dipeptidyl peptidase 2,23460,150,1.20 [0.95-1.51],0.1306124238134882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPT,Dermatopontin,23938,149,0.85 [0.49-1.49],0.5800320593055777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DPY30,Protein dpy-30 homolog,23781,151,1.17 [0.94-1.47],0.1656351013803298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DRAXIN,Draxin,23436,150,1.10 [0.78-1.54],0.5904043978641839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DRG2,Developmentally-regulated GTP-binding protein 2,23526,149,1.30 [1.02-1.66],0.0368290980095392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSC2,Desmocollin-2,23368,146,1.40 [0.93-2.12],0.1110704971363291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSCAM,Down syndrome cell adhesion molecule,20447,131,1.10 [0.69-1.75],0.692604462353609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSG2,Desmoglein-2,23652,147,1.59 [0.94-2.69],0.0834085953597161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSG3,Desmoglein-3,23766,151,0.79 [0.52-1.20],0.2660013665547277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DSG4,Desmoglein-4,23450,149,0.75 [0.55-1.01],0.0552325020643908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTD1,D-aminoacyl-tRNA deacylase 1,20023,132,1.20 [0.99-1.45],0.0635722646829406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTNB,Dystrobrevin beta,20371,129,0.81 [0.54-1.21],0.3033806912303943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19939,127,1.02 [0.77-1.35],0.913341298157406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTX3,Probable E3 ubiquitin-protein ligase DTX3,23526,149,0.75 [0.40-1.40],0.3676148327578082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DTYMK,Thymidylate kinase,20484,132,1.43 [1.13-1.82],0.0029764243258779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUOX2,Dual oxidase 2,23208,146,0.95 [0.77-1.19],0.6705021597852507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUSP13,Dual specificity protein phosphatase 13 isoform A,20415,129,0.70 [0.46-1.07],0.0969272519048615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUSP29,Dual specificity phosphatase 29,19939,127,0.90 [0.68-1.19],0.447895933753077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUSP3,Dual specificity protein phosphatase 3,23119,148,0.97 [0.82-1.16],0.7726596065605329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",20422,129,1.14 [0.97-1.34],0.1055266605163157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DXO,Decapping and exoribonuclease protein,20438,131,1.46 [1.03-2.06],0.0351355919939639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,20415,129,1.05 [0.74-1.48],0.7866424392038948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DYNLT1,Dynein light chain Tctex-type 1,19939,127,1.06 [0.86-1.31],0.5896523657522019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,DYNLT3,Dynein light chain Tctex-type 3,20415,129,1.08 [0.74-1.58],0.676511786028442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,23436,150,1.13 [0.97-1.31],0.1208921365316133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EBI3_IL27,Interleukin-27,23818,151,1.09 [0.68-1.75],0.7311612265464391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECE1,Endothelin-converting enzyme 1,23119,148,1.00 [0.66-1.51],0.991472433808136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20484,132,0.94 [0.75-1.19],0.6294206454747345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19922,125,1.09 [0.91-1.30],0.3483069499122402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECI2,Enoyl-CoA delta isomerase 2,19790,124,1.13 [0.86-1.48],0.3843216645751061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECM1,Extracellular matrix protein 1,19978,131,0.83 [0.54-1.27],0.3851566089024464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ECSCR,Endothelial cell-specific chemotaxis regulator,19830,123,1.07 [0.78-1.47],0.6907277388343773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDA2R,Tumor necrosis factor receptor superfamily member 27,23846,151,1.00 [0.70-1.44],0.9834563233034932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDAR,Tumor necrosis factor receptor superfamily member EDAR,23613,149,1.11 [0.95-1.30],0.2027798904571041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDDM3B,Epididymal secretory protein E3-beta,20415,129,1.02 [0.78-1.35],0.8714700541384213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19790,124,0.79 [0.46-1.35],0.3894701297040481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDF1,Endothelial differentiation-related factor 1,20447,131,0.95 [0.74-1.23],0.7196807607861788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,23208,146,0.85 [0.55-1.31],0.4536599284107775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDN1,Endothelin-1,19922,125,0.62 [0.34-1.13],0.1155968820445653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EDNRB,Endothelin receptor type B,19884,122,1.08 [0.74-1.57],0.6934140201331999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EEF1D,Elongation factor 1-delta,20484,132,1.06 [0.89-1.27],0.4988608945169497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFCAB14,EF-hand calcium-binding domain-containing protein 14,20422,129,1.50 [0.95-2.36],0.0799718217550611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFCAB2,Dynein regulatory complex protein 8,20126,125,1.41 [0.90-2.24],0.1371746605181777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23715,148,0.93 [0.59-1.49],0.7738941250159801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFHD1,EF-hand domain-containing protein D1,20447,131,0.79 [0.48-1.31],0.3595665988062538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFNA1,Ephrin-A1,23609,147,1.41 [0.87-2.30],0.1627054387316694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFNA4,Ephrin-A4,23393,149,1.27 [0.81-1.99],0.2982953127691206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EFNB2,Ephrin-B2,19939,127,1.31 [1.05-1.63],0.0148569159970934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGF,Pro-epidermal growth factor,23570,146,1.08 [0.94-1.24],0.2832330696305212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGFL7,Epidermal growth factor-like protein 7,23083,148,1.04 [0.72-1.51],0.8404236704244671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGFLAM,Pikachurin,20422,129,1.30 [0.77-2.19],0.3230459234600718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGFR,Epidermal growth factor receptor,23938,149,0.84 [0.34-2.06],0.7032370908449107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EGLN1,Egl nine homolog 1,23613,149,1.17 [0.95-1.45],0.1465731582118951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EHBP1,EH domain-binding protein 1,20484,132,1.09 [0.88-1.36],0.4430680763093108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EHD3,EH domain-containing protein 3,19922,125,1.04 [0.89-1.20],0.6371825430258737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",20438,131,1.05 [0.79-1.40],0.7393317634177123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",20343,129,1.12 [0.97-1.31],0.1269717707198032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19790,124,0.94 [0.72-1.24],0.6798218050801033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19922,125,1.31 [0.92-1.87],0.1376752933697838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4B,Eukaryotic translation initiation factor 4B,23436,150,1.28 [0.98-1.68],0.0665383679941182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4E,Eukaryotic translation initiation factor 4E,19884,122,1.22 [1.01-1.48],0.0401019467723942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,23640,150,1.35 [1.10-1.65],0.0041719945582107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23917,149,1.09 [0.94-1.26],0.261289130045738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,20447,131,1.03 [0.80-1.32],0.8417725504264255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF5,Eukaryotic translation initiation factor 5,19790,124,1.20 [0.84-1.72],0.3234096472444214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EIF5A,Eukaryotic translation initiation factor 5A-1,23231,145,0.91 [0.55-1.49],0.6940908225781057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELAC1,Zinc phosphodiesterase ELAC protein 1,20447,131,1.19 [0.97-1.45],0.0923717149484602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELAVL4,ELAV-like protein 4,19830,123,1.09 [0.90-1.34],0.3709997337142041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELN,Elastin,20484,132,1.17 [0.72-1.91],0.5234666865949921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELOA,Elongin-A,23526,149,1.07 [0.84-1.37],0.5663537451298242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ELOB,Elongin-B,19790,124,1.25 [0.85-1.83],0.2612308313175342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENAH,Protein enabled homolog,23231,145,0.98 [0.72-1.34],0.8996447709801952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENDOU,Poly(U)-specific endoribonuclease,18905,127,0.83 [0.61-1.13],0.236821738708603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENG,Endoglin,23938,149,1.53 [0.67-3.49],0.3123267371530668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENO1,Alpha-enolase,23634,148,1.17 [0.97-1.41],0.1047994394062991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENO2,Gamma-enolase,23855,150,1.28 [1.03-1.60],0.0248150247621754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENO3,Beta-enolase,19922,125,0.68 [0.50-0.93],0.0173907707674751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENOPH1,Enolase-phosphatase E1,20415,129,0.86 [0.61-1.22],0.3927589750130369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19790,124,1.11 [0.61-2.03],0.733841884626892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPEP,Glutamyl aminopeptidase,19790,124,0.85 [0.54-1.35],0.4893529301730556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23938,149,1.43 [0.80-2.55],0.2240025278149947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23725,148,0.91 [0.67-1.24],0.5433148581840443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19922,125,1.48 [0.91-2.41],0.1178400076612172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22920,145,1.00 [0.84-1.20],0.9855585772231736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENSA,Alpha-endosulfine,20415,129,1.06 [0.77-1.44],0.7307924887020145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23083,148,0.95 [0.67-1.34],0.7764332162581304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,23208,146,0.85 [0.44-1.64],0.6286618294530915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,23208,146,1.16 [0.67-2.00],0.5987365088707832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ENTR1,Endosome-associated-trafficking regulator 1,19922,125,0.95 [0.71-1.27],0.720479130926966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EP300,Histone acetyltransferase p300,19884,122,1.26 [0.76-2.10],0.3709289446899148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPB41L5,Band 4.1-like protein 5,19939,127,0.83 [0.61-1.13],0.2384596645156098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPCAM,Epithelial cell adhesion molecule,23601,148,1.03 [0.88-1.20],0.7099213120745318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPGN,Epigen,20415,129,1.13 [0.82-1.56],0.4667253613210237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA1,Ephrin type-A receptor 1,23680,148,0.87 [0.55-1.36],0.5358070992628207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA10,Ephrin type-A receptor 10,23119,148,1.09 [0.89-1.34],0.3823632112209328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA2,Ephrin type-A receptor 2,22765,145,1.37 [0.87-2.16],0.1733606522169358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHA4,Ephrin type-A receptor 4,20023,132,1.45 [0.82-2.58],0.2036199842028159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHB4,Ephrin type-B receptor 4,23938,149,1.38 [0.79-2.41],0.2589105509428339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHB6,Ephrin type-B receptor 6,23403,150,0.74 [0.47-1.16],0.186544305353316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPHX2,Bifunctional epoxide hydrolase 2,23208,146,0.89 [0.68-1.15],0.3620731041747632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPN1,Epsin-1,20126,125,1.29 [0.92-1.82],0.1395902349646449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPO,Erythropoietin,23613,149,0.88 [0.71-1.09],0.2525661046459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPPK1,Epiplakin,19922,125,0.86 [0.68-1.10],0.2400054647929194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23809,151,0.61 [0.37-1.01],0.0532265684164045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBB2,Receptor tyrosine-protein kinase erbB-2,23701,148,1.01 [0.55-1.84],0.9850766909240748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBB3,Receptor tyrosine-protein kinase erbB-3,23520,148,1.00 [0.48-2.10],0.9936545718650212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBB4,Receptor tyrosine-protein kinase erbB-4,23701,148,1.99 [1.08-3.66],0.0268471896959673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERBIN,Erbin,23526,149,1.11 [0.97-1.28],0.1391867921300983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERC2,ERC protein 2,19939,127,0.95 [0.75-1.22],0.703356194201348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERCC1,DNA excision repair protein ERCC-1,19767,126,0.75 [0.42-1.34],0.3308857032496516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EREG,Proepiregulin,23403,150,1.16 [0.98-1.38],0.0829402284709812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERI1,3'-5' exoribonuclease 1,20126,125,1.28 [0.80-2.04],0.2986359408597578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERMAP,Erythroid membrane-associated protein,19884,122,1.17 [0.79-1.73],0.4354497519573059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20415,129,1.00 [0.63-1.59],0.9991586298327167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERP29,Endoplasmic reticulum resident protein 29,20023,132,1.14 [0.99-1.32],0.0634023921642609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERP44,Endoplasmic reticulum resident protein 44,23490,149,1.81 [1.05-3.13],0.0319744829551392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19790,124,1.02 [0.68-1.52],0.9197316637366224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESAM,Endothelial cell-selective adhesion molecule,23938,149,1.67 [1.09-2.55],0.0175352749628973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESM1,Endothelial cell-specific molecule 1,23606,148,0.95 [0.62-1.46],0.8243560222010544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESPL1,Separin,19767,126,1.23 [0.97-1.56],0.0891068842494044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESR1,Estrogen receptor,19884,122,0.76 [0.52-1.11],0.1499046660457909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ESYT2,Extended synaptotagmin-2,20438,131,1.05 [0.86-1.29],0.6091380438393792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EVI2B,Protein EVI2B,19767,126,1.23 [0.85-1.76],0.2699686091339452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EVI5,Ecotropic viral integration site 5 protein homolog,19884,122,1.12 [0.93-1.36],0.241342990633196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EVPL,Envoplakin,20126,125,1.05 [0.63-1.76],0.8566532590242378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EXOSC10,Exosome component 10,19790,124,0.80 [0.56-1.15],0.2334397233805967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EXTL1,Exostosin-like 1,19790,124,1.04 [0.74-1.48],0.8106471487999872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,EZR,Ezrin,23855,150,0.90 [0.50-1.63],0.7289253313944009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F10,Coagulation factor X,20513,128,1.58 [1.02-2.46],0.0418519134771831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F11,Coagulation factor XI,20218,131,0.96 [0.55-1.68],0.8920346506205077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F11R,Junctional adhesion molecule A,23652,147,1.14 [0.88-1.47],0.3160940520452003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F12,Coagulation factor XII,20510,132,0.93 [0.62-1.39],0.7164334085724223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F13B,Coagulation factor XIII B chain,20407,132,0.74 [0.39-1.42],0.3700972431243794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F2,Prothrombin,20510,132,3.85 [1.32-11.23],0.0138166965886912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F2R,Proteinase-activated receptor 1,23689,148,1.32 [1.03-1.70],0.0276288504906574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F3,Tissue factor,23693,151,1.18 [0.68-2.03],0.5593037948571605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F7,Coagulation factor VII,23711,148,1.24 [0.77-2.00],0.3666566769263196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,F9,Coagulation factor IX,23717,148,1.98 [0.90-4.36],0.0892638268207494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP1,"Fatty acid-binding protein, liver",23606,148,0.96 [0.82-1.13],0.6285847618574898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP2,"Fatty acid-binding protein, intestinal",23640,150,0.95 [0.79-1.14],0.5790410248730127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP3,"Fatty acid-binding protein, heart",20484,132,1.07 [0.79-1.45],0.6745528335946971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP4,"Fatty acid-binding protein, adipocyte",23938,149,0.96 [0.72-1.29],0.8047551522388239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP5,Fatty acid-binding protein 5,23775,150,1.18 [0.96-1.46],0.1131657173851212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP6,Gastrotropin,23174,146,0.85 [0.65-1.11],0.2389305563457227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FABP9,Fatty acid-binding protein 9,23613,149,0.77 [0.59-1.00],0.0503777021141927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FADD,FAS-associated death domain protein,23640,150,1.18 [0.98-1.42],0.0886638396264021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM13A,Protein FAM13A,20422,129,1.16 [0.91-1.48],0.2172930946559936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM171A2,Protein FAM171A2,20447,131,0.94 [0.84-1.05],0.2987124195351928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM171B,Protein FAM171B,20415,129,1.03 [0.55-1.92],0.9244544211082036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM172A,Cotranscriptional regulator FAM172A,19922,125,1.15 [0.87-1.52],0.3379546111920796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM20A,Pseudokinase FAM20A,20484,132,0.97 [0.53-1.75],0.910181168600203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM3B,Protein FAM3B,23526,149,1.10 [0.73-1.66],0.6506884860955015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM3C,Protein FAM3C,23609,150,1.39 [0.87-2.24],0.1665597485563663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAM3D,Protein FAM3D,20422,129,1.00 [0.82-1.21],0.960947583730361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAP,Prolyl endopeptidase FAP,23938,149,0.90 [0.53-1.53],0.6980051138883694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FARSA,Phenylalanine--tRNA ligase alpha subunit,19939,127,1.09 [0.87-1.38],0.4464493046224208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FAS,Tumor necrosis factor receptor superfamily member 6,23859,148,1.15 [0.78-1.69],0.4689753994457672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FASLG,Tumor necrosis factor ligand superfamily member 6,23917,149,0.92 [0.62-1.36],0.6632609860508463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FBLN2,Fibulin-2,20492,132,0.70 [0.41-1.18],0.1816065585373721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FBN2,Fibrillin-2,19939,127,1.08 [0.81-1.45],0.5869841666384552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FBP1,"Fructose-1,6-bisphosphatase 1",23640,150,0.90 [0.74-1.11],0.3300137198697633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20484,132,0.94 [0.74-1.19],0.6039146871345759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCAR,Immunoglobulin alpha Fc receptor,23613,149,1.03 [0.76-1.39],0.8574387065372759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,20447,131,1.59 [0.83-3.08],0.1644558742706312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCER2,Low affinity immunoglobulin epsilon Fc receptor,23652,147,1.16 [0.89-1.50],0.2747116504023356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,23558,148,0.96 [0.75-1.22],0.7256181187032946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23083,148,1.01 [0.79-1.30],0.9096803256786968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,23675,148,1.12 [0.83-1.51],0.4708568208964376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCN1,Ficolin-1,20477,128,0.99 [0.73-1.34],0.9464914211958269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCN2,Ficolin-2,23558,146,0.98 [0.69-1.40],0.9118280037667362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL1,Fc receptor-like protein 1,23640,150,1.13 [0.83-1.54],0.4470136237103966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL2,Fc receptor-like protein 2,23804,149,1.09 [0.83-1.44],0.5403241964417507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL3,Fc receptor-like protein 3,23231,145,0.96 [0.73-1.26],0.7808998426526137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL5,Fc receptor-like protein 5,23652,147,0.92 [0.72-1.18],0.51261295179523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRL6,Fc receptor-like protein 6,23613,149,1.02 [0.83-1.26],0.8610253152846534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FCRLB,Fc receptor-like B,23083,148,0.93 [0.73-1.20],0.5820328377015453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FDX1,"Adrenodoxin, mitochondrial",19790,124,0.94 [0.70-1.25],0.6537516919429582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FDX2,"Ferredoxin-2, mitochondrial",19790,124,1.09 [0.81-1.47],0.5531864319210917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FEN1,Flap endonuclease 1,23083,148,1.12 [0.93-1.35],0.2327643476178706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FES,Tyrosine-protein kinase Fes/Fps,23083,148,1.15 [0.87-1.53],0.3240537674047531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FETUB,Fetuin-B,23717,148,0.97 [0.62-1.52],0.8940365705416765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGA,Fibrinogen alpha chain,20040,126,1.03 [0.59-1.80],0.9244200602645184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",20447,131,1.15 [0.94-1.41],0.1736056176408599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF12,Fibroblast growth factor 12,19884,122,1.08 [0.77-1.51],0.6671443651236946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF16,Fibroblast growth factor 16,19884,122,1.17 [0.82-1.66],0.3872730977906832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF19,Fibroblast growth factor 19,23725,148,1.05 [0.87-1.26],0.6272009441384019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF2,Fibroblast growth factor 2,23613,149,1.05 [0.86-1.29],0.6229884921517257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF20,Fibroblast growth factor 20,19884,122,1.35 [0.98-1.88],0.0695600649699369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF21,Fibroblast growth factor 21,23818,151,0.91 [0.80-1.03],0.1435812853244399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF23,Fibroblast growth factor 23,23805,151,0.81 [0.59-1.11],0.1910669816723482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF3,Fibroblast growth factor 3,19884,122,0.79 [0.41-1.51],0.4692961081552168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF5,Fibroblast growth factor 5,23231,145,1.02 [0.66-1.57],0.9320553795219731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF6,Fibroblast growth factor 6,19884,122,1.19 [0.81-1.74],0.3867406646978925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF7,Fibroblast growth factor 7,19767,126,1.21 [1.02-1.43],0.0318000631187393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGF9,Fibroblast growth factor 9,19731,126,0.74 [0.49-1.12],0.1521102055991248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFBP1,Fibroblast growth factor-binding protein 1,23701,148,0.50 [0.33-0.77],0.001494348855622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFBP2,Fibroblast growth factor-binding protein 2,20492,132,0.99 [0.72-1.38],0.9738323984211776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFBP3,Fibroblast growth factor-binding protein 3,20438,131,0.93 [0.59-1.47],0.7588456775848883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFR2,Fibroblast growth factor receptor 2,23701,148,0.89 [0.46-1.73],0.7342958938592279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGFR4,Fibroblast growth factor receptor 4,20023,132,1.14 [0.83-1.56],0.4263306000873751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGL1,Fibrinogen-like protein 1,20513,128,1.38 [1.07-1.79],0.013536629314416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FGR,Tyrosine-protein kinase Fgr,23119,148,1.12 [0.91-1.39],0.2784302709162713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FH,"Fumarate hydratase, mitochondrial",19830,123,1.00 [0.81-1.24],0.97646604021913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19790,124,0.89 [0.60-1.30],0.5376901057122846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FHIT,Bis(5'-adenosyl)-triphosphatase,23119,148,1.21 [0.99-1.49],0.0649327406197185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FIS1,Mitochondrial fission 1 protein,23603,148,1.15 [0.95-1.38],0.1528906416176844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,20447,131,1.15 [0.97-1.36],0.0975451281925279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,23729,148,1.07 [0.95-1.22],0.2728751819856414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,23436,150,1.53 [1.09-2.16],0.0146463106728391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,23436,150,1.12 [0.96-1.31],0.1482297313436564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23086,148,1.23 [0.96-1.57],0.1030195248603509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FKBPL,FK506-binding protein-like,20422,129,1.46 [1.11-1.91],0.0062087390001192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLI1,Friend leukemia integration 1 transcription factor,23083,148,1.13 [0.99-1.28],0.0692917824370244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,23436,150,0.60 [0.36-1.01],0.0541121611909252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT1,Vascular endothelial growth factor receptor 1,23485,149,0.68 [0.34-1.37],0.2839680401179921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT3,Receptor-type tyrosine-protein kinase FLT3,23083,148,0.97 [0.60-1.58],0.9097018227898408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT3LG,Fms-related tyrosine kinase 3 ligand,23917,149,0.79 [0.53-1.18],0.2526296471469049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FLT4,Vascular endothelial growth factor receptor 3,23701,148,1.52 [0.98-2.36],0.0631823803851774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FMNL1,Formin-like protein 1,23119,148,0.98 [0.78-1.23],0.878093037899247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FMR1,Synaptic functional regulator FMR1,23083,148,1.27 [0.85-1.90],0.2368029837113922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FN1,Fibronectin,20510,132,0.98 [0.53-1.82],0.9434657225337496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FNDC1,Fibronectin type III domain-containing protein 1,20438,131,1.07 [0.75-1.52],0.7264125663088008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,20415,129,1.10 [0.69-1.75],0.6993702940709561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLH1,Glutamate carboxypeptidase 2,19884,122,0.94 [0.78-1.13],0.4861118046098719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLR1,Folate receptor alpha,23601,145,1.09 [0.66-1.80],0.7407740617682333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLR2,Folate receptor beta,23855,150,0.97 [0.59-1.59],0.9004282894039787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOLR3,Folate receptor gamma,23628,147,1.05 [0.98-1.12],0.1653631147876281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOS,Proto-oncogene c-Fos,19731,126,0.95 [0.59-1.53],0.8357090533780718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOSB,Protein fosB,23119,148,0.64 [0.40-1.02],0.0590807805609863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOXJ3,Forkhead box protein J3,19884,122,1.19 [0.84-1.70],0.3216044549578904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOXO1,Forkhead box protein O1,23613,149,1.09 [0.93-1.29],0.2950703719946315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FOXO3,Forkhead box protein O3,23083,148,1.10 [0.95-1.27],0.2185805349542039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FRMD4B,FERM domain-containing protein 4B,19790,124,0.96 [0.75-1.24],0.7579893745603483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FRMD7,FERM domain-containing protein 7,19939,127,1.18 [0.74-1.88],0.4948637187673433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FRZB,Secreted frizzled-related protein 3,23363,148,0.79 [0.44-1.39],0.408003153002025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FSHB,Follitropin subunit beta,19922,125,1.09 [0.73-1.62],0.6752011184787559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FST,Follistatin,23689,148,0.89 [0.65-1.20],0.4345822803389799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FSTL1,Follistatin-related protein 1,19922,125,1.13 [0.53-2.42],0.7485515391107445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FSTL3,Follistatin-related protein 3,23572,148,0.90 [0.56-1.45],0.6717836423948322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FTCD,Formimidoyltransferase-cyclodeaminase,20394,131,0.87 [0.71-1.07],0.1934247791756968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUCA1,Tissue alpha-L-fucosidase,23774,147,0.93 [0.78-1.09],0.3642660386145945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUOM,Fucose mutarotase,20023,132,0.95 [0.73-1.25],0.7257531583352481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FURIN,Furin,23701,148,0.98 [0.63-1.53],0.9175306030028828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUS,RNA-binding protein FUS,23042,148,1.32 [0.94-1.84],0.1093474861377133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20092,125,0.83 [0.61-1.14],0.2477767705996045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23855,150,0.89 [0.65-1.21],0.4577555454933183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FUT8,"Alpha-(1,6)-fucosyltransferase",23436,150,1.23 [0.96-1.56],0.0963666314634891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FXN,"Frataxin, mitochondrial",23846,151,1.22 [1.01-1.48],0.0440427314299033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FXYD5,FXYD domain-containing ion transport regulator 5,23231,145,1.20 [0.97-1.49],0.0991717103763519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FYB1,FYN-binding protein 1,23608,147,1.08 [0.92-1.27],0.3250088597087633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FZD10,Frizzled-10,19939,127,1.14 [0.89-1.46],0.3096046101240952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,FZD8,Frizzled-8,19830,123,0.80 [0.50-1.26],0.3252475119977162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GABARAP,Gamma-aminobutyric acid receptor-associated protein,20415,129,0.99 [0.69-1.42],0.9695844416424584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20126,125,0.98 [0.75-1.28],0.8723332620570194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19830,123,0.93 [0.70-1.25],0.6445392658570075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAD1,Glutamate decarboxylase 1,19767,126,0.92 [0.48-1.78],0.8149454354238691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAD2,Glutamate decarboxylase 2,19884,122,1.03 [0.71-1.50],0.8884379180240324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20126,125,1.01 [0.71-1.45],0.9380612828364908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19922,125,1.19 [0.87-1.63],0.2738305428789539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAGE2A,G antigen 2A,19767,126,1.19 [0.97-1.48],0.1019296273587495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAL,Galanin peptides,23725,148,0.87 [0.70-1.08],0.2172137345670692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23526,149,1.18 [0.70-1.98],0.5327997520351477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23846,151,0.70 [0.41-1.20],0.1934332442357251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,23231,145,0.86 [0.61-1.22],0.4071434080013668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20484,132,0.67 [0.37-1.21],0.1822463573169715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GALNT7,N-acetylgalactosaminyltransferase 7,23526,149,1.16 [0.58-2.34],0.6704097038312302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAMT,Guanidinoacetate N-methyltransferase,19790,124,1.43 [0.97-2.12],0.0747037892560386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19583,129,1.42 [0.79-2.56],0.2362988516771555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GART,Trifunctional purine biosynthetic protein adenosine-3,20447,131,0.84 [0.42-1.65],0.61134350682969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAS2,Growth arrest-specific protein 2,20126,125,0.77 [0.52-1.14],0.1935498645727777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAS6,Growth arrest-specific protein 6,23792,148,1.24 [0.69-2.23],0.4675476979629704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GASK1A,Golgi-associated kinase 1A,19790,124,1.00 [0.67-1.51],0.9824615269729008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GAST,Gastrin,20438,131,1.00 [0.88-1.13],0.9888609413706628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19767,126,2.08 [1.12-3.85],0.0203608589992779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19922,125,1.08 [0.86-1.35],0.5243206413726468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBA,Lysosomal acid glucosylceramidase,19939,127,0.79 [0.57-1.09],0.15485221114379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP1,Guanylate-binding protein 1,20398,131,1.00 [0.77-1.30],0.991479597863561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP2,Guanylate-binding protein 2,23231,145,1.08 [0.85-1.37],0.5316726123945856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP4,Guanylate-binding protein 4,23119,148,1.02 [0.75-1.37],0.9208898700907212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GBP6,Guanylate-binding protein 6,19790,124,0.98 [0.66-1.47],0.9310630091050748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GC,Vitamin D-binding protein,20510,132,1.71 [0.91-3.22],0.0961829893395087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCC1,GRIP and coiled-coil domain-containing protein 1,20438,131,1.09 [0.94-1.28],0.2626246544378077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCG,Pro-glucagon,23083,148,1.02 [0.90-1.14],0.7801455054917888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19518,128,1.19 [0.86-1.64],0.2869389449970068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCLM,Glutamate--cysteine ligase regulatory subunit,19790,124,1.12 [0.77-1.62],0.5487133829434883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23526,149,1.30 [0.86-1.96],0.2204739580566188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GDF15,Growth/differentiation factor 15,23938,149,1.15 [0.84-1.58],0.3850278802438169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GDF2,Growth/differentiation factor 2,23640,150,1.29 [0.86-1.94],0.2120026749699112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GDNF,Glial cell line-derived neurotrophic factor,23119,148,0.82 [0.55-1.23],0.3408816368060322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GET3,ATPase GET3,20484,132,1.06 [0.78-1.43],0.7152589352740552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFAP,Glial fibrillary acidic protein,23045,147,0.86 [0.62-1.18],0.3443203069635978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFER,FAD-linked sulfhydryl oxidase ALR,23083,148,1.04 [0.82-1.31],0.7622025609770632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23083,148,1.06 [0.95-1.18],0.309792358891036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRA1,GDNF family receptor alpha-1,23818,151,1.32 [0.80-2.19],0.2751370847675849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRA2,GDNF family receptor alpha-2,23526,149,1.79 [0.89-3.57],0.1006120642648438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRA3,GDNF family receptor alpha-3,23363,149,0.92 [0.54-1.56],0.7595665096573326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GFRAL,GDNF family receptor alpha-like,19847,126,1.06 [0.81-1.39],0.6634651752641283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGA1,ADP-ribosylation factor-binding protein GGA1,23119,148,0.96 [0.77-1.21],0.7369309825006741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGACT,Gamma-glutamylaminecyclotransferase,20484,132,1.28 [1.02-1.61],0.0341073571452432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGCT,Gamma-glutamylcyclotransferase,20450,132,1.47 [1.07-2.02],0.017674087373732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGH,Gamma-glutamyl hydrolase,23256,143,0.62 [0.39-0.97],0.0368099434217664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGT1,Glutathione hydrolase 1 proenzyme,23609,147,1.03 [0.77-1.38],0.8366410576433507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GGT5,Glutathione hydrolase 5 proenzyme,23436,150,0.44 [0.23-0.82],0.0103153320207112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GH1,Somatotropin,23609,150,1.06 [0.98-1.15],0.1267985027612881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GH2,Growth hormone variant,23083,148,1.10 [1.02-1.19],0.0124797653584852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GHR,Growth hormone receptor,20023,132,0.72 [0.40-1.32],0.2913141410225608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GHRHR,Growth hormone-releasing hormone receptor,23119,148,1.01 [0.77-1.32],0.95152291906214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GHRL,Appetite-regulating hormone,23640,150,0.94 [0.79-1.12],0.5026393890310827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GID8,Glucose-induced degradation protein 8 homolog,20447,131,1.23 [0.82-1.85],0.3147342122629853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIGYF2,GRB10-interacting GYF protein 2,20447,131,1.06 [0.86-1.32],0.572290545737182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIMAP7,GTPase IMAP family member 7,20023,132,0.90 [0.52-1.56],0.7163085555691551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIMAP8,GTPase IMAP family member 8,19767,126,1.07 [0.77-1.50],0.6769150005395639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIP,Gastric inhibitory polypeptide,19922,125,1.14 [0.83-1.56],0.4277284505461705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIPC2,PDZ domain-containing protein GIPC2,20438,131,1.35 [0.80-2.27],0.2632418035701865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIPC3,PDZ domain-containing protein GIPC3,20422,129,1.10 [0.93-1.31],0.2781248255796186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIPR,Gastric inhibitory polypeptide receptor,19884,122,1.07 [0.74-1.55],0.7076742138971485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GIT1,ARF GTPase-activating protein GIT1,19884,122,1.08 [0.90-1.29],0.4279947654996074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GJA8,Gap junction alpha-8 protein,19767,126,1.07 [0.82-1.39],0.6271651969135937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GKN1,Gastrokine-1,22686,146,0.94 [0.55-1.60],0.8107797105662973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLA,Alpha-galactosidase A,19991,132,1.23 [0.80-1.91],0.3434629216052969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLB1,Beta-galactosidase,23436,150,1.15 [0.82-1.60],0.4202045087079304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLI2,Zinc finger protein GLI2,19884,122,0.93 [0.54-1.61],0.7992010046275031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLO1,Lactoylglutathione lyase,23208,146,1.37 [1.07-1.76],0.0124172547796419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLOD4,Glyoxalase domain-containing protein 4,23567,148,1.49 [0.98-2.27],0.0637080153185095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLP1R,Glucagon-like peptide 1 receptor,19830,123,0.78 [0.46-1.33],0.3647063642202318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLRX,Glutaredoxin-1,23489,149,1.33 [1.05-1.69],0.0176920043983025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20023,132,1.17 [0.97-1.41],0.1001985177221287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23119,148,1.07 [0.79-1.44],0.666854143487765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GLYR1,Putative oxidoreductase GLYR1,20415,129,1.05 [0.80-1.39],0.7132346390444391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GM2A,Ganglioside GM2 activator,19996,131,0.90 [0.57-1.43],0.6567865720261563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GMFG,Glia maturation factor gamma,20484,132,1.26 [1.00-1.59],0.0514666516099944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GMPR,GMP reductase 1,23917,149,1.20 [0.88-1.63],0.2544389822350374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GMPR2,GMP reductase 2,20023,132,1.32 [1.03-1.69],0.0277817150399412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNAS,Neuroendocrine secretory protein 55,20447,131,1.17 [0.98-1.39],0.0807556659294827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23083,148,1.11 [0.89-1.38],0.3500680851134717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19939,127,1.16 [0.86-1.55],0.3291771234749585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNLY,Granulysin,23652,147,0.92 [0.71-1.20],0.5543410420664951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNPDA1,Glucosamine-6-phosphate isomerase 1,19922,125,1.03 [0.62-1.69],0.915834543423851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GNPDA2,Glucosamine-6-phosphate isomerase 2,20023,132,1.42 [0.92-2.20],0.1164989592311953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOLGA3,Golgin subfamily A member 3,20447,131,1.11 [0.90-1.37],0.3280263757960768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOLM2,Protein GOLM2,23855,150,0.89 [0.47-1.68],0.711932791477617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,23613,149,1.10 [0.95-1.27],0.1928552681103284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GORASP2,Golgi reassembly-stacking protein 2,20422,129,1.36 [0.97-1.90],0.0754457310361019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GOT1,"Aspartate aminotransferase, cytoplasmic",20492,132,0.79 [0.52-1.20],0.2688856660430793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP1BA,Platelet glycoprotein Ib alpha chain,23561,147,1.31 [0.85-2.01],0.2160278978420005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP1BB,Platelet glycoprotein Ib beta chain,19790,124,1.06 [0.83-1.37],0.6344820075482208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22906,143,1.02 [0.86-1.22],0.8059463810407895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP5,Platelet glycoprotein V,20023,132,1.32 [0.83-2.12],0.2447254844855883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GP6,Platelet glycoprotein VI,23608,147,1.16 [0.98-1.37],0.0772741588362574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPA33,Cell surface A33 antigen,23526,149,0.97 [0.87-1.08],0.5590865464789474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPC1,Glypican-1,23846,151,0.82 [0.50-1.33],0.4152641974628528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPC5,Glypican-5,23436,150,1.02 [0.78-1.32],0.902904226897671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPD1,Glycerol-3-phosphate dehydrogenase,20415,129,0.84 [0.60-1.17],0.293914667314727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPHA2,Glycoprotein hormone alpha-2,20422,129,1.18 [0.83-1.66],0.3563185165097761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPI,Glucose-6-phosphate isomerase,20513,128,1.36 [0.97-1.90],0.0706832405655424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,20422,129,1.13 [0.88-1.45],0.3399227138706469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPKOW,G-patch domain and KOW motifs-containing protein,23119,148,0.72 [0.41-1.27],0.2542910539096539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPNMB,Transmembrane glycoprotein NMB,23001,145,1.01 [0.61-1.69],0.9610502958605088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR101,Probable G-protein coupled receptor 101,19830,123,0.74 [0.50-1.10],0.1388987541482978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR158,Probable G-protein coupled receptor 158,20447,131,0.55 [0.30-0.98],0.0421550013577448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR15L,Protein GPR15L,20422,129,0.95 [0.73-1.25],0.7317247207498612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPR37,Prosaposin receptor GPR37,23208,146,1.02 [0.81-1.28],0.8544431448143481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GPRC5C,G-protein coupled receptor family C group 5 member C,20415,129,1.10 [0.82-1.47],0.516948028200153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRAP2,GRB2-related adapter protein 2,23640,150,1.10 [0.99-1.24],0.0862780896862762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20484,132,1.35 [1.04-1.76],0.0247282567322229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRIK2,"Glutamate receptor ionotropic, kainate 2",20447,131,0.87 [0.57-1.33],0.5272936354466554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19830,123,0.74 [0.50-1.12],0.1524136169709928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRK5,G protein-coupled receptor kinase 5,23208,146,1.20 [0.93-1.55],0.1532210272474951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRN,Progranulin,23526,147,1.03 [0.57-1.88],0.9140446309953258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRP,Gastrin-releasing peptide,19922,125,0.88 [0.64-1.21],0.4321281678462518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRPEL1,"GrpE protein homolog 1, mitochondrial",23526,149,1.16 [0.92-1.47],0.2014548170088018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GRSF1,G-rich sequence factor 1,19657,126,1.14 [0.93-1.39],0.1975129316564863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSAP,Gamma-secretase-activating protein,23083,148,0.98 [0.82-1.18],0.8396828940068778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSN,Gelsolin,20427,128,0.48 [0.20-1.13],0.0921859079785471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSR,"Glutathione reductase, mitochondrial",20404,127,0.74 [0.34-1.60],0.4447487378956136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTA1,Glutathione S-transferase A1,23603,150,0.91 [0.76-1.08],0.2775241100413914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTA3,Glutathione S-transferase A3,23083,148,0.86 [0.70-1.05],0.1287543239456051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTM4,Glutathione S-transferase Mu 4,19790,124,0.85 [0.65-1.12],0.2461256459995393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTP1,Glutathione S-transferase P,22970,146,1.03 [0.83-1.27],0.800769431065641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GSTT2B,Glutathione S-transferase theta-2B,20438,131,1.00 [0.93-1.07],0.9455863011742834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20126,125,1.11 [0.89-1.39],0.3474915268681604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GTPBP2,GTP-binding protein 2,19939,127,1.18 [0.96-1.45],0.1199987435308695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUCA2A,Guanylin,23527,146,1.18 [0.77-1.80],0.4402905756704052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUCY2C,Heat-stable enterotoxin receptor,20126,125,1.02 [0.83-1.26],0.8226528486553167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUK1,Guanylate kinase,19790,124,1.17 [0.80-1.72],0.4241918989692839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GUSB,Beta-glucuronidase,23740,146,1.03 [0.82-1.31],0.7838776501482967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GYS1,"Glycogen [starch] synthase, muscle",23208,146,1.09 [0.93-1.28],0.2705441610086839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GZMA,Granzyme A,23917,149,1.02 [0.67-1.57],0.9131496930128982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GZMB,Granzyme B,23613,149,1.04 [0.84-1.27],0.7445613810369727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,GZMH,Granzyme H,23208,146,0.99 [0.82-1.19],0.9166672959879436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,H2AP,Huntingtin-interacting protein M,19767,126,0.90 [0.61-1.31],0.5777699575922608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19790,124,1.14 [0.92-1.41],0.2410058186802369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23782,151,1.16 [0.95-1.42],0.1399022649939202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAO1,Hydroxyacid oxidase 1,23846,151,0.99 [0.88-1.11],0.862618187854401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HARS1,"Histidine--tRNA ligase, cytoplasmic",23652,147,1.15 [0.95-1.39],0.1467791859827235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAVCR1,Hepatitis A virus cellular receptor 1,23810,151,1.29 [1.04-1.60],0.0180348542092744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HAVCR2,Hepatitis A virus cellular receptor 2,23652,147,1.19 [0.79-1.80],0.3990660694263241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HBEGF,Proheparin-binding EGF-like growth factor,23782,151,0.98 [0.81-1.19],0.8233200935550322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HBQ1,Hemoglobin subunit theta-1,23846,151,1.18 [0.95-1.47],0.1305664358775075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HBZ,Hemoglobin subunit zeta,20484,132,1.12 [0.97-1.30],0.1342423398769191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HCG22,Protein PBMUCL2,19790,124,1.10 [0.85-1.43],0.4801998211878716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HCLS1,Hematopoietic lineage cell-specific protein,23917,149,1.19 [0.92-1.55],0.1889540042263071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDAC8,Histone deacetylase 8,19884,122,1.16 [0.91-1.48],0.2185150781926032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDAC9,Histone deacetylase 9,19830,123,1.08 [0.85-1.36],0.5216704950669596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDDC2,5'-deoxynucleotidase HDDC2,20422,129,1.29 [0.90-1.85],0.1711243418736553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDGF,Hepatoma-derived growth factor,23806,151,1.23 [1.05-1.43],0.0093243641266816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HDGFL2,Hepatoma-derived growth factor-related protein 2,20438,131,1.27 [1.00-1.60],0.0472599776759483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEBP1,Heme-binding protein 1,23208,146,1.04 [0.79-1.36],0.7878121204406179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEG1,Protein HEG homolog 1,20023,132,2.32 [1.27-4.24],0.0060800275450311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEPACAM2,HEPACAM family member 2,20438,131,0.96 [0.65-1.42],0.8447606301884772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEPH,Hephaestin,20484,132,1.09 [0.59-2.03],0.7772576613627838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HEXIM1,Protein HEXIM1,23613,149,1.12 [0.94-1.35],0.1976808005833395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HGF,Hepatocyte growth factor,23917,149,0.98 [0.64-1.50],0.9280608247695548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HGFAC,Hepatocyte growth factor activator,20329,125,1.17 [0.61-2.23],0.6350846214645467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23083,148,1.22 [1.02-1.46],0.0320623532251473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HHEX,Hematopoietically-expressed homeobox protein HHEX,20438,131,1.17 [0.94-1.44],0.1620591650864909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HIF1A,Hypoxia-inducible factor 1-alpha,19884,122,1.18 [0.94-1.48],0.1534156876850007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HIP1,Huntingtin-interacting protein 1,19790,124,0.94 [0.55-1.60],0.8085677748231859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HIP1R,Huntingtin-interacting protein 1-related protein,20398,130,1.03 [0.72-1.48],0.8736192078393321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HJV,Hemojuvelin,20447,131,0.72 [0.46-1.11],0.139126314134919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HK2,Hexokinase-2,23208,146,0.95 [0.55-1.63],0.8442542244686059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",20447,131,1.12 [0.67-1.86],0.6687896071711992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23535,149,0.69 [0.46-1.04],0.0740967826699346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23613,149,1.61 [1.02-2.56],0.0421794118340041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMBS,Porphobilinogen deaminase,23846,151,1.34 [0.94-1.91],0.1035085551061148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMCN2,Hemicentin-2,19987,132,0.97 [0.73-1.30],0.8615214904528896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19922,125,1.03 [0.72-1.46],0.8884207424719481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19790,124,1.22 [0.86-1.74],0.264955304437341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMMR,Hyaluronan mediated motility receptor,19723,126,0.99 [0.69-1.41],0.9556510290757771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMOX1,Heme oxygenase 1,23380,149,0.95 [0.70-1.28],0.7295641958588786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HMOX2,Heme oxygenase 2,23119,148,0.89 [0.64-1.25],0.5129617645653827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNF1A,Hepatocyte nuclear factor 1-alpha,19939,127,0.87 [0.66-1.16],0.3504023912433539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNMT,Histamine N-methyltransferase,23330,149,0.88 [0.65-1.20],0.4228209349105923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23128,145,1.35 [1.13-1.61],0.0010147816595199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,20447,131,1.43 [1.12-1.84],0.0045580249190886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HPCAL1,Hippocalcin-like protein 1,23917,149,1.13 [0.92-1.38],0.2342745203520112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HPGDS,Hematopoietic prostaglandin D synthase,23083,148,0.72 [0.48-1.07],0.1031766929739338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HPSE,Heparanase,20238,132,1.16 [0.97-1.39],0.1016432553888256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HRAS,GTPase Hras,20090,125,0.98 [0.82-1.18],0.8502910495118018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19922,125,0.82 [0.47-1.45],0.5051471240170224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HRG,Histidine-rich glycoprotein,20407,132,0.85 [0.50-1.42],0.527113850515625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS1BP3,HCLS1-binding protein 3,19922,125,1.17 [0.97-1.41],0.1085175426655697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,23526,149,0.97 [0.66-1.43],0.876968266071251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23846,151,0.90 [0.59-1.38],0.6389168322309773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19884,122,0.96 [0.60-1.55],0.8731629508617496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSBP1,Heat shock factor-binding protein 1,19922,125,1.15 [0.96-1.38],0.1174611390056683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,23613,149,0.86 [0.60-1.24],0.420054227301222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20438,131,0.88 [0.67-1.16],0.3711333066922643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19790,124,1.04 [0.73-1.49],0.8137504577255712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19922,125,0.77 [0.53-1.12],0.1717500202531933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSP90B1,Endoplasmin,23009,145,0.94 [0.74-1.20],0.6367507185363479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPA1A,Heat shock 70 kDa protein 1A,23680,148,1.10 [0.90-1.34],0.369852839284178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPA2,Heat shock-related 70 kDa protein 2,20415,129,0.83 [0.50-1.40],0.4852195163975246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPB1,Heat shock protein beta-1,23274,148,1.19 [0.95-1.48],0.12778535290127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPB6,Heat shock protein beta-6,23846,151,0.86 [0.59-1.24],0.420283856363028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23488,147,1.03 [0.59-1.80],0.9170824904771548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HTR1A,5-hydroxytryptamine receptor 1A,19830,123,1.02 [0.80-1.30],0.8602519743865361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HTR1B,5-hydroxytryptamine receptor 1B,19830,123,0.81 [0.52-1.26],0.3478508899278653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HTRA2,"Serine protease HTRA2, mitochondrial",23701,148,1.17 [0.93-1.48],0.1796497237836961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HYAL1,Hyaluronidase-1,23539,145,1.30 [0.69-2.44],0.4211487304352301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,HYOU1,Hypoxia up-regulated protein 1,23938,149,1.17 [0.63-2.19],0.6125396731502428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICA1,Islet cell autoantigen 1,23231,145,1.12 [0.93-1.34],0.2276080063247314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM1,Intercellular adhesion molecule 1,23556,147,1.30 [0.78-2.15],0.3099102008667528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM2,Intercellular adhesion molecule 2,23938,149,1.89 [1.20-2.98],0.0059588210428629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM3,Intercellular adhesion molecule 3,23938,149,1.27 [0.75-2.16],0.3728164232863329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM4,Intercellular adhesion molecule 4,23613,149,1.37 [1.03-1.81],0.0278775286541542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICAM5,Intercellular adhesion molecule 5,23640,150,1.15 [0.84-1.57],0.3769399072928421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ICOSLG,ICOS ligand,23526,149,0.96 [0.45-2.06],0.915945603634708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ID4,DNA-binding protein inhibitor ID-4,20126,125,1.08 [0.74-1.57],0.6989027092319045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDI2,Isopentenyl-diphosphate delta-isomerase 2,23119,148,0.86 [0.63-1.18],0.3604826504640684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDO1,"Indoleamine 2,3-dioxygenase 1",19922,125,0.93 [0.71-1.23],0.6316056118144685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDS,Iduronate 2-sulfatase,23917,149,1.15 [0.23-5.78],0.8649317108803827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IDUA,Alpha-L-iduronidase,23846,151,0.87 [0.65-1.18],0.3714217237765141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19935,126,1.06 [0.69-1.65],0.781108353634481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20126,125,1.02 [0.73-1.43],0.9023234913228564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20126,125,1.33 [0.89-1.98],0.1708649795297518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNAR1,Interferon alpha/beta receptor 1,20422,129,1.26 [0.66-2.38],0.4815372338150839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNG,Interferon gamma,23231,145,1.01 [0.89-1.15],0.8545256933175954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNGR1,Interferon gamma receptor 1,23725,148,1.27 [0.65-2.46],0.4868847301028979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNGR2,Interferon gamma receptor 2,23436,150,1.13 [0.86-1.48],0.3773676555297808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNL1,Interferon lambda-1,23119,148,1.02 [0.74-1.42],0.8919113473449441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNL2,Interferon lambda-2,19830,123,0.98 [0.73-1.32],0.8945005366005673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNLR1,Interferon lambda receptor 1,23613,149,0.77 [0.49-1.20],0.2419647911902382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFNW1,Interferon omega-1,19790,124,0.76 [0.43-1.35],0.3523599921290873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IFT20,Intraflagellar transport protein 20 homolog,19939,127,1.09 [0.74-1.59],0.6630374158116372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGBP1,Immunoglobulin-binding protein 1,20447,131,1.43 [1.10-1.86],0.0072095751245234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19830,123,0.79 [0.51-1.21],0.2750392677487031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20492,132,0.63 [0.35-1.14],0.1245972681629526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGF1R,Insulin-like growth factor 1 receptor,23526,149,2.31 [1.32-4.05],0.0034549124921469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19790,124,1.11 [0.78-1.58],0.5537457430704824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGF2R,Cation-independent mannose-6-phosphate receptor,23652,147,1.13 [0.61-2.08],0.7014791929877091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP1,Insulin-like growth factor-binding protein 1,23905,149,0.98 [0.87-1.10],0.7377046885613456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP2,Insulin-like growth factor-binding protein 2,23903,149,1.27 [1.00-1.62],0.0520153763431304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP3,Insulin-like growth factor-binding protein 3,23752,148,0.94 [0.60-1.46],0.7864009044687703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP4,Insulin-like growth factor-binding protein 4,23368,145,1.31 [0.96-1.79],0.092737861576696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP6,Insulin-like growth factor-binding protein 6,23561,148,1.09 [0.69-1.74],0.7083879770545438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBP7,Insulin-like growth factor-binding protein 7,23938,149,0.91 [0.56-1.48],0.6954920262108665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFBPL1,Insulin-like growth factor-binding protein-like 1,23640,150,0.74 [0.47-1.17],0.1940912109156369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGFL4,Insulin growth factor-like family member 4,19884,122,0.95 [0.73-1.23],0.7086712043103298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGHMBP2,DNA-binding protein SMUBP-2,19790,124,1.17 [0.89-1.55],0.2688636036507479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGLC2,Immunoglobulin lambda constant 2,20482,132,0.76 [0.35-1.66],0.4899287640706113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGLON5,IgLON family member 5,19767,126,0.92 [0.74-1.13],0.4192749930312621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF21,Immunoglobulin superfamily member 21,19922,125,1.15 [0.76-1.72],0.5087668960995535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF3,Immunoglobulin superfamily member 3,23526,149,1.24 [0.85-1.81],0.2722675953576387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF8,Immunoglobulin superfamily member 8,23640,150,1.63 [1.07-2.49],0.0242991512698874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IGSF9,Protein turtle homolog A,20484,132,0.95 [0.78-1.16],0.623272159816961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IKBKG,NF-kappa-B essential modulator,23613,149,1.04 [0.89-1.22],0.6260557532088376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IKZF2,Zinc finger protein Helios,23083,148,0.91 [0.75-1.10],0.3189360591096448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL10,Interleukin-10,23231,145,1.14 [0.96-1.35],0.1458761720992124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL10RA,Interleukin-10 receptor subunit alpha,23231,145,1.05 [0.82-1.34],0.6875619867678746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL10RB,Interleukin-10 receptor subunit beta,23725,148,1.13 [0.70-1.85],0.6135149040981269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL11,Interleukin-11,23231,145,0.75 [0.56-0.99],0.0446747360180289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12A_IL12B,Interleukin-12,23526,149,1.06 [0.88-1.28],0.5111488779996294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12B,Interleukin-12 subunit beta,23917,149,1.05 [0.81-1.37],0.7010107458326769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12RB1,Interleukin-12 receptor subunit beta-1,23231,145,0.95 [0.64-1.41],0.7997441811909305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL12RB2,Interleukin-12 receptor subunit beta-2,19884,122,1.23 [0.84-1.81],0.2921818741904274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL13,Interleukin-13,23231,145,1.02 [0.75-1.38],0.8939344920586694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL13RA1,Interleukin-13 receptor subunit alpha-1,23341,143,0.69 [0.38-1.28],0.2414330728966709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL13RA2,Interleukin-13 receptor subunit alpha-2,19830,123,0.74 [0.41-1.33],0.3116667673225329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL15,Interleukin-15,23613,149,1.00 [0.65-1.56],0.9919528161321898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL15RA,Interleukin-15 receptor subunit alpha,23231,145,1.42 [0.93-2.16],0.1056926071492046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL16,Pro-interleukin-16,23917,149,0.94 [0.67-1.32],0.7126788867957381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17A,Interleukin-17A,23183,143,0.97 [0.68-1.38],0.867243068546765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17C,Interleukin-17C,23231,145,1.14 [0.94-1.38],0.1767868170066612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17D,Interleukin-17D,23231,145,0.72 [0.43-1.20],0.2035509397995822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17F,Interleukin-17F,23231,145,1.12 [0.93-1.34],0.2279369471584578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17RA,Interleukin-17 receptor A,23652,147,1.07 [0.77-1.48],0.7041477348057881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL17RB,Interleukin-17 receptor B,23318,148,1.28 [0.98-1.68],0.0697019511723552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18,Interleukin-18,23526,148,1.17 [0.85-1.60],0.3476609546807778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18BP,Interleukin-18-binding protein,23752,148,1.39 [0.89-2.19],0.1506641175454787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18R1,Interleukin-18 receptor 1,23917,149,1.27 [0.82-1.96],0.2848281205374934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL18RAP,Interleukin-18 receptor accessory protein,23285,149,0.98 [0.89-1.07],0.6118383442239567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL19,Interleukin-19,23050,146,1.12 [0.92-1.37],0.2396263081500712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1A,Interleukin-1 alpha,23231,145,0.95 [0.74-1.23],0.7024169282653996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1B,Interleukin-1 beta,23122,145,1.25 [1.00-1.57],0.0527854064377059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1R1,Interleukin-1 receptor type 1,23609,147,2.27 [1.27-4.06],0.0057121567535797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1R2,Interleukin-1 receptor type 2,23565,148,1.04 [0.50-2.15],0.9254026915907708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RAP,Interleukin-1 receptor accessory protein,23652,147,1.15 [0.84-1.57],0.3931946965235631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RL1,Interleukin-1 receptor-like 1,23859,148,1.35 [0.99-1.85],0.0609757442802509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RL2,Interleukin-1 receptor-like 2,23231,145,1.04 [0.70-1.54],0.8526906211185523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL1RN,Interleukin-1 receptor antagonist protein,23566,147,1.03 [0.78-1.35],0.8444564585923685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2,Interleukin-2,23231,145,0.90 [0.57-1.43],0.6568423233543215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL20,Interleukin-20,23231,145,0.81 [0.57-1.15],0.2324482765627587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL20RA,Interleukin-20 receptor subunit alpha,23231,145,0.93 [0.65-1.31],0.6656742933351161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL20RB,Interleukin-20 receptor subunit beta,19884,122,0.86 [0.56-1.32],0.4944204958593481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL21R,Interleukin-21 receptor,19884,122,1.23 [0.96-1.57],0.1040468481250469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL22,Interleukin-22,20415,129,1.04 [0.82-1.33],0.7334853604679787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL22RA1,Interleukin-22 receptor subunit alpha-1,23231,145,1.05 [0.76-1.45],0.7710768719210926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL24,Interleukin-24,23231,145,0.98 [0.72-1.33],0.9040865169479064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL25,Interleukin-25,19694,126,0.78 [0.47-1.29],0.3318528574307142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2RA,Interleukin-2 receptor subunit alpha,23493,146,1.26 [0.89-1.77],0.1903610896383418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2RB,Interleukin-2 receptor subunit beta,23231,145,0.96 [0.64-1.44],0.8344424019958825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL2RG,Cytokine receptor common subunit gamma,20415,129,1.07 [0.67-1.70],0.7730622897770961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL3,Interleukin-3,19767,126,0.97 [0.74-1.27],0.8272880480843914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL31,Interleukin-31,19884,122,0.88 [0.62-1.24],0.4555430744014785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL31RA,Interleukin-31 receptor subunit alpha,19814,122,0.98 [0.62-1.56],0.9333511305155188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL32,Interleukin-32,23613,149,0.69 [0.48-0.98],0.0386437194740141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL33,Interleukin-33,23231,145,0.92 [0.63-1.34],0.6700301337060245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL34,Interleukin-34,23077,146,0.72 [0.49-1.07],0.1042937541090823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL36A,Interleukin-36 alpha,19884,122,0.95 [0.68-1.31],0.7381216109669357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL36G,Interleukin-36 gamma,19815,122,1.01 [0.78-1.31],0.935441275263326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL3RA,Interleukin-3 receptor subunit alpha,23231,145,1.24 [0.79-1.96],0.3521183339510871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL4,Interleukin-4,23231,145,0.99 [0.84-1.16],0.8789299123602895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL4R,Interleukin-4 receptor subunit alpha,23613,149,1.34 [0.91-1.96],0.1399958765919928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL5,Interleukin-5,23231,145,1.00 [0.89-1.11],0.9528341758498892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL5RA,Interleukin-5 receptor subunit alpha,23613,149,0.99 [0.76-1.28],0.921693333326278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL6,Interleukin-6,23526,149,1.13 [0.95-1.35],0.1523809662556113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL6R,Interleukin-6 receptor subunit alpha,23524,147,1.22 [0.80-1.86],0.3607982347079164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL6ST,Interleukin-6 receptor subunit beta,23640,150,1.48 [0.65-3.37],0.347117849582463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL7,Interleukin-7,23613,149,1.15 [0.92-1.43],0.2201606839857378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL7R,Interleukin-7 receptor subunit alpha,23652,147,1.21 [0.91-1.61],0.1943659440089702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IL9,Interleukin-9,20126,125,0.97 [0.70-1.34],0.8471816866808133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23078,147,1.01 [0.79-1.30],0.9440027721670178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMMT,MICOS complex subunit MIC60,20415,129,1.07 [0.73-1.55],0.7343490912638786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMPA1,Inositol monophosphatase 1,23436,150,1.27 [1.01-1.60],0.0421431273896477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMPACT,Protein IMPACT,20438,131,1.39 [1.03-1.87],0.0317462378236035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IMPG1,Interphotoreceptor matrix proteoglycan 1,19830,123,0.87 [0.47-1.59],0.6458937744571538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ING1,Inhibitor of growth protein 1,23086,148,1.21 [0.93-1.56],0.155149479044091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INHBB,Inhibin beta B chain,20023,132,1.29 [0.94-1.76],0.1138236224644334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INHBC,Inhibin beta C chain,23652,147,1.15 [0.79-1.67],0.4773308189081203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPP1,Inositol polyphosphate 1-phosphatase,23526,149,1.02 [0.78-1.34],0.8742062276034209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19922,125,1.25 [0.93-1.67],0.1344251325037072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",20447,131,0.95 [0.63-1.45],0.8181145653566901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",23526,149,1.06 [0.91-1.23],0.4757530312796714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSL3,Insulin-like 3,20438,131,0.90 [0.75-1.08],0.2503771901438668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSL4,Early placenta insulin-like peptide,20415,129,0.95 [0.66-1.38],0.7938279256870122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSL5,Insulin-like peptide INSL5,20422,129,1.04 [0.88-1.23],0.6749404810046955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,INSR,Insulin receptor,19884,122,1.48 [0.54-4.01],0.4462584935200514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IPCEF1,Interactor protein for cytohesin exchange factors 1,23393,149,1.09 [0.92-1.28],0.3200836247305597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IQGAP2,Ras GTPase-activating-like protein IQGAP2,23526,149,0.94 [0.71-1.23],0.6296478838145597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",23208,146,0.89 [0.74-1.06],0.1929494714936361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IRAK1,Interleukin-1 receptor-associated kinase 1,23231,145,1.08 [0.87-1.33],0.4986779728797688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IRAK4,Interleukin-1 receptor-associated kinase 4,23613,149,1.15 [1.00-1.33],0.0561550456900491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22779,147,0.94 [0.64-1.39],0.7606520143214874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ISM1,Isthmin-1,23613,149,0.88 [0.61-1.27],0.4848484599510758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ISM2,Isthmin-2,20492,132,0.84 [0.56-1.26],0.4075614874385223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IST1,IST1 homolog,20266,129,1.23 [1.03-1.47],0.020810572243132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA11,Integrin alpha-11,23613,149,0.82 [0.53-1.26],0.3613452258458349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA2,Integrin alpha-2,20023,132,1.10 [0.67-1.78],0.7138917789275094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA5,Integrin alpha-5,23652,147,1.10 [0.61-1.98],0.7621840274052599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGA6,Integrin alpha-6,23613,149,1.20 [0.92-1.57],0.1762727190892768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAL,Integrin alpha-L,19884,122,1.21 [0.80-1.82],0.3728005583324445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAM,Integrin alpha-M,23652,147,1.58 [1.01-2.46],0.0449505455238311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAV,Integrin alpha-V,23846,151,0.95 [0.40-2.26],0.9009270923923564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGAX,Integrin alpha-X,20126,125,1.17 [0.87-1.58],0.2842178179056571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB1,Integrin beta-1,23638,148,1.60 [0.83-3.11],0.1631516688694625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB1BP1,Integrin beta-1-binding protein 1,23083,148,0.77 [0.54-1.11],0.1672609363278344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB1BP2,Integrin beta-1-binding protein 2,23208,146,1.13 [0.99-1.29],0.0775537840410517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB2,Integrin beta-2,23526,145,1.73 [1.07-2.80],0.0262573104530728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB5,Integrin beta-5,23701,148,1.15 [0.79-1.68],0.4538196581912678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB6,Integrin beta-6,23231,145,0.92 [0.57-1.50],0.7495854293026909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGB7,Integrin beta-7,23846,151,1.14 [0.84-1.54],0.4059626060109413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITGBL1,Integrin beta-like protein 1,20492,132,0.67 [0.42-1.06],0.0896101113469979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20510,132,1.66 [0.71-3.90],0.2410064736145613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23752,148,1.30 [0.89-1.91],0.1777502020544488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20510,132,1.10 [0.56-2.17],0.7770145270462108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,20415,129,0.71 [0.47-1.08],0.1123585971997636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITM2A,Integral membrane protein 2A,23613,149,0.98 [0.77-1.24],0.8436219669331504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITPA,Inosine triphosphate pyrophosphatase,19790,124,1.49 [1.18-1.89],0.000810544846412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19922,125,1.14 [0.91-1.43],0.2695404948839112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19830,123,1.01 [0.68-1.48],0.974302737440726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23119,148,1.18 [0.91-1.54],0.218417464288967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,IZUMO1,Izumo sperm-egg fusion protein 1,19767,126,1.16 [0.85-1.60],0.3547961503987807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JAM2,Junctional adhesion molecule B,23855,150,1.36 [0.80-2.29],0.2522132497340005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JAM3,Junctional adhesion molecule C,20023,132,1.22 [0.89-1.68],0.220970312534659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JCHAIN,Immunoglobulin J chain,23231,145,1.05 [0.83-1.34],0.6696607038273642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19767,126,1.11 [0.84-1.46],0.4667029006453672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JPT2,Jupiter microtubule associated homolog 2,20422,129,1.24 [1.02-1.51],0.0299248132566319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,JUN,Transcription factor AP-1,23231,145,0.86 [0.61-1.22],0.3999317275936768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,23526,149,1.26 [0.90-1.76],0.1796639667781352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KAZN,Kazrin,20422,129,1.08 [0.92-1.27],0.3742824445351447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCNC4,Potassium voltage-gated channel subfamily C member 4,19830,123,1.02 [0.74-1.39],0.9174608100146552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCNH2,Potassium voltage-gated channel subfamily H member 2,19939,127,1.08 [0.88-1.33],0.4766196298001971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCNIP4,Kv channel-interacting protein 4,23119,148,1.12 [0.86-1.45],0.3998948296419966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KCTD5,BTB/POZ domain-containing protein KCTD5,20049,126,0.80 [0.53-1.20],0.2829438552493374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KDM3A,Lysine-specific demethylase 3A,19884,122,0.94 [0.76-1.16],0.543473998521283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KDR,Vascular endothelial growth factor receptor 2,23701,148,1.67 [0.93-3.00],0.0870345157073917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KEL,Kell blood group glycoprotein,23119,148,1.31 [0.87-1.95],0.1929653975088941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KHDC3L,KH domain-containing protein 3,19767,126,0.96 [0.74-1.26],0.7940089525209197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KHK,Ketohexokinase,19922,125,0.97 [0.73-1.28],0.8213897097825551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA0319,Dyslexia-associated protein KIAA0319,20438,131,0.90 [0.52-1.57],0.7097064580484758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA1549,UPF0606 protein KIAA1549,20126,125,1.05 [0.82-1.35],0.7061652371557503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA1549L,UPF0606 protein KIAA1549L,20126,125,1.31 [0.73-2.36],0.3614885060377595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIAA2013,Uncharacterized protein KIAA2013,20415,129,0.95 [0.68-1.33],0.7684053955769556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIF1C,Kinesin-like protein KIF1C,19790,124,1.32 [0.87-1.99],0.1951547685528391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIF20B,Kinesin-like protein KIF20B,19830,123,1.06 [0.85-1.32],0.6151582071494037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIF22,Kinesin-like protein KIF22,19790,124,1.04 [0.90-1.20],0.5937385764208984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIFBP,KIF-binding protein,23526,149,1.17 [0.98-1.40],0.0775890619584744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,20415,129,0.98 [0.81-1.18],0.8131633559903283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23083,148,1.01 [0.84-1.22],0.9144195705529656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,20422,129,0.98 [0.89-1.08],0.7144177746807785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23083,148,1.01 [0.90-1.13],0.880362531020016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19767,126,1.03 [0.85-1.26],0.7342597008294192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIRREL1,Kin of IRRE-like protein 1,19830,123,1.28 [1.02-1.60],0.0324299702504012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIRREL2,Kin of IRRE-like protein 2,23119,148,0.95 [0.66-1.38],0.801254472613814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KIT,Mast/stem cell growth factor receptor Kit,23717,148,1.25 [0.76-2.04],0.3825545936039397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KITLG,Kit ligand,23640,150,0.99 [0.67-1.45],0.9399056674230596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLB,Beta-klotho,23119,148,1.02 [0.84-1.23],0.8780258682428419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLF4,Krueppel-like factor 4,19830,123,1.02 [0.68-1.54],0.9053574330679026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLHL41,Kelch-like protein 41,20447,131,1.04 [0.76-1.44],0.7912811703134904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK1,Kallikrein-1,23420,146,1.05 [0.94-1.17],0.384235527440579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK10,Kallikrein-10,23635,148,0.76 [0.52-1.09],0.1368257395570008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK11,Kallikrein-11,23474,147,0.92 [0.57-1.48],0.7284152049276125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK12,Kallikrein-12,23083,148,1.07 [0.96-1.20],0.210659722384976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK13,Kallikrein-13,23101,148,1.05 [0.76-1.45],0.7697772609649307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK14,Kallikrein-14,23846,151,0.70 [0.52-0.96],0.0272659671982262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK15,Kallikrein-15,20374,129,1.02 [0.74-1.42],0.890120195689132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK3,Prostate-specific antigen,20492,132,0.90 [0.78-1.04],0.1391358179856672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK4,Kallikrein-4,23846,151,1.12 [0.90-1.40],0.309444534938611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK6,Kallikrein-6,23657,148,0.88 [0.55-1.42],0.6076067576366482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK7,Kallikrein-7,19530,130,0.58 [0.37-0.91],0.0176572731403206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLK8,Kallikrein-8,22834,142,0.67 [0.44-1.02],0.0649351775543666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLKB1,Plasma kallikrein,20093,131,1.34 [0.67-2.68],0.4025285697787576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRB1,Killer cell lectin-like receptor subfamily B member 1,23917,149,1.26 [0.88-1.82],0.2124227798653608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19830,123,0.91 [0.67-1.25],0.5781996350187502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRD1,Natural killer cells antigen CD94,23917,149,1.21 [0.89-1.63],0.2255821411992739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19884,122,1.12 [0.80-1.56],0.5251869843084109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KLRK1,NKG2-D type II integral membrane protein,20438,131,1.06 [0.74-1.52],0.7371410321880946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT14,"Keratin, type I cytoskeletal 14",22414,147,0.73 [0.42-1.26],0.2559152165572386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT17,"Keratin, type I cytoskeletal 17",19790,124,0.91 [0.58-1.44],0.6991291557980188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT18,"Keratin, type I cytoskeletal 18",23526,149,0.95 [0.79-1.13],0.5587560556019173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT19,"Keratin, type I cytoskeletal 19",23570,149,1.08 [0.87-1.33],0.5010502050196459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT5,"Keratin, type II cytoskeletal 5",23119,148,0.72 [0.53-0.97],0.0291755892514856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT6C,"Keratin, type II cytoskeletal 6C",19790,124,0.61 [0.35-1.07],0.0831121308346817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KRT8,"Keratin, type II cytoskeletal 8",19830,123,0.88 [0.68-1.14],0.3336540495599882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KYAT1,Kynurenine--oxoglutarate transaminase 1,23602,149,1.27 [1.00-1.62],0.0542211921174804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,KYNU,Kynureninase,23917,149,0.92 [0.67-1.27],0.6197058119674982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,L1CAM,Neural cell adhesion molecule L1,23701,148,1.38 [0.85-2.25],0.1926875244547353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20484,132,1.16 [0.96-1.39],0.1231993663922237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LACRT,Extracellular glycoprotein lacritin,20375,129,0.82 [0.53-1.25],0.3453897179055692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LACTB2,Endoribonuclease LACTB2,23640,150,1.25 [1.01-1.54],0.0427366550288429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAG3,Lymphocyte activation gene 3 protein,23526,149,1.19 [0.84-1.68],0.3388471193112206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23606,148,1.13 [0.79-1.61],0.5126604750256589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,23436,150,1.05 [0.91-1.20],0.527861821405698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMA1,Laminin subunit alpha-1,19790,124,1.07 [0.78-1.47],0.6747311807002125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMA4,Laminin subunit alpha-4,23725,148,1.00 [0.65-1.54],0.9829148160872598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMB1,Laminin subunit beta-1,19922,125,0.84 [0.48-1.46],0.5300217278729767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMP1,Lysosome-associated membrane glycoprotein 1,19929,130,1.02 [0.57-1.85],0.9364968277055424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMP2,Lysosome-associated membrane glycoprotein 2,22924,146,1.01 [0.49-2.07],0.9720819846054743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMP3,Lysosome-associated membrane glycoprotein 3,23878,149,0.97 [0.73-1.28],0.8200911765854406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAMTOR5,Ragulator complex protein LAMTOR5,20415,129,0.70 [0.44-1.11],0.1304104966546532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAP3,Cytosol aminopeptidase,23231,145,0.95 [0.70-1.30],0.764871283579204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LARP1,La-related protein 1,20415,129,1.28 [1.02-1.61],0.0349394011300719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAT,Linker for activation of T-cells family member 1,23917,149,1.21 [1.00-1.48],0.0526459551575629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAT2,Linker for activation of T-cells family member 2,23526,149,1.08 [0.97-1.21],0.1698269777009669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LATS1,Serine/threonine-protein kinase LATS1,19884,122,1.17 [0.96-1.43],0.1243392917492205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LAYN,Layilin,23403,150,1.08 [0.71-1.63],0.719779494272583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LBP,Lipopolysaccharide-binding protein,23752,148,1.11 [0.87-1.42],0.4148997367128231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LBR,Delta(14)-sterol reductase LBR,23855,150,1.13 [0.93-1.36],0.2197678124288532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCAT,Phosphatidylcholine-sterol acyltransferase,20513,128,1.15 [0.52-2.54],0.7225177617635942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCN15,Lipocalin-15,20447,131,1.24 [1.00-1.56],0.0545922362830479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCN2,Neutrophil gelatinase-associated lipocalin,22942,142,1.06 [0.73-1.55],0.7522206331232787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LCP1,Plastin-2,20492,132,0.77 [0.53-1.11],0.1588864259928601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LDLR,Low-density lipoprotein receptor,23707,147,1.10 [0.83-1.47],0.5012266693006946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LDLRAP1,Low density lipoprotein receptor adapter protein 1,20447,131,1.14 [0.97-1.35],0.1149195007805643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LECT2,Leukocyte cell-derived chemotaxin-2,20484,132,0.71 [0.54-0.92],0.0089527741689845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEFTY2,Left-right determination factor 2,23818,151,1.04 [0.78-1.37],0.7989911399644924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEG1,Protein LEG1 homolog,19365,128,1.25 [0.99-1.57],0.0641528378175472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LELP1,Late cornified envelope-like proline-rich protein 1,19830,123,0.95 [0.74-1.23],0.7147193547155345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEO1,RNA polymerase-associated protein LEO1,20447,131,1.00 [0.58-1.73],0.9968144876700188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEP,Leptin,23640,150,0.99 [0.80-1.22],0.9284495186135516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LEPR,Leptin receptor,23640,150,1.64 [1.09-2.47],0.0166634263730752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LETM1,Mitochondrial proton/calcium exchanger protein,20447,131,1.24 [0.93-1.65],0.1478848856887495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS1,Galectin-1,23640,150,1.29 [0.86-1.92],0.2145340149594977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS3,Galectin-3,23715,148,1.26 [0.77-2.05],0.3597870758074113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS3BP,Galectin-3-binding protein,20510,132,0.84 [0.48-1.49],0.5588015060372304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS4,Galectin-4,23606,148,1.28 [1.00-1.64],0.0503962987298003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS7_LGALS7B,Galectin-7,23579,151,0.47 [0.33-0.69],8.426255611490235e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS8,Galectin-8,23855,150,1.24 [0.99-1.56],0.0600083638586041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGALS9,Galectin-9,23612,148,1.18 [0.74-1.89],0.4935637415655963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LGMN,Legumain,23725,148,1.30 [0.88-1.94],0.1901300723809175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LHB,Lutropin subunit beta,23083,148,0.85 [0.70-1.03],0.0886272211919441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,23643,147,1.16 [0.92-1.47],0.2108537893071386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LIF,Leukemia inhibitory factor,23119,148,0.81 [0.59-1.12],0.2023807796390962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LIFR,Leukemia inhibitory factor receptor,23613,149,1.46 [0.80-2.66],0.2145189757717748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23652,147,1.10 [0.73-1.65],0.6496800071564685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20492,132,0.96 [0.86-1.07],0.4263086795700571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19790,124,1.18 [0.86-1.61],0.301491111213488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23609,150,1.14 [0.73-1.77],0.5632279126739195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20484,132,1.05 [0.84-1.32],0.6414843106797519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23938,149,1.01 [0.60-1.71],0.9622059446056432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23824,148,1.12 [0.73-1.70],0.6055727837202385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,23231,145,1.10 [0.78-1.53],0.5885539904602791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23938,149,1.03 [0.84-1.27],0.7581289522209972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LIPF,Gastric triacylglycerol lipase,19922,125,1.11 [0.85-1.46],0.450470993907643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMNB1,Lamin-B1,20385,129,1.13 [0.88-1.46],0.3246241237382924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMNB2,Lamin-B2,20438,131,1.13 [0.62-2.04],0.6923158004888376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMOD1,Leiomodin-1,20447,131,0.92 [0.56-1.53],0.7556393557736174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LMOD2,Leiomodin-2,19830,123,0.82 [0.60-1.12],0.2180520178414413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LONP1,"Lon protease homolog, mitochondrial",19922,125,1.14 [0.94-1.39],0.1770199629693367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPA,Apolipoprotein(a),20048,129,0.97 [0.88-1.06],0.4846390821250934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPCAT2,Lysophosphatidylcholine acyltransferase 2,23526,149,1.07 [0.79-1.45],0.6695987031824963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPL,Lipoprotein lipase,23640,150,1.19 [0.88-1.62],0.2555930500622323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPO,Lactoperoxidase,22802,143,1.19 [0.93-1.51],0.1661975986305058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LPP,Lipoma-preferred partner,19790,124,1.13 [0.87-1.47],0.3616999305922136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19790,124,1.21 [0.95-1.53],0.1243618244390966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19939,127,0.94 [0.63-1.40],0.7493338652125738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRG1,Leucine-rich alpha-2-glycoprotein,20510,132,1.15 [0.61-2.16],0.662493805199946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23782,151,1.59 [1.07-2.37],0.0218953870942091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19822,122,1.05 [0.56-1.99],0.870999227566537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP1,Prolow-density lipoprotein receptor-related protein 1,23526,149,0.97 [0.56-1.68],0.9136295094320728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP11,Low-density lipoprotein receptor-related protein 11,23640,150,1.00 [0.67-1.48],0.9871365979876752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP2,Low-density lipoprotein receptor-related protein 2,19939,127,1.01 [0.63-1.61],0.9774554966593216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRP2BP,LRP2-binding protein,19939,127,0.94 [0.74-1.18],0.5858867716962729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23855,150,1.13 [0.89-1.43],0.3131067979077118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC25,Leucine-rich repeat-containing protein 25,23526,149,1.16 [0.81-1.65],0.4183677716061369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC37A2,Leucine-rich repeat-containing protein 37A2,20422,129,1.07 [0.73-1.58],0.7154200801585947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC38,Leucine-rich repeat-containing protein 38,19939,127,1.17 [0.82-1.65],0.3846099695177001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRC59,Leucine-rich repeat-containing protein 59,20484,132,1.35 [0.99-1.85],0.056619224164432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,20415,129,0.92 [0.65-1.32],0.6657754711646889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRRN1,Leucine-rich repeat neuronal protein 1,23231,145,0.75 [0.52-1.09],0.1334754142276178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19939,127,1.09 [0.73-1.61],0.6711381696757208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,20447,131,0.72 [0.37-1.42],0.3472432050551467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LSM1,U6 snRNA-associated Sm-like protein LSm1,23083,148,1.11 [0.86-1.42],0.4337644572995903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LSM8,U6 snRNA-associated Sm-like protein LSm8,20126,125,1.13 [0.95-1.36],0.1773874492130626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LSP1,Lymphocyte-specific protein 1,23613,149,1.19 [0.84-1.68],0.3362714702331252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTA,Lymphotoxin-alpha,23613,149,0.88 [0.61-1.27],0.4908947491383474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTA4H,Leukotriene A-4 hydrolase,23846,151,0.88 [0.68-1.13],0.3261475163394287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTB,Lymphotoxin-beta,20415,129,1.09 [0.69-1.72],0.7201875025477524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTBP2,Latent-transforming growth factor beta-binding protein 2,23938,149,0.96 [0.60-1.54],0.8521244355488418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTBP3,Latent-transforming growth factor beta-binding protein 3,23083,148,0.98 [0.74-1.29],0.8708552227935002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTBR,Tumor necrosis factor receptor superfamily member 3,23484,148,1.00 [0.60-1.65],0.9894208694492884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LTO1,Protein LTO1 homolog,23231,145,1.28 [0.96-1.71],0.0897311778480284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LUZP2,Leucine zipper protein 2,20415,129,0.78 [0.52-1.18],0.2423871476791884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LXN,Latexin,23322,149,1.13 [0.93-1.37],0.2328579033807136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY6D,Lymphocyte antigen 6D,23491,145,0.75 [0.50-1.12],0.1609487602024463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY75,Lymphocyte antigen 75,23613,149,1.23 [0.84-1.80],0.2788802716156463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY9,T-lymphocyte surface antigen Ly-9,23343,145,1.15 [0.70-1.87],0.582736536881296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LY96,Lymphocyte antigen 96,23436,150,0.75 [0.49-1.13],0.1660258496252931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYAR,Cell growth-regulating nucleolar protein,23083,148,1.05 [0.82-1.34],0.7109415498172169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYN,Tyrosine-protein kinase Lyn,23526,149,1.20 [1.01-1.42],0.0421437307929155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPD1,Ly6/PLAUR domain-containing protein 1,23119,148,0.97 [0.76-1.24],0.7976248513347772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPD3,Ly6/PLAUR domain-containing protein 3,23520,147,0.98 [0.63-1.52],0.9392636135718326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPD8,Ly6/PLAUR domain-containing protein 8,23083,148,1.19 [0.93-1.51],0.163670938470884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYPLA2,Acyl-protein thioesterase 2,19830,123,1.00 [0.85-1.18],0.9827535566696192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19939,127,1.00 [0.84-1.18],0.9617320041435232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20510,132,1.40 [0.59-3.31],0.4396259009946462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LYZL2,Lysozyme-like protein 2,19767,126,1.20 [0.76-1.88],0.4286895532298405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,LZTFL1,Leucine zipper transcription factor-like protein 1,20023,132,1.26 [1.01-1.59],0.0449441752559592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,M6PR,Cation-dependent mannose-6-phosphate receptor,19922,125,0.88 [0.54-1.43],0.617349371240749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,23365,150,1.09 [0.83-1.42],0.5349648370450152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAEA,E3 ubiquitin-protein transferase MAEA,23083,148,1.11 [0.77-1.60],0.574020615857634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAG,Myelin-associated glycoprotein,19939,127,0.84 [0.59-1.19],0.3158686382173796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAGEA3,Melanoma-associated antigen 3,20126,125,0.98 [0.81-1.20],0.8786103161962396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAGED1,Melanoma-associated antigen D1,23083,148,1.27 [0.97-1.68],0.0857077456193861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAMDC2,MAM domain-containing protein 2,20484,132,0.75 [0.46-1.22],0.2493213991870565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAMDC4,Apical endosomal glycoprotein,20415,129,1.10 [0.82-1.48],0.5173740699821319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19922,125,0.67 [0.34-1.31],0.240214429438995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAN2B2,Epididymis-specific alpha-mannosidase,20484,132,1.04 [0.78-1.37],0.8040992681430199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19767,126,0.86 [0.61-1.21],0.3775044401074334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANF,Mesencephalic astrocyte-derived neurotrophic factor,23725,148,1.08 [0.96-1.23],0.2008759602879413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANSC1,MANSC domain-containing protein 1,23701,148,1.25 [0.74-2.10],0.4084366349544687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MANSC4,MANSC domain-containing protein 4,19790,124,0.90 [0.69-1.17],0.4356823935995103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19830,123,0.94 [0.55-1.63],0.8330171004355154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19790,124,1.14 [0.91-1.42],0.2463088024351552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP2,Microtubule-associated protein 2,20438,131,1.27 [0.91-1.77],0.1584574390105495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,20422,129,1.23 [0.95-1.59],0.123094321852281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,23613,149,1.07 [0.92-1.24],0.3745007480373159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23083,148,0.92 [0.78-1.07],0.2667759257711395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,23403,150,1.12 [0.98-1.28],0.0903820147351217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPK13,Mitogen-activated protein kinase 13,19767,126,0.98 [0.66-1.46],0.9389720772414948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPK9,Mitogen-activated protein kinase 9,23613,149,1.00 [0.72-1.41],0.9811171791792146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPKAPK2,MAP kinase-activated protein kinase 2,20126,125,1.16 [0.92-1.45],0.2034375094385089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPRE3,Microtubule-associated protein RP/EB family member 3,19767,126,0.95 [0.84-1.08],0.4454738904398601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAPT,Microtubule-associated protein tau,23119,148,1.01 [0.76-1.34],0.945941227701924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MARCO,Macrophage receptor MARCO,23640,150,1.07 [0.61-1.87],0.8114856587657585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MARS1,"Methionine--tRNA ligase, cytoplasmic",19991,132,1.13 [0.93-1.38],0.2063152128368267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MASP1,Mannan-binding lectin serine protease 1,23403,150,0.75 [0.40-1.40],0.3711605415556936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MATN2,Matrilin-2,23642,148,0.86 [0.52-1.42],0.5517966946826816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MATN3,Matrilin-3,23393,149,0.74 [0.48-1.16],0.1883226532711919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAVS,Mitochondrial antiviral-signaling protein,23083,148,0.98 [0.83-1.15],0.786123539773662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MAX,Protein max,23119,148,1.06 [0.92-1.22],0.4009098410979592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MB,Myoglobin,23938,149,1.01 [0.78-1.31],0.9365751732340394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MBL2,Mannose-binding protein C,20227,130,0.97 [0.83-1.13],0.6722252208015003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCAM,Cell surface glycoprotein MUC18,23752,148,1.32 [0.85-2.06],0.2143370411462496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20447,131,1.30 [0.94-1.81],0.1137057799009563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCEMP1,Mast cell-expressed membrane protein 1,19884,122,1.10 [0.91-1.34],0.3097897541216438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCFD2,Multiple coagulation factor deficiency protein 2,23517,149,1.38 [1.01-1.89],0.0464668095984816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MCTS1,Malignant T-cell-amplified sequence 1,20422,129,1.63 [1.02-2.62],0.0412360642703526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,23436,150,0.79 [0.64-0.97],0.0219837873926262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDH1,"Malate dehydrogenase, cytoplasmic",20407,128,1.50 [1.02-2.20],0.0409179437650621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDK,Midkine,23623,147,1.26 [0.98-1.63],0.0767814022887364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MDM1,Nuclear protein MDM1,19939,127,1.01 [0.58-1.76],0.9656981646613574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19922,125,1.10 [0.91-1.32],0.324869245863688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MED18,Mediator of RNA polymerase II transcription subunit 18,23083,148,1.11 [0.92-1.35],0.2766543413233695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MED21,Mediator of RNA polymerase II transcription subunit 21,19790,124,0.89 [0.60-1.31],0.5434938815444862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEGF10,Multiple epidermal growth factor-like domains protein 10,23606,148,0.84 [0.58-1.21],0.3504207968883738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEGF11,Multiple epidermal growth factor-like domains protein 11,19790,124,0.67 [0.36-1.25],0.2062726724771138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEGF9,Multiple epidermal growth factor-like domains protein 9,23859,148,1.14 [0.54-2.40],0.7265476281082563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MELTF,Melanotransferrin,20484,132,0.95 [0.54-1.64],0.8414202543357423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MENT,Protein MENT,20023,132,1.51 [0.74-3.07],0.2541314738762074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEP1A,Meprin A subunit alpha,20422,129,1.11 [0.89-1.39],0.3406205741684525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEP1B,Meprin A subunit beta,23640,150,0.97 [0.85-1.09],0.5926734444642523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MEPE,Matrix extracellular phosphoglycoprotein,23606,148,0.61 [0.34-1.09],0.096127799353705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MERTK,Tyrosine-protein kinase Mer,23917,149,1.14 [0.63-2.04],0.6692727316051243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MESD,LRP chaperone MESD,23652,147,1.11 [0.98-1.24],0.100201101272363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MET,Hepatocyte growth factor receptor,23702,148,1.51 [0.71-3.20],0.2831595946402329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,METAP1,Methionine aminopeptidase 1,23119,148,1.22 [0.76-1.96],0.4097999861844923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",23613,149,1.14 [0.96-1.35],0.1483024214237696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,METAP2,Methionine aminopeptidase 2,23818,151,1.24 [0.95-1.61],0.1072303410360128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP3,Microfibril-associated glycoprotein 3,23208,146,1.13 [0.85-1.50],0.3864285918591175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP3L,Microfibrillar-associated protein 3-like,19939,127,1.12 [0.89-1.41],0.3309891079332692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP4,Microfibril-associated glycoprotein 4,20023,132,1.18 [0.70-1.98],0.5387548337494074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFAP5,Microfibrillar-associated protein 5,23938,149,0.96 [0.67-1.38],0.8434215314779434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MFGE8,Lactadherin,23652,147,1.10 [0.80-1.52],0.5536683842905734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MGLL,Monoglyceride lipase,23689,148,1.13 [0.95-1.34],0.153601708124934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MGMT,Methylated-DNA--protein-cysteine methyltransferase,23613,149,1.11 [0.98-1.26],0.1002402264798075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MIA,Melanoma-derived growth regulatory protein,23701,148,0.65 [0.43-0.97],0.0362343427368354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MICALL2,MICAL-like protein 2,19939,127,0.91 [0.70-1.19],0.4805449290516014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,23613,149,0.96 [0.87-1.04],0.3151765315155156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MIF,Macrophage migration inhibitory factor,23606,147,1.24 [1.00-1.55],0.0544152076437739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MILR1,Allergin-1,23231,145,1.01 [0.75-1.34],0.962266808713388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,20415,129,1.04 [0.89-1.21],0.6399092146346232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MINK1,Misshapen-like kinase 1,20438,131,1.08 [0.90-1.30],0.4064624788276071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MITD1,MIT domain-containing protein 1,23436,150,1.11 [0.96-1.30],0.1639040151500037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MKI67,Proliferation marker protein Ki-67,19884,122,1.02 [0.67-1.56],0.922241736600584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MLLT1,Protein ENL,19767,126,0.78 [0.58-1.06],0.114177717689356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MLN,Promotilin,23613,149,0.91 [0.78-1.07],0.2763599527919881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MME,Neprilysin,23526,149,1.01 [0.84-1.22],0.9029104930657929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP1,Interstitial collagenase,22850,142,1.13 [0.95-1.33],0.1706624602675125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP10,Stromelysin-2,23564,148,0.94 [0.73-1.22],0.6482962663512757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP12,Macrophage metalloelastase,23672,151,1.13 [0.87-1.47],0.3448285143442261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP13,Collagenase 3,23119,148,0.77 [0.49-1.22],0.2604804173336024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP15,Matrix metalloproteinase-15,20484,132,1.22 [0.94-1.59],0.135882203862435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP3,Stromelysin-1,23652,147,0.86 [0.64-1.16],0.3158427335504306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP7,Matrilysin,23176,145,0.94 [0.70-1.26],0.6845855780971384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP8,Neutrophil collagenase,23818,150,1.17 [0.96-1.42],0.1180970027657267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMP9,Matrix metalloproteinase-9,23617,147,1.24 [0.97-1.58],0.0832784531385432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19790,124,1.24 [0.90-1.69],0.1823280161927086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MN1,Transcriptional activator MN1,19939,127,1.04 [0.78-1.40],0.767462888465062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MNAT1,CDK-activating kinase assembly factor MAT1,20126,125,0.96 [0.64-1.42],0.8260760311330722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MNDA,Myeloid cell nuclear differentiation antigen,23603,150,1.09 [0.96-1.25],0.1679847556167217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MOCS2,Molybdopterin synthase catalytic subunit,20023,132,0.94 [0.73-1.21],0.6375024226841886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MOG,Myelin-oligodendrocyte glycoprotein,23846,151,0.92 [0.60-1.41],0.7026757417596554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORC3,MORC family CW-type zinc finger protein 3,20438,131,0.98 [0.54-1.80],0.9602495838274628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORF4L1,Mortality factor 4-like protein 1,20126,125,1.07 [0.71-1.62],0.755118283077757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORF4L2,Mortality factor 4-like protein 2,19767,126,0.85 [0.52-1.39],0.5169342598132354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MORN4,MORN repeat-containing protein 4,19767,126,1.07 [0.88-1.31],0.4903524816399711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPHOSPH8,M-phase phosphoprotein 8,23208,146,1.24 [1.03-1.49],0.0202272487290345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPI,Mannose-6-phosphate isomerase,23526,149,1.19 [1.01-1.40],0.0409217488158007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,23689,148,1.09 [0.89-1.32],0.4077915227166193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPO,Myeloperoxidase,23652,147,1.26 [0.95-1.69],0.1114598195362829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MPRIP,Myosin phosphatase Rho-interacting protein,20381,129,0.91 [0.62-1.35],0.6423782175702449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRC1,Macrophage mannose receptor 1,20513,128,1.54 [0.86-2.77],0.146094087211111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRI1,Methylthioribose-1-phosphate isomerase,19939,127,1.40 [1.08-1.83],0.0126285762042831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL24,"39S ribosomal protein L24, mitochondrial",19790,124,0.81 [0.49-1.34],0.4066033449577184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL28,"39S ribosomal protein L28, mitochondrial",20447,131,0.89 [0.53-1.48],0.6481083287110481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL46,"39S ribosomal protein L46, mitochondrial",23119,148,0.91 [0.53-1.57],0.7325226224635267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL52,"39S ribosomal protein L52, mitochondrial",19723,126,1.14 [0.63-2.06],0.6546936635248775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",20447,131,1.03 [0.81-1.29],0.8272412700561085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MRPS16,"28S ribosomal protein S16, mitochondrial",19884,122,1.12 [0.63-1.99],0.6976958720280699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSLN,Mesothelin,23487,149,0.98 [0.76-1.26],0.8722319649255521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSLNL,Mesothelin-like protein,19939,127,0.89 [0.55-1.43],0.6210860977900613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSMB,Beta-microseminoprotein,23621,146,0.86 [0.70-1.05],0.1459659634888261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSR1,Macrophage scavenger receptor types I and II,23855,150,1.06 [0.78-1.45],0.7148312551603742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSRA,Mitochondrial peptide methionine sulfoxide reductase,23701,148,1.18 [0.96-1.44],0.1134588118863431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MST1,Hepatocyte growth factor-like protein,20212,125,1.03 [0.79-1.34],0.8370540042211958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MSTN,Growth/differentiation factor 8,23208,146,0.85 [0.65-1.12],0.2525544632680563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTDH,Protein LYRIC,19884,122,1.22 [1.01-1.46],0.0352443299052081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",20438,131,1.20 [0.64-2.24],0.5695751319784979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20126,125,1.14 [0.98-1.33],0.0819408741273143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTIF3,"Translation initiation factor IF-3, mitochondrial",20422,129,1.10 [0.91-1.33],0.3272571493373114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTPN,Myotrophin,23208,146,0.96 [0.61-1.52],0.86974850839559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTR,Methionine synthase,19790,124,0.93 [0.70-1.23],0.6275321127429103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTSS1,Protein MTSS 1,20422,129,1.01 [0.87-1.17],0.9098008964612944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTSS2,Protein MTSS 2,20415,129,1.11 [0.94-1.31],0.2339564458532398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MTUS1,Microtubule-associated tumor suppressor 1,20126,125,0.95 [0.69-1.31],0.7740405496158975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUC13,Mucin-13,23119,148,1.17 [0.89-1.55],0.2608940254152495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUC16,Mucin-16,23526,149,1.05 [0.97-1.14],0.250211725950017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUC2,Mucin-2,20492,132,1.13 [0.95-1.35],0.1596122250719593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MUCL3,Mucin-like protein 3,19767,126,1.00 [0.66-1.50],0.98181458212715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MVK,Mevalonate kinase,23231,145,1.04 [0.87-1.25],0.6400989542309032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MXRA8,Matrix remodeling-associated protein 8,20023,132,0.66 [0.38-1.15],0.14194683255204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYBPC1,"Myosin-binding protein C, slow-type",20484,132,1.01 [0.81-1.25],0.9546490425679176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYBPC2,"Myosin-binding protein C, fast-type",19922,125,1.05 [0.86-1.27],0.6546732172459347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,20447,131,0.98 [0.75-1.27],0.8683979435657512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYDGF,Myeloid-derived growth factor,20484,132,1.14 [0.97-1.35],0.1233870084109957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYH4,Myosin-4,19790,124,1.28 [0.94-1.75],0.1233896120276916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYH7B,Myosin-7B,19767,126,1.02 [0.68-1.52],0.9246624745378548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYH9,Myosin-9,20492,132,1.12 [0.97-1.29],0.1271526632739485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19790,124,1.07 [0.70-1.62],0.7660855075707337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL3,Myosin light chain 3,19922,125,1.01 [0.81-1.26],0.9309685002024178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL4,Myosin light chain 4,19922,125,1.08 [0.79-1.47],0.6273557956842784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYL6B,Myosin light chain 6B,19939,127,0.94 [0.78-1.15],0.5635122657958012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19939,127,0.91 [0.65-1.28],0.6029123042382598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYO6,Unconventional myosin-VI,20447,131,0.88 [0.54-1.41],0.5863788622978849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYO9B,Unconventional myosin-IXb,23231,145,0.90 [0.71-1.14],0.3855732470322703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOC,Myocilin,23652,147,0.70 [0.50-0.97],0.0301079380726929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOM1,Myomesin-1,19830,123,0.88 [0.59-1.32],0.5394281901180848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOM2,Myomesin-2,19790,124,0.97 [0.70-1.34],0.856713138662291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MYOM3,Myomesin-3,20023,132,0.95 [0.80-1.14],0.5792356769277807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MZB1,Marginal zone B- and B1-cell-specific protein,23678,148,0.79 [0.59-1.06],0.1109464365676347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,MZT1,Mitotic-spindle organizing protein 1,23083,148,1.02 [0.77-1.35],0.8991542132933766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAA10,N-alpha-acetyltransferase 10,19790,124,1.25 [0.89-1.76],0.1990553333590354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAA80,N-alpha-acetyltransferase 80,19939,127,1.11 [0.97-1.28],0.1340951819471617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAAA,N-acylethanolamine-hydrolyzing acid amidase,23330,149,0.88 [0.69-1.13],0.3173486648789426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NACC1,Nucleus accumbens-associated protein 1,20415,129,1.21 [0.92-1.60],0.1800647391753502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NADK,NAD kinase,23640,150,1.22 [0.97-1.52],0.0862275170808853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAGA,Alpha-N-acetylgalactosaminidase,19850,122,0.95 [0.69-1.30],0.7292206107964696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAGK,N-acetyl-D-glucosamine kinase,19888,125,1.06 [0.78-1.44],0.7110330935721084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20023,132,2.19 [1.01-4.74],0.0475523306810515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAMPT,Nicotinamide phosphoribosyltransferase,23083,148,1.02 [0.77-1.33],0.9128243940249232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAP1L4,Nucleosome assembly protein 1-like 4,20378,129,1.86 [1.20-2.88],0.005716393269488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NAPRT,Nicotinate phosphoribosyltransferase,20438,131,1.28 [0.80-2.04],0.2992737831216305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NARS1,"Asparagine--tRNA ligase, cytoplasmic",20447,131,1.20 [0.83-1.72],0.330018313307954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NBL1,Neuroblastoma suppressor of tumorigenicity 1,23701,148,0.99 [0.57-1.70],0.967544283864974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NBN,Nibrin,23231,145,1.16 [0.93-1.45],0.1958981014959914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCAM1,Neural cell adhesion molecule 1,23752,148,0.98 [0.63-1.53],0.9199121472017464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCAM2,Neural cell adhesion molecule 2,23652,147,1.47 [0.86-2.51],0.158717958739454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCAN,Neurocan core protein,23855,150,0.89 [0.61-1.29],0.5294527009882344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCF2,Neutrophil cytosol factor 2,23566,149,1.13 [0.97-1.31],0.12778677756856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCK2,Cytoplasmic protein NCK2,23725,148,1.10 [0.96-1.26],0.1866677070781752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCLN,Nicalin,23231,145,0.93 [0.68-1.27],0.6675535306174335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCR1,Natural cytotoxicity triggering receptor 1,23580,149,1.22 [0.84-1.79],0.2942023904616901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20422,129,1.39 [0.86-2.24],0.1741632220679412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NCS1,Neuronal calcium sensor 1,23846,151,0.92 [0.56-1.54],0.7606424883125473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDRG1,Protein NDRG1,23119,148,0.87 [0.67-1.13],0.2924950219916165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,20415,129,0.81 [0.58-1.13],0.2177956235335085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19853,122,1.37 [0.85-2.18],0.1944957929874403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,20422,129,1.12 [0.92-1.35],0.2539963570714758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23083,148,1.04 [0.87-1.24],0.6795866452569321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEB,Nebulin,19790,124,0.82 [0.50-1.33],0.4181371844204636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECAP2,Adaptin ear-binding coat-associated protein 2,19790,124,1.14 [0.89-1.46],0.2915027472929811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECTIN1,Nectin-1,19884,122,1.10 [0.67-1.81],0.7114913603526434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECTIN2,Nectin-2,23609,150,1.57 [1.00-2.46],0.0517194704255795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NECTIN4,Nectin-4,23701,148,0.84 [0.53-1.33],0.4510763506074589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19884,122,1.70 [1.14-2.52],0.0086663611401188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEDD9,Enhancer of filamentation 1,19884,122,0.99 [0.60-1.64],0.9639744378485532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEFL,Neurofilament light polypeptide,23049,148,1.23 [0.90-1.67],0.1874057188032204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEK7,Serine/threonine-protein kinase Nek7,20126,125,1.05 [0.84-1.31],0.6445988615721581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NELL1,Protein kinase C-binding protein NELL1,23701,148,0.63 [0.45-0.89],0.0090126283931493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NELL2,Protein kinase C-binding protein NELL2,23725,148,0.89 [0.54-1.47],0.6505439071973049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NENF,Neudesin,20415,129,0.92 [0.77-1.08],0.3080899798512794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEO1,Neogenin,20447,131,1.06 [0.52-2.19],0.8649899939048012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NEXN,Nexilin,20513,128,1.04 [0.82-1.32],0.7642391069342067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFASC,Neurofascin,23917,149,1.30 [0.79-2.14],0.2960108563368804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFAT5,Nuclear factor of activated T-cells 5,19884,122,0.94 [0.76-1.16],0.5725200793635676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",23613,149,1.04 [0.90-1.21],0.5720753547503358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",23231,145,0.83 [0.64-1.08],0.1600870105051292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFE2,Transcription factor NF-E2 45 kDa subunit,19922,125,1.08 [0.85-1.36],0.5394868135470506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFIC,Nuclear factor 1 C-type,20447,131,1.03 [0.71-1.49],0.8723716856010262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19790,124,1.18 [0.93-1.48],0.172246730652691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFKB2,Nuclear factor NF-kappa-B p100 subunit,20126,125,1.06 [0.80-1.41],0.6691095585520587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFKBIE,NF-kappa-B inhibitor epsilon,23083,148,1.33 [1.01-1.75],0.0442144030745328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",20422,129,1.11 [0.94-1.30],0.223656014905099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFX1,Transcriptional repressor NF-X1,19790,124,1.27 [1.00-1.61],0.0456170336799224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NFYA,Nuclear transcription factor Y subunit alpha,19790,124,0.91 [0.57-1.44],0.6798618250252839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NGF,Beta-nerve growth factor,23436,150,0.55 [0.17-1.80],0.3194387620283433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NGFR,Tumor necrosis factor receptor superfamily member 16,20484,132,0.98 [0.56-1.72],0.9434209163010258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NGRN,Neugrin,20438,131,1.02 [0.49-2.15],0.9480076615877658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NHLRC3,NHL repeat-containing protein 3,19549,128,1.68 [0.97-2.90],0.0650958685851383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NID1,Nidogen-1,23680,148,1.37 [0.92-2.03],0.116293381819961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NID2,Nidogen-2,23652,147,1.11 [0.91-1.34],0.3128934087376009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NINJ1,Ninjurin-1,23083,148,0.98 [0.74-1.30],0.9062617249110932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NIT1,Deaminated glutathione amidase,19922,125,1.29 [0.86-1.93],0.2150696196386531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NIT2,Omega-amidase NIT2,20400,132,1.12 [0.89-1.41],0.3430782108376188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NLGN1,Neuroligin-1,19939,127,0.96 [0.73-1.25],0.7461911485662215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NLGN2,Neuroligin-2,19830,123,0.95 [0.64-1.41],0.8019079924470428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NME1,Nucleoside diphosphate kinase A,19884,122,1.29 [0.58-2.85],0.527707798083807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NME3,Nucleoside diphosphate kinase 3,23642,148,0.41 [0.21-0.77],0.0061714900126082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMI,N-myc-interactor,20331,129,1.26 [1.01-1.57],0.036303916763741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,23436,150,0.92 [0.75-1.13],0.420227499839903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMRK2,Nicotinamide riboside kinase 2,19767,126,1.15 [0.79-1.69],0.4648313802481931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,20447,131,1.07 [0.84-1.35],0.5954216146291913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOMO1,Nodal modulator 1,23652,147,0.81 [0.43-1.51],0.501226916388798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOP56,Nucleolar protein 56,19790,124,1.01 [0.87-1.18],0.8531259762054525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOS1,"Nitric oxide synthase, brain",23119,148,0.94 [0.73-1.22],0.6543805729153882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOS2,"Nitric oxide synthase, inducible",19790,124,0.98 [0.63-1.50],0.9118734573928644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOS3,"Nitric oxide synthase, endothelial",23119,148,0.91 [0.67-1.23],0.5366662197897083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOTCH1,Neurogenic locus notch homolog protein 1,23938,149,2.40 [1.00-5.79],0.0505937907157828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOTCH2,Neurogenic locus notch homolog protein 2,20492,132,1.59 [0.78-3.24],0.204378841744162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NOTCH3,Neurogenic locus notch homolog protein 3,23938,149,0.81 [0.52-1.26],0.3595462634289449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPC2,NPC intracellular cholesterol transporter 2,20148,132,1.01 [0.60-1.71],0.9715048861684924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPDC1,Neural proliferation differentiation and control protein 1,23640,150,1.37 [0.90-2.08],0.1394590051039872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPHS1,Nephrin,19884,122,0.73 [0.43-1.24],0.2430784084830949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPHS2,Podocin,19884,122,0.85 [0.70-1.04],0.1120819881288255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPL,N-acetylneuraminate lyase,20484,132,0.90 [0.63-1.30],0.5788357120036834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPPB,Natriuretic peptides B,23208,146,1.00 [0.90-1.11],0.9817923501508892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPPC,C-type natriuretic peptide,23613,149,0.84 [0.63-1.12],0.2403224954983769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPR1,Atrial natriuretic peptide receptor 1,19790,124,1.14 [0.78-1.67],0.5035705604448801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTN,Neuroplastin,23083,148,0.88 [0.70-1.09],0.2409635116949332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTX1,Neuronal pentraxin-1,23652,147,1.20 [0.85-1.69],0.3073778307448458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTX2,Neuronal pentraxin-2,20492,132,1.15 [0.70-1.89],0.5842774707178664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPTXR,Neuronal pentraxin receptor,23640,150,0.82 [0.53-1.27],0.3727291318894283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NPY,Pro-neuropeptide Y,23846,151,0.99 [0.79-1.23],0.904325766494162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRCAM,Neuronal cell adhesion molecule,23640,150,1.60 [0.98-2.61],0.0609121708389152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRGN,Neurogranin,20513,128,1.15 [0.95-1.38],0.148296511988515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRN1,Neuritin,20447,131,1.21 [0.83-1.76],0.3151992349364335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRP1,Neuropilin-1,23790,148,1.11 [0.65-1.90],0.697431758029613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRP2,Neuropilin-2,23652,147,1.00 [0.59-1.67],0.9875734779256464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRTN,Neurturin,23231,145,0.98 [0.73-1.32],0.9025521985470712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NRXN3,Neurexin-3,19939,127,1.01 [0.63-1.63],0.9623858395838596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NSFL1C,NSFL1 cofactor p47,23855,150,1.30 [1.04-1.62],0.0202558229543345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20484,132,1.27 [1.01-1.59],0.0397220691838114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5C1A,Cytosolic 5'-nucleotidase 1A,20438,131,1.04 [0.61-1.77],0.8858139005328572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5C3A,Cytosolic 5'-nucleotidase 3A,23571,149,1.13 [0.95-1.35],0.1530914407896147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NT5E,5'-nucleotidase,23701,148,1.04 [0.80-1.37],0.7489746041664967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTF3,Neurotrophin-3,23613,149,1.12 [0.75-1.69],0.5723978720445909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTF4,Neurotrophin-4,23083,148,0.71 [0.44-1.15],0.1692968729537396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTRK2,BDNF/NT-3 growth factors receptor,23640,150,1.40 [0.79-2.48],0.2465590084699311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTRK3,NT-3 growth factor receptor,23855,150,0.97 [0.50-1.90],0.9315921599895344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NTproBNP,N-terminal prohormone of brain natriuretic peptide,23640,150,1.08 [0.95-1.23],0.2224832076136277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUB1,NEDD8 ultimate buster 1,23613,149,1.14 [0.97-1.35],0.1216874502779869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,20415,129,0.95 [0.80-1.13],0.5637857852527496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUCB2,Nucleobindin-2,23811,151,1.54 [1.07-2.23],0.0212920973439598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDC,Nuclear migration protein nudC,23917,149,1.09 [0.86-1.37],0.4739506214192192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19922,125,0.57 [0.25-1.30],0.1810004987055652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19790,124,1.19 [0.91-1.57],0.2091946927781924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT16,U8 snoRNA-decapping enzyme,20388,128,1.19 [0.98-1.43],0.0788814482670832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],23526,149,1.05 [0.81-1.35],0.7135054082563891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUDT5,ADP-sugar pyrophosphatase,23652,147,1.38 [1.05-1.83],0.0228717811046584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUMB,Protein numb homolog,19884,122,1.17 [0.95-1.45],0.1427463126110231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NUP50,Nuclear pore complex protein Nup50,19790,124,1.01 [0.59-1.74],0.9721734801645908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NXPE4,NXPE family member 4,19790,124,0.60 [0.32-1.13],0.1110571875230536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NXPH1,Neurexophilin-1,23119,148,0.76 [0.51-1.12],0.1688741796896979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,NXPH3,Neurexophilin-3,19884,122,0.75 [0.42-1.33],0.3287073517703835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OBP2B,Odorant-binding protein 2b,23354,149,0.84 [0.66-1.07],0.1564622537959793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OCLN,Occludin,20447,131,0.71 [0.47-1.08],0.1135891724531545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ODAM,Odontogenic ameloblast-associated protein,23077,146,1.12 [0.87-1.44],0.3939266148028799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OFD1,Oral-facial-digital syndrome 1 protein,20126,125,0.90 [0.67-1.21],0.4904557688434426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGA,Protein O-GlcNAcase,20422,129,1.21 [0.96-1.53],0.1098804597944734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGFR,Opioid growth factor receptor,23526,149,1.20 [0.77-1.87],0.4136727929264303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGN,Mimecan,23652,147,1.40 [1.01-1.95],0.0449747770136822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20126,125,1.04 [0.80-1.35],0.7536894017377491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OLFM4,Olfactomedin-4,19279,130,1.13 [0.98-1.31],0.0823171688812046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OLR1,Oxidized low-density lipoprotein receptor 1,23407,148,1.17 [0.93-1.47],0.1742775303743576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OMD,Osteomodulin,23725,148,0.75 [0.53-1.06],0.1026790268532249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OMG,Oligodendrocyte-myelin glycoprotein,23526,149,1.07 [0.87-1.31],0.5362771718199919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OMP,Olfactory marker protein,19830,123,1.06 [0.75-1.51],0.7283981870289215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OPHN1,Oligophrenin-1,20438,131,1.04 [0.89-1.21],0.6380121319564349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OPLAH,5-oxoprolinase,19922,125,1.11 [0.87-1.42],0.4122607424502463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OPTC,Opticin,23526,149,1.04 [0.76-1.43],0.7967821981884335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ORM1,Alpha-1-acid glycoprotein 1,20434,132,0.86 [0.37-2.00],0.7269092700928088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSBPL2,Oxysterol-binding protein-related protein 2,20438,131,1.14 [0.77-1.69],0.502315447421841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSCAR,Osteoclast-associated immunoglobulin-like receptor,23642,148,1.06 [0.69-1.61],0.7938413808437718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSM,Oncostatin-M,23498,148,1.19 [0.97-1.47],0.0999112161261882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSMR,Oncostatin-M-specific receptor subunit beta,23790,148,1.06 [0.50-2.26],0.8765021802350044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OSTN,Osteocrin,19939,127,0.79 [0.49-1.28],0.3369475145110537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OTOA,Otoancorin,19830,123,0.68 [0.45-1.05],0.0798948691550464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OTUD6B,Deubiquitinase OTUD6B,20422,129,1.17 [0.88-1.56],0.2717673257983445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OTUD7B,OTU domain-containing protein 7B,20447,131,1.10 [0.85-1.44],0.4713967546585695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19922,125,1.23 [0.97-1.55],0.0916036559807228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,OXT,Oxytocin-neurophysin 1,23855,150,0.99 [0.90-1.09],0.8586290103986949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,P4HB,Protein disulfide-isomerase,23514,146,1.37 [0.95-1.99],0.0925353477669417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PACS2,Phosphofurin acidic cluster sorting protein 2,19790,124,1.25 [0.95-1.63],0.1110002474228652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PADI2,Protein-arginine deiminase type-2,23231,145,1.04 [0.82-1.32],0.7333055707060526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PADI4,Protein-arginine deiminase type-4,23077,146,1.06 [0.89-1.27],0.5219506984237874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAEP,Glycodelin,23436,150,0.98 [0.85-1.12],0.7492318511670737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20447,131,0.97 [0.84-1.13],0.7228773942637116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20126,125,1.30 [0.96-1.77],0.0944081180541487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,23208,146,1.09 [0.84-1.41],0.5228230861606719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAGR1,PAXIP1-associated glutamate-rich protein 1,19922,125,1.43 [1.02-2.01],0.0405036304580843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19731,126,1.03 [0.74-1.41],0.8757053772233301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAK4,Serine/threonine-protein kinase PAK 4,23119,148,1.15 [0.92-1.44],0.220067063695839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALLD,Palladin,19884,122,0.86 [0.52-1.41],0.551745981367679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALM,Paralemmin-1,20303,129,0.86 [0.50-1.47],0.5791339605915053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALM2,Paralemmin-2,20438,131,0.64 [0.40-1.02],0.0608437162083699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PALM3,Paralemmin-3,19790,124,1.11 [0.91-1.35],0.3099076585471835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAM,Peptidyl-glycine alpha-amidating monooxygenase,23838,149,0.97 [0.58-1.62],0.90685970864608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAMR1,Inactive serine protease PAMR1,23652,147,0.97 [0.56-1.68],0.9098221965112788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAPPA,Pappalysin-1,23231,145,1.09 [0.80-1.49],0.5959264837840574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PARD3,Partitioning defective 3 homolog,20126,125,1.13 [0.92-1.39],0.2376150949628508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PARK7,Parkinson disease protein 7,23652,147,1.40 [1.06-1.85],0.0181614539923102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PARP1,Poly [ADP-ribose] polymerase 1,23613,149,1.19 [0.98-1.44],0.0737820713367892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PAXX,Protein PAXX,20023,132,1.51 [1.08-2.10],0.0152952492449317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19767,126,1.42 [0.83-2.45],0.2038559061210156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PBLD,Phenazine biosynthesis-like domain-containing protein,23119,148,0.88 [0.66-1.18],0.4029711550188934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,20422,129,0.74 [0.40-1.35],0.321145345389914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCARE,Photoreceptor cilium actin regulator,19830,123,0.99 [0.80-1.23],0.9368170009637607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19984,132,1.15 [0.81-1.63],0.4271617716064633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCBP2,Poly(rC)-binding protein 2,20447,131,1.30 [1.03-1.63],0.0247726339598535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH1,Protocadherin-1,23839,149,0.57 [0.27-1.21],0.1443329629586837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH12,Protocadherin-12,20447,131,1.09 [0.56-2.11],0.7998314926456105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH17,Protocadherin-17,23640,150,1.52 [1.05-2.19],0.025563900930165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH7,Protocadherin-7,20422,129,0.82 [0.49-1.38],0.4508096012269746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDH9,Protocadherin-9,20422,129,0.92 [0.57-1.50],0.7476003225205607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCDHB15,Protocadherin beta-15,20415,129,1.14 [0.75-1.72],0.5363636498919646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCNA,Proliferating cell nuclear antigen,19767,126,1.07 [0.84-1.36],0.5838968725084916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCSK7,Proprotein convertase subtilisin/kexin type 7,20415,129,1.00 [0.69-1.46],0.9818484152368412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCSK9,Proprotein convertase subtilisin/kexin type 9,23938,149,0.76 [0.53-1.08],0.1300813711698734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PCYT2,Ethanolamine-phosphate cytidylyltransferase,20422,129,1.14 [0.91-1.42],0.2602073738949342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDAP1,28 kDa heat- and acid-stable phosphoprotein,20484,132,1.21 [1.02-1.43],0.0316964734198063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD1,Programmed cell death protein 1,23802,151,1.18 [0.84-1.65],0.343878124618131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD1LG2,Programmed cell death 1 ligand 2,23526,149,1.25 [0.79-1.96],0.3395163500673741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD5,Programmed cell death protein 5,23855,150,1.35 [1.06-1.71],0.0143442018038818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCD6,Programmed cell death protein 6,23640,150,1.13 [0.90-1.42],0.2978821952966713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDCL2,Phosducin-like protein 2,19767,126,0.80 [0.54-1.17],0.2435845985803261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19767,126,1.03 [0.75-1.41],0.8747354909391104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19790,124,1.10 [0.85-1.43],0.4503646220079659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20023,132,1.07 [0.91-1.27],0.3859677462676437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFA,Platelet-derived growth factor subunit A,23938,149,1.21 [0.99-1.48],0.0578580160859773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFB,Platelet-derived growth factor subunit B,23725,148,1.10 [0.93-1.30],0.2724679323098767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFC,Platelet-derived growth factor C,23083,148,0.76 [0.44-1.30],0.3199196803966746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFRA,Platelet-derived growth factor receptor alpha,23640,150,1.28 [0.77-2.13],0.3473979031548309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDGFRB,Platelet-derived growth factor receptor beta,23938,149,0.96 [0.64-1.45],0.8449882040839006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA2,Protein disulfide-isomerase A2,19767,126,0.84 [0.53-1.34],0.4683771344031469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA3,Protein disulfide-isomerase A3,20023,132,1.09 [0.56-2.12],0.7956559608579784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA4,Protein disulfide-isomerase A4,20492,132,1.24 [0.96-1.61],0.1008836425797561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDIA5,Protein disulfide-isomerase A5,19767,126,1.11 [0.85-1.44],0.4517053307377311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDLIM5,PDZ and LIM domain protein 5,20447,131,1.06 [0.92-1.23],0.3932445282683513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDLIM7,PDZ and LIM domain protein 7,23725,148,1.02 [0.91-1.14],0.7821768942722062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23083,148,1.13 [0.86-1.47],0.3747925569820828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDRG1,p53 and DNA damage-regulated protein 1,19939,127,0.96 [0.68-1.36],0.8221975048796998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19767,126,1.18 [0.94-1.49],0.1430999589042137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDZD2,PDZ domain-containing protein 2,19790,124,0.97 [0.71-1.31],0.8261087039052076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19884,122,0.98 [0.66-1.46],0.9179619249790568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PEAR1,Platelet endothelial aggregation receptor 1,23938,149,2.60 [1.39-4.86],0.0028541260628196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PEBP1,Phosphatidylethanolamine-binding protein 1,23652,147,1.33 [1.04-1.70],0.0217926559085103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PECAM1,Platelet endothelial cell adhesion molecule,23652,147,1.67 [1.05-2.64],0.0290225404409968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19922,125,0.76 [0.39-1.48],0.4211617015426094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PENK,Proenkephalin-A,20023,132,0.84 [0.48-1.48],0.5536917860426853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PEPD,Xaa-Pro dipeptidase,20513,128,0.81 [0.42-1.54],0.5131943125700213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PER3,Period circadian protein homolog 3,19884,122,1.03 [0.89-1.19],0.7025784482562507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PF4,Platelet factor 4,20353,129,1.09 [0.92-1.30],0.3048339739085804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFDN2,Prefoldin subunit 2,23119,148,1.17 [0.90-1.51],0.2460731565871735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFDN4,Prefoldin subunit 4,19767,126,0.97 [0.69-1.36],0.8671074109230035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFDN6,Prefoldin subunit 6,19939,127,0.78 [0.56-1.09],0.1414303182102814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",23490,149,1.21 [1.00-1.45],0.0452253928634978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGA4,Pepsin A-4,20513,128,0.99 [0.79-1.24],0.9261851124282292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20484,132,1.41 [1.05-1.90],0.0225299035565099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGF,Placenta growth factor,23917,149,1.09 [0.62-1.93],0.7643173276306179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGLYRP1,Peptidoglycan recognition protein 1,23824,148,1.20 [0.87-1.67],0.2683028935512654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,20255,131,1.08 [0.61-1.92],0.7949166078156144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGLYRP4,Peptidoglycan recognition protein 4,19790,124,1.04 [0.78-1.39],0.7674870534307529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGM2,Phosphoglucomutase-2,19939,127,0.82 [0.58-1.16],0.2716013815903826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PGR,Progesterone receptor,19884,122,0.94 [0.78-1.14],0.5219488266071413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHACTR2,Phosphatase and actin regulator 2,20447,131,1.10 [0.95-1.27],0.1962075630531502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHLDB1,Pleckstrin homology-like domain family B member 1,20422,129,0.91 [0.66-1.26],0.5670646204022363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHLDB2,Pleckstrin homology-like domain family B member 2,19767,126,0.97 [0.80-1.18],0.7938183478739403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,23436,150,1.05 [0.64-1.71],0.8587375673239706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20023,132,1.18 [0.79-1.76],0.4115243304127706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PI16,Peptidase inhibitor 16,20513,128,0.71 [0.35-1.43],0.3405920346219914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PI3,Elafin,23337,144,0.91 [0.69-1.20],0.510403875156993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",20447,131,1.15 [0.93-1.41],0.2030145100324166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIGR,Polymeric immunoglobulin receptor,23343,145,1.04 [0.69-1.56],0.8676663994332987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,23613,149,1.29 [1.04-1.61],0.0225743052828035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23652,147,1.54 [0.96-2.48],0.0730718535472344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19884,122,0.93 [0.67-1.29],0.6707711989563508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PILRA,Paired immunoglobulin-like type 2 receptor alpha,23652,147,1.46 [1.03-2.07],0.0345379716953244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PILRB,Paired immunoglobulin-like type 2 receptor beta,23640,150,1.27 [0.98-1.66],0.0715054918396934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20023,132,0.99 [0.78-1.26],0.9336346870883512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PITHD1,PITH domain-containing protein 1,19731,126,0.94 [0.74-1.19],0.6055711589917937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKD1,Polycystin-1,20484,132,1.18 [0.63-2.23],0.6044352756678854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKD2,Polycystin-2,19790,124,1.20 [0.91-1.58],0.1917819000418464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKLR,Pyruvate kinase PKLR,23644,148,1.23 [0.99-1.52],0.0576219798321102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PKN3,Serine/threonine-protein kinase N3,20126,125,1.05 [0.84-1.32],0.6758307627434437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G10,Group 10 secretory phospholipase A2,23436,150,1.24 [0.97-1.60],0.0921943084506269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G15,Phospholipase A2 group XV,23701,148,0.91 [0.53-1.57],0.7430844486958791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G1B,Phospholipase A2,23904,149,0.96 [0.69-1.33],0.8085115722321193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G2A,"Phospholipase A2, membrane associated",23625,146,1.05 [0.81-1.38],0.6972163796092953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G4A,Cytosolic phospholipase A2,23725,148,1.10 [0.93-1.30],0.2562209634223237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLA2G7,Platelet-activating factor acetylhydrolase,23652,147,0.60 [0.39-0.92],0.019730280314865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLAT,Tissue-type plasminogen activator,23859,148,1.07 [0.81-1.43],0.6270616949596054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLAU,Urokinase-type plasminogen activator,23652,147,0.83 [0.49-1.41],0.4943258779642127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLAUR,Urokinase plasminogen activator surface receptor,23449,148,1.02 [0.60-1.73],0.9518360281195488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLB1,"Phospholipase B1, membrane-associated",20438,131,0.80 [0.61-1.06],0.1209165425273206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19884,122,1.11 [0.75-1.63],0.6061300599197275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",20438,131,1.12 [0.95-1.33],0.1796187916300634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLEKHO1,Pleckstrin homology domain-containing family O member 1,20438,131,1.16 [0.92-1.47],0.20373063310424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLG,Plasminogen,20005,128,1.30 [0.59-2.83],0.5124696425994606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLIN1,Perilipin-1,23119,148,0.79 [0.50-1.25],0.3089693127413142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLIN3,Perilipin-3,23640,150,1.38 [1.00-1.89],0.0498824898439764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLPBP,Pyridoxal phosphate homeostasis protein,23640,150,1.28 [1.04-1.58],0.0212730853864029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLSCR3,Phospholipid scramblase 3,20393,131,1.03 [0.77-1.38],0.822497588143996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLTP,Phospholipid transfer protein,23870,149,1.16 [0.78-1.71],0.4703550066122022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXDC1,Plexin domain-containing protein 1,23083,148,0.82 [0.50-1.33],0.4155751884882908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXDC2,Plexin domain-containing protein 2,20438,131,1.38 [0.79-2.40],0.2563048225359569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXNA4,Plexin-A4,23613,149,1.16 [0.97-1.39],0.1075586647140757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXNB2,Plexin-B2,23820,148,2.28 [1.31-3.95],0.0033824719899348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PLXNB3,Plexin-B3,23562,150,1.34 [1.00-1.80],0.0490339640922926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,23537,149,0.96 [0.89-1.03],0.266502336538906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMCH,Pro-MCH,19790,124,0.78 [0.57-1.05],0.0973750717242929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMM2,Phosphomannomutase 2,19790,124,1.18 [0.89-1.58],0.2451325263207918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMS1,PMS1 protein homolog 1,19939,127,1.09 [0.79-1.50],0.5851257814149113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PMVK,Phosphomevalonate kinase,23082,148,1.07 [0.93-1.23],0.3389373709337365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNLIP,Pancreatic triacylglycerol lipase,20513,128,1.10 [0.85-1.42],0.4524743982859226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNLIPRP1,Inactive pancreatic lipase-related protein 1,20438,131,1.06 [0.86-1.30],0.5883529221779061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNLIPRP2,Pancreatic lipase-related protein 2,23606,148,0.99 [0.94-1.03],0.5620998834507474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNMA1,Paraneoplastic antigen Ma1,19922,125,1.20 [0.90-1.60],0.2176635709185264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNMA2,Paraneoplastic antigen Ma2,19830,123,0.95 [0.64-1.41],0.8001815797867152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",23231,145,1.01 [0.89-1.15],0.8419106184210632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PODXL,Podocalyxin,23526,149,3.26 [1.27-8.39],0.014358005340784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PODXL2,Podocalyxin-like protein 2,23701,148,0.64 [0.38-1.08],0.0972069422435291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POF1B,Protein POF1B,19884,122,1.38 [0.99-1.91],0.0576851948512153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19884,122,1.19 [0.68-2.09],0.5477665307615234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",23526,149,1.24 [0.87-1.76],0.2299783803956454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POMC,Pro-opiomelanocortin,19922,125,0.89 [0.70-1.13],0.3450694600994303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PON1,Serum paraoxonase/arylesterase 1,20513,128,0.92 [0.50-1.70],0.7859686728009937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PON2,Serum paraoxonase/arylesterase 2,23208,146,0.86 [0.57-1.31],0.4891044779729115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PON3,Serum paraoxonase/lactonase 3,23725,148,0.81 [0.52-1.24],0.3287489548316013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,POSTN,Periostin,20492,132,1.10 [0.71-1.72],0.6693038673314308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPBP,Platelet basic protein,20353,129,1.17 [0.96-1.42],0.127713513114272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPCDC,Phosphopantothenoylcysteine decarboxylase,23855,150,1.18 [0.87-1.59],0.2961384311370836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPIB,Peptidyl-prolyl cis-trans isomerase B,23672,148,1.17 [1.01-1.37],0.0428114854412229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPIE,Peptidyl-prolyl cis-trans isomerase E,20126,125,1.08 [0.83-1.40],0.5822299572301757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20492,132,1.20 [0.95-1.51],0.1284229019353306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPL,Periplakin,19884,122,0.59 [0.33-1.07],0.0803051834239337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPM1A,Protein phosphatase 1A,23083,148,0.84 [0.51-1.36],0.473329906340721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPM1B,Protein phosphatase 1B,19884,122,0.94 [0.69-1.27],0.6643196919585275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPM1F,Protein phosphatase 1F,20484,132,1.27 [0.93-1.72],0.1295550649386699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPME1,Protein phosphatase methylesterase 1,23526,149,1.36 [1.07-1.74],0.0124588012324647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,20415,129,1.10 [0.90-1.34],0.3402942293032786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,23701,148,1.15 [0.99-1.33],0.0744568938101172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20126,125,0.87 [0.66-1.14],0.3145413283258305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,20447,131,1.11 [0.90-1.36],0.3404929843392114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,20447,131,1.00 [0.65-1.55],0.9879931078167123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R2,Protein phosphatase inhibitor 2,23640,150,1.20 [1.01-1.43],0.0399774850685306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP1R9B,Neurabin-2,23917,149,1.03 [0.89-1.20],0.6926796138773388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,20422,129,1.11 [0.97-1.28],0.1290061071813239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPP3R1,Calcineurin subunit B type 1,23436,150,1.06 [0.74-1.51],0.7574442178704369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPT1,Palmitoyl-protein thioesterase 1,19939,127,0.93 [0.73-1.18],0.5494394361034352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PPY,Pancreatic prohormone,23568,147,0.99 [0.86-1.14],0.8691594870488301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PQBP1,Polyglutamine-binding protein 1,23083,148,1.00 [0.78-1.29],0.979016936479534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRAME,Melanoma antigen preferentially expressed in tumors,19767,126,0.93 [0.47-1.84],0.825841275678866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRAP1,Proline-rich acidic protein 1,20492,132,1.07 [0.70-1.64],0.7594133996154306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRC1,Protein regulator of cytokinesis 1,20415,129,0.92 [0.60-1.41],0.706000008167649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRCP,Lysosomal Pro-X carboxypeptidase,23785,147,1.50 [0.96-2.33],0.0720913121919017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX1,Peroxiredoxin-1,22946,147,1.11 [0.95-1.30],0.2017443842466021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX2,Peroxiredoxin-2,20168,127,1.25 [0.96-1.62],0.1019181580628675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",23231,145,1.12 [0.92-1.37],0.2686241208616368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX5,"Peroxiredoxin-5, mitochondrial",23917,149,1.13 [0.90-1.41],0.2939934459034476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRDX6,Peroxiredoxin-6,23846,151,1.07 [0.85-1.34],0.5761157322605248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PREB,Prolactin regulatory element-binding protein,23231,145,0.76 [0.44-1.30],0.3172560231542559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRELP,Prolargin,23606,148,1.18 [0.62-2.23],0.6203965731768153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRG2,Bone marrow proteoglycan,20492,132,1.35 [0.99-1.84],0.0606388833046234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRG3,Proteoglycan 3,20492,132,1.29 [0.93-1.79],0.1241227554902605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,23231,145,1.16 [0.89-1.51],0.2647422294394285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19939,127,1.08 [0.63-1.83],0.7873832834794439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,23640,150,1.15 [0.97-1.38],0.1070288554889541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,20394,131,1.04 [0.84-1.28],0.748054970989916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKCQ,Protein kinase C theta type,23231,145,0.95 [0.67-1.36],0.7797183342525424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKD2,Serine/threonine-protein kinase D2,19790,124,1.28 [0.93-1.76],0.1352789083754519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKG1,cGMP-dependent protein kinase 1,20023,132,1.08 [0.95-1.24],0.2350416739088943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23083,148,1.18 [0.96-1.46],0.1162418522037347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRL,Prolactin,23855,150,1.03 [0.84-1.25],0.7882270511393877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRND,Prion-like protein doppel,20438,131,1.10 [0.78-1.56],0.5733294133529956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROC,Vitamin K-dependent protein C,23717,148,1.40 [0.79-2.48],0.2488881714885354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROCR,Endothelial protein C receptor,19790,124,0.86 [0.49-1.52],0.6093334498403454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROK1,Prokineticin-1,23613,149,0.90 [0.67-1.20],0.4563193360511649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PROS1,Vitamin K-dependent protein S,20510,132,1.43 [0.75-2.71],0.2749966148887097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRR4,Proline-rich protein 4,19871,132,1.00 [0.79-1.27],0.9876791865378576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRR5,Proline-rich protein 5,19884,122,1.24 [0.88-1.74],0.2203670088513855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRRT3,Proline-rich transmembrane protein 3,19922,125,0.98 [0.62-1.54],0.9146069757047196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS2,Trypsin-2,23752,148,1.01 [0.78-1.30],0.9562818055127172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS22,Brain-specific serine protease 4,19884,122,0.91 [0.54-1.54],0.7233316210766656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS27,Serine protease 27,23562,149,1.42 [1.00-2.03],0.0528505808937765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS53,Serine protease 53,20438,131,0.95 [0.62-1.45],0.811799129315053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRSS8,Prostasin,23530,147,1.13 [0.80-1.60],0.4962203299736984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23119,148,1.10 [0.96-1.26],0.1655837094658386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRTG,Protogenin,23846,151,1.23 [0.69-2.21],0.4870553562372104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRTN3,Myeloblastin,23075,141,1.27 [0.97-1.65],0.0800475468372483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PRUNE2,Protein prune homolog 2,20126,125,0.97 [0.53-1.78],0.9169161678731896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSAP,Prosaposin,20303,132,1.37 [0.79-2.36],0.2615710415014908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSAPL1,Proactivator polypeptide-like 1,20422,129,0.71 [0.51-1.00],0.0502076978477675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSCA,Prostate stem cell antigen,20422,129,0.98 [0.92-1.04],0.4628809562724395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSG1,Pregnancy-specific beta-1-glycoprotein 1,23436,150,1.10 [0.96-1.26],0.1881301031567248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSIP1,PC4 and SFRS1-interacting protein,23613,149,1.13 [0.93-1.38],0.2107724336043432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMA1,Proteasome subunit alpha type-1,23083,148,0.80 [0.56-1.13],0.2076721520241152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMC3,26S proteasome regulatory subunit 6A,19767,126,0.66 [0.37-1.18],0.1588848335177312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMD1,26S proteasome non-ATPase regulatory subunit 1,20447,131,1.07 [0.78-1.49],0.6640838433892574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19939,127,1.24 [0.95-1.61],0.1149516198289219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMD9,26S proteasome non-ATPase regulatory subunit 9,23526,149,1.22 [0.96-1.55],0.1086087935712958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSME1,Proteasome activator complex subunit 1,23393,150,1.25 [0.85-1.84],0.2647927800733084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSME2,Proteasome activator complex subunit 2,23330,150,1.47 [0.99-2.18],0.0557674019255057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMG3,Proteasome assembly chaperone 3,23613,149,1.27 [0.96-1.67],0.0945919932680156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSMG4,Proteasome assembly chaperone 4,19884,122,1.25 [0.94-1.65],0.1218664864665955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSPN,Persephin,23613,149,1.14 [0.97-1.35],0.1144856630048213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSRC1,Proline/serine-rich coiled-coil protein 1,23083,148,1.26 [1.01-1.57],0.0431133266525276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19325,128,1.09 [0.92-1.28],0.3263209104030028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23119,148,0.83 [0.51-1.35],0.4593470824201324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTGDS,Prostaglandin-H2 D-isomerase,23486,146,1.07 [0.67-1.71],0.7740325692633512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTGES2,Prostaglandin E synthase 2,19746,122,1.11 [0.81-1.53],0.5169315067722473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTGR1,Prostaglandin reductase 1,20484,132,0.97 [0.79-1.18],0.734136523310809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTH,Parathyroid hormone,19939,127,0.94 [0.76-1.17],0.5857254201057208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,23613,149,1.26 [0.92-1.72],0.1463691988917925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTK7,Inactive tyrosine-protein kinase 7,23119,148,0.88 [0.60-1.30],0.5186538805733991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTN,Pleiotrophin,23208,146,1.13 [0.84-1.52],0.4079778452728229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTP4A3,Protein tyrosine phosphatase type IVA 3,19884,122,1.19 [0.87-1.61],0.277769842224592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,23436,150,1.10 [0.92-1.32],0.294611631559574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,23689,148,1.13 [0.95-1.34],0.1549306257118372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19851,122,1.04 [0.67-1.61],0.8632052969319124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRB,Receptor-type tyrosine-protein phosphatase beta,20484,132,1.40 [0.80-2.44],0.2426333688080235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRC,Receptor-type tyrosine-protein phosphatase C,20492,132,1.36 [0.68-2.71],0.3838201580352615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRF,Receptor-type tyrosine-protein phosphatase F,23938,149,1.47 [0.89-2.44],0.1366045032246372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRH,Receptor-type tyrosine-protein phosphatase H,20422,129,1.57 [1.14-2.16],0.0061688921138132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,20422,129,1.49 [0.76-2.88],0.2428510717251105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRM,Receptor-type tyrosine-protein phosphatase mu,23573,149,1.52 [0.84-2.74],0.1634059639470488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,23360,150,0.94 [0.61-1.46],0.7899209620154002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRR,Receptor-type tyrosine-protein phosphatase R,20438,131,0.66 [0.42-1.05],0.0788069554192116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRS,Receptor-type tyrosine-protein phosphatase S,23938,149,0.98 [0.55-1.74],0.9485417503796616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20484,132,0.90 [0.52-1.55],0.7059307364950659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20023,132,1.54 [1.16-2.03],0.0024074255397072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTS,6-pyruvoyl tetrahydrobiopterin synthase,23003,147,0.95 [0.72-1.25],0.6894173561745987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTTG1,Securin,20126,125,0.85 [0.54-1.32],0.4700352024945702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PTX3,Pentraxin-related protein PTX3,23613,149,0.84 [0.64-1.10],0.204227199430886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PVALB,Parvalbumin alpha,23746,151,1.17 [1.03-1.34],0.0197191243483596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PVR,Poliovirus receptor,23855,150,1.11 [0.76-1.63],0.5966427171122376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PXDNL,Peroxidasin-like protein,20415,129,0.95 [0.70-1.29],0.7329016744299087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PXN,Paxillin,23119,148,0.98 [0.74-1.30],0.897144177755263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PYDC1,Pyrin domain-containing protein 1,19922,125,0.43 [0.26-0.70],0.0008212259845559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PYY,Peptide YY,19790,124,1.11 [0.94-1.31],0.2249550340440257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,PZP,Pregnancy zone protein,20510,132,1.12 [0.69-1.82],0.6517024927179568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,QDPR,Dihydropteridine reductase,23522,150,1.56 [1.12-2.17],0.0079317982874537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,QPCT,Glutaminyl-peptide cyclotransferase,23659,146,0.82 [0.48-1.38],0.4487162651636348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,QSOX1,Sulfhydryl oxidase 1,20099,132,0.94 [0.60-1.49],0.7976652168291323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB10,Ras-related protein Rab-10,20484,132,1.26 [0.93-1.71],0.1293121472868153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB11FIP3,Rab11 family-interacting protein 3,20484,132,1.07 [0.91-1.24],0.4235087112187146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB27B,Ras-related protein Rab-27B,20484,132,1.07 [0.87-1.31],0.5166124366759439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB2B,Ras-related protein Rab-2B,20415,129,1.09 [0.83-1.43],0.5516261074041946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB33A,Ras-related protein Rab-33A,19790,124,1.18 [0.92-1.50],0.1843109290169293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB37,Ras-related protein Rab-37,23231,145,1.02 [0.86-1.22],0.792352108211299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB39B,Ras-related protein Rab-39B,19790,124,1.10 [0.94-1.29],0.2511819070791179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19830,123,0.91 [0.66-1.27],0.5786206032062235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB44,Ras-related protein Rab-44,20415,129,1.10 [0.80-1.52],0.5630953846951278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB6A,Ras-related protein Rab-6A,23613,149,0.65 [0.47-0.90],0.0097933618566855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAB6B,Ras-related protein Rab-6B,23119,148,0.97 [0.71-1.33],0.8412373344552116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RABEP1,Rab GTPase-binding effector protein 1,20023,132,1.18 [0.95-1.46],0.1391284087733403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RABEPK,Rab9 effector protein with kelch motifs,23083,148,1.17 [0.94-1.47],0.1612111409264356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RABGAP1L,Rab GTPase-activating protein 1-like,23231,145,1.22 [0.97-1.54],0.0955597832126876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAC3,Ras-related C3 botulinum toxin substrate 3,19939,127,0.82 [0.60-1.12],0.2176885393247944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAD23B,UV excision repair protein RAD23 homolog B,23083,148,1.36 [1.02-1.80],0.0358808397762836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAD51,DNA repair protein RAD51 homolog 1,20126,125,1.08 [0.80-1.45],0.6306180766089116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RALB,Ras-related protein Ral-B,19884,122,1.08 [0.61-1.93],0.7908767225656992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RALY,RNA-binding protein Raly,20415,129,1.18 [0.88-1.59],0.2672526287968477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RANBP1,Ran-specific GTPase-activating protein,19922,125,1.30 [0.94-1.79],0.1088251337069831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RANBP2,E3 SUMO-protein ligase RanBP2,19830,123,1.16 [0.69-1.94],0.5738927514506257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RANGAP1,Ran GTPase-activating protein 1,23083,148,0.90 [0.65-1.24],0.5173000668078468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAP1A,Ras-related protein Rap-1A,19884,122,0.81 [0.59-1.11],0.18791546059247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RAPGEF2,Rap guanine nucleotide exchange factor 2,20126,125,1.39 [1.04-1.85],0.0240994612489945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RARRES1,Retinoic acid receptor responder protein 1,23083,148,0.98 [0.62-1.56],0.9416544704922232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RARRES2,Retinoic acid receptor responder protein 2,23790,148,1.10 [0.83-1.48],0.499094238873774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RASA1,Ras GTPase-activating protein 1,23119,148,0.75 [0.47-1.19],0.2194668238761709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19767,126,1.15 [0.79-1.67],0.4814974737578864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RASSF2,Ras association domain-containing protein 2,23083,148,1.08 [0.85-1.36],0.521692407851684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBFOX3,RNA binding protein fox-1 homolog 3,20447,131,1.10 [0.72-1.67],0.6718978916813099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBKS,Ribokinase,23090,148,1.11 [0.83-1.48],0.4852543830290728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBM17,Splicing factor 45,20447,131,1.22 [0.99-1.50],0.0660726882246434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBM19,Probable RNA-binding protein 19,19790,124,1.37 [1.04-1.80],0.0240880964910804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBM25,RNA-binding protein 25,19767,126,1.10 [0.77-1.59],0.5948141244643503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP1,Retinol-binding protein 1,19939,127,1.04 [0.82-1.31],0.7451036084361686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP2,Retinol-binding protein 2,23526,149,0.95 [0.79-1.15],0.6108958034958755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP5,Retinol-binding protein 5,23526,149,0.97 [0.74-1.26],0.8015737313908331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBP7,Retinoid-binding protein 7,20422,129,1.20 [0.94-1.52],0.1449420662405566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBPMS,RNA-binding protein with multiple splicing,19884,122,0.96 [0.73-1.27],0.7906339311985808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RBPMS2,RNA-binding protein with multiple splicing 2,19922,125,1.06 [0.90-1.26],0.4630938338881961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RCC1,Regulator of chromosome condensation,20415,129,0.99 [0.71-1.39],0.9588073451516584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RCOR1,REST corepressor 1,23208,146,0.96 [0.67-1.37],0.8042523044234078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19922,125,0.59 [0.27-1.30],0.1887080663420848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REEP4,Receptor expression-enhancing protein 4,20447,131,0.97 [0.74-1.28],0.8278743632987106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG1A,Lithostathine-1-alpha,23520,147,1.11 [0.83-1.47],0.493291434502228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG1B,Lithostathine-1-beta,23938,149,1.01 [0.79-1.31],0.91129508276187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG3A,Regenerating islet-derived protein 3-alpha,23938,149,1.11 [0.89-1.38],0.364433073798465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG3G,Regenerating islet-derived protein 3-gamma,20415,129,1.13 [0.74-1.71],0.5739509436929373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REG4,Regenerating islet-derived protein 4,23642,148,1.24 [0.94-1.64],0.1229743520975469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RELB,Transcription factor RelB,19884,122,1.06 [0.74-1.52],0.7593895285896679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RELT,Tumor necrosis factor receptor superfamily member 19L,23652,147,1.05 [0.64-1.74],0.8425595232557057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REN,Renin,23640,150,1.12 [0.95-1.33],0.1814056870840275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REPS1,RalBP1-associated Eps domain-containing protein 1,19884,122,1.05 [0.67-1.64],0.8341980832872524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REST,RE1-silencing transcription factor,19767,126,1.04 [0.63-1.71],0.8737998608083617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23526,149,0.83 [0.56-1.23],0.3546399059168242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RETN,Resistin,23597,145,1.16 [0.83-1.61],0.391341270789192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,REXO2,"Oligoribonuclease, mitochondrial",19790,124,0.72 [0.46-1.12],0.140106149433578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RFC4,Replication factor C subunit 4,20415,129,1.25 [0.60-2.61],0.5491621628959105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGCC,Regulator of cell cycle RGCC,20447,131,1.07 [0.86-1.34],0.5215720470499432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20126,125,1.13 [0.89-1.43],0.2998789264103176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGMA,Repulsive guidance molecule A,23855,150,0.78 [0.50-1.23],0.2858532666609646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGMB,RGM domain family member B,23855,150,1.05 [0.62-1.75],0.8635430111859408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGS10,Regulator of G-protein signaling 10,20447,131,1.33 [1.02-1.73],0.036103271097235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RGS8,Regulator of G-protein signaling 8,23231,145,1.01 [0.81-1.27],0.9086691162983008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RHOC,Rho-related GTP-binding protein RhoC,23313,149,1.08 [0.95-1.22],0.2344447822416521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RICTOR,Rapamycin-insensitive companion of mTOR,19884,122,1.26 [0.95-1.69],0.1105796797848131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20023,132,1.04 [0.74-1.46],0.8112827305728931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RILP,Rab-interacting lysosomal protein,23782,151,1.39 [1.10-1.76],0.0058574717263301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RILPL2,RILP-like protein 2,20484,132,1.12 [0.94-1.32],0.2062927377191201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19790,124,0.97 [0.74-1.27],0.8330213033947699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RLN1,Prorelaxin H1,20447,131,0.84 [0.52-1.35],0.4750273603662029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RLN2,Prorelaxin H2,19986,132,1.05 [0.76-1.44],0.7721081953398268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE1,Ribonuclease pancreatic,20513,128,1.00 [0.51-1.99],0.9922814119282812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE10,Inactive ribonuclease-like protein 10,19922,125,1.09 [0.77-1.56],0.6242139165805454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE3,Eosinophil cationic protein,23525,149,1.13 [1.02-1.27],0.0252385039073427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE4,Ribonuclease 4,19844,119,0.81 [0.42-1.58],0.5387320509446032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASE6,Ribonuclease K6,20376,128,1.46 [0.96-2.23],0.075613258732868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASEH2A,Ribonuclease H2 subunit A,20447,131,1.24 [0.92-1.66],0.1540130241462783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNASET2,Ribonuclease T2,23825,147,2.00 [1.21-3.29],0.0065766771217759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF149,E3 ubiquitin-protein ligase RNF149,19922,125,1.24 [0.72-2.13],0.4390803877427828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF168,E3 ubiquitin-protein ligase RNF168,19884,122,0.88 [0.56-1.38],0.5731454373153523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF31,E3 ubiquitin-protein ligase RNF31,19884,122,1.25 [0.84-1.86],0.2694242513767951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF4,E3 ubiquitin-protein ligase RNF4,20126,125,0.95 [0.72-1.24],0.6886948903869534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF41,E3 ubiquitin-protein ligase NRDP1,23083,148,1.07 [0.86-1.33],0.5285833919318056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF43,E3 ubiquitin-protein ligase RNF43,20126,125,1.05 [0.79-1.41],0.718423704355641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RNF5,E3 ubiquitin-protein ligase RNF5,19922,125,1.00 [0.79-1.27],0.9951444855894536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROBO1,Roundabout homolog 1,23642,148,0.86 [0.46-1.61],0.6464357803182835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROBO2,Roundabout homolog 2,23855,150,0.68 [0.35-1.29],0.2359401744343707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROBO4,Roundabout homolog 4,19922,125,1.17 [0.45-3.07],0.7472052217079936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23640,150,1.15 [0.73-1.81],0.5376126706506412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RP2,Protein XRP2,23526,149,1.35 [0.99-1.85],0.057470782879496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPA2,Replication protein A 32 kDa subunit,19884,122,0.94 [0.53-1.67],0.8258790382716399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPE,Ribulose-phosphate 3-epimerase,20126,125,1.16 [0.93-1.45],0.1874363581655331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPGR,X-linked retinitis pigmentosa GTPase regulator,19939,127,1.06 [0.70-1.61],0.796337195344682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPL14,60S ribosomal protein L14,19922,125,1.37 [0.94-1.99],0.1046019708985306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RPS10,40S ribosomal protein S10,19790,124,0.96 [0.63-1.48],0.8694880461232029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRAS,Ras-related protein R-Ras,19939,127,1.09 [0.96-1.24],0.1814845570215337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRM2,Ribonucleoside-diphosphate reductase subunit M2,23083,148,1.00 [0.73-1.35],0.9810524884178392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23083,148,0.97 [0.78-1.20],0.7503204255341943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RRP15,RRP15-like protein,19830,123,1.14 [0.96-1.37],0.1436952896907525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RSPO1,R-spondin-1,23436,150,0.97 [0.63-1.49],0.8784493327731551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RSPO3,R-spondin-3,23846,151,1.29 [0.77-2.15],0.3278589935727461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTBDN,Retbindin,23526,149,0.98 [0.60-1.59],0.9376839448147934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTKN2,Rhotekin-2,19790,124,1.05 [0.75-1.46],0.7769925550175386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",20447,131,1.13 [0.95-1.36],0.1690110718749385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RTN4R,Reticulon-4 receptor,23846,151,1.12 [0.73-1.71],0.6086409159013205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RUVBL1,RuvB-like 1,23083,148,1.00 [0.86-1.16],0.9865240916124068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RWDD1,RWD domain-containing protein 1,23855,150,1.20 [0.96-1.51],0.1123937834653037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,RYR1,Ryanodine receptor 1,19790,124,0.79 [0.45-1.39],0.4123133032026524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A11,Protein S100-A11,23463,150,1.24 [0.96-1.60],0.10375624844629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A12,Protein S100-A12,23289,148,1.08 [0.89-1.32],0.4210000287921058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A13,Protein S100-A13,19884,122,0.75 [0.44-1.25],0.2650981735413804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A14,Protein S100-A14,20447,131,0.84 [0.60-1.18],0.3149693237014966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A16,Protein S100-A16,23077,146,0.83 [0.64-1.07],0.1570755800554253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A3,Protein S100-A3,20415,129,0.77 [0.47-1.25],0.2874188410933443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100A4,Protein S100-A4,23701,148,1.27 [0.98-1.66],0.0730734018867921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100G,Protein S100-G,20447,131,0.96 [0.68-1.36],0.8332168062789973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,S100P,Protein S100-P,23208,146,0.90 [0.68-1.18],0.4431594788840968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAA4,Serum amyloid A-4 protein,20510,132,0.87 [0.46-1.66],0.6687832077735023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAFB2,Scaffold attachment factor B2,20447,131,1.40 [0.84-2.35],0.1997694381215102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAG,S-arrestin,19830,123,0.83 [0.58-1.18],0.2896767532048965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAMD9L,Sterile alpha motif domain-containing protein 9-like,23613,149,1.12 [0.92-1.36],0.2488660169456839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAP18,Histone deacetylase complex subunit SAP18,20126,125,1.10 [0.89-1.36],0.3592806535883154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SARG,Specifically androgen-regulated gene protein,20411,132,1.11 [0.95-1.29],0.175833106526506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19790,124,1.24 [0.87-1.76],0.242426064400394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAT1,Diamine acetyltransferase 1,19790,124,0.90 [0.62-1.32],0.600800428961658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SAT2,Thialysine N-epsilon-acetyltransferase,20126,125,0.95 [0.73-1.24],0.7192663214553952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SATB1,DNA-binding protein SATB1,20447,131,1.16 [0.69-1.96],0.5704333714977483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SBSN,Suprabasin,20456,132,0.64 [0.40-1.04],0.0693583823131433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCAMP3,Secretory carrier-associated membrane protein 3,23526,149,1.14 [0.96-1.35],0.129467335337371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARA5,Scavenger receptor class A member 5,23855,150,1.36 [0.84-2.19],0.2090601781815072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARB1,Scavenger receptor class B member 1,23119,148,1.06 [0.83-1.36],0.630353289878125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARB2,Lysosome membrane protein 2,22975,149,1.11 [0.70-1.77],0.6462826382451254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARF1,Scavenger receptor class F member 1,23938,149,1.56 [1.12-2.16],0.0079067909668575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCARF2,Scavenger receptor class F member 2,23855,150,1.30 [0.78-2.17],0.3202543530048228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCG2,Secretogranin-2,23747,151,1.29 [0.84-1.99],0.2421439250382921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCG3,Secretogranin-3,23642,148,0.86 [0.56-1.33],0.4902500502080487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB1A1,Uteroglobin,23647,148,0.90 [0.69-1.19],0.4676332545734645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB2A2,Mammaglobin-A,19790,124,1.01 [0.57-1.78],0.9803592426364404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB3A1,Secretoglobin family 3A member 1,20023,132,0.73 [0.38-1.41],0.3533144912632724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGB3A2,Secretoglobin family 3A member 2,23689,148,0.97 [0.80-1.17],0.7401735405304076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCGN,Secretagogin,23231,145,1.07 [0.77-1.49],0.6725600785729223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCIN,Adseverin,19830,123,1.18 [0.96-1.44],0.1195549964450432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCLY,Selenocysteine lyase,23782,151,1.00 [0.73-1.35],0.9746669529235944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN2A,Sodium channel protein type 2 subunit alpha,19830,123,0.94 [0.64-1.36],0.7296982898758061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN2B,Sodium channel subunit beta-2,19939,127,0.78 [0.41-1.50],0.4598324944301883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN3A,Sodium channel protein type 3 subunit alpha,19939,127,1.02 [0.64-1.64],0.922316150832542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN3B,Sodium channel subunit beta-3,19830,123,0.97 [0.67-1.41],0.8688039208344694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCN4B,Sodium channel subunit beta-4,19922,125,0.70 [0.47-1.06],0.0923617998609116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCP2,Non-specific lipid-transfer protein,23083,148,0.98 [0.81-1.20],0.8729356422019078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCPEP1,Retinoid-inducible serine carboxypeptidase,19856,125,1.57 [1.14-2.17],0.0058348675820972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCRG1,Scrapie-responsive protein 1,20484,132,0.43 [0.22-0.83],0.0117018606515486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCRIB,Protein scribble homolog,19922,125,0.95 [0.78-1.17],0.6461195334035179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCRN1,Secernin-1,23613,149,1.17 [0.91-1.50],0.2109204209512589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SCT,Secretin,19939,127,1.05 [0.74-1.50],0.7820596288614701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDC1,Syndecan-1,23640,150,1.07 [0.74-1.54],0.71484415930456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDC4,Syndecan-4,23640,150,1.23 [0.90-1.68],0.1944811502976186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDCCAG8,Serologically defined colon cancer antigen 8,20415,129,0.98 [0.85-1.14],0.8060939791035793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDHB,Succinate dehydrogenase,20422,129,1.08 [0.84-1.39],0.5579591316532554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SDK2,Protein sidekick-2,20023,132,1.45 [1.01-2.06],0.0417089767114519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEC31A,Protein transport protein Sec31A,19922,125,1.16 [0.92-1.46],0.2041077741688541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEL1L,Protein sel-1 homolog 1,19922,125,1.17 [0.71-1.92],0.5444987965466502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELE,E-selectin,23938,149,1.38 [1.03-1.85],0.0283797756259604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELENOP,Selenoprotein P,20510,132,1.37 [0.68-2.75],0.37338229974366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELL,L-selectin,20510,132,1.45 [0.73-2.91],0.2893735766442905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELP,P-selectin,23752,148,1.33 [1.03-1.70],0.0279131088934375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SELPLG,P-selectin glycoprotein ligand 1,23613,149,1.03 [0.62-1.72],0.9000337519171766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA3F,Semaphorin-3F,23640,150,1.00 [0.58-1.72],0.99458450440597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA3G,Semaphorin-3G,20023,132,0.92 [0.63-1.35],0.6846853432827702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA4C,Semaphorin-4C,23526,149,1.72 [1.24-2.40],0.0013090432291614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA4D,Semaphorin-4D,23855,150,1.68 [1.03-2.72],0.0360284697283256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA6C,Semaphorin-6C,19884,122,1.31 [0.72-2.38],0.3730567313408228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEMA7A,Semaphorin-7A,23859,148,1.86 [1.24-2.77],0.0024431983280354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN3,Neuronal-specific septin-3,20447,131,1.03 [0.84-1.28],0.7575483174868402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN7,Septin-7,20126,125,1.05 [0.78-1.43],0.739693705786963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN8,Septin-8,20400,131,1.46 [0.91-2.32],0.112774207179526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEPTIN9,Septin-9,23526,149,1.04 [0.63-1.70],0.8846808719795705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA1,Alpha-1-antitrypsin,20137,131,1.44 [0.19-10.60],0.7223659500966704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA11,Serpin A11,23938,149,1.71 [1.19-2.44],0.0033297577752321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA12,Serpin A12,22967,143,1.05 [0.92-1.19],0.4818942922253963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA3,Alpha-1-antichymotrypsin,20446,132,0.68 [0.21-2.14],0.5067110503334855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA4,Kallistatin,20148,130,0.86 [0.42-1.78],0.6896413244870783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA5,Plasma serine protease inhibitor,20218,130,1.10 [0.64-1.88],0.7233725385140386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA6,Corticosteroid-binding globulin,20510,132,1.98 [0.69-5.70],0.2038073635165857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA7,Thyroxine-binding globulin,20510,132,1.00 [0.41-2.47],0.9970443845233362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINA9,Serpin A9,23429,148,1.14 [0.94-1.40],0.1920024723346549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB1,Leukocyte elastase inhibitor,23571,147,1.10 [0.94-1.29],0.2206988930534348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB5,Serpin B5,23208,146,0.62 [0.47-0.82],0.0006497771683652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB6,Serpin B6,23775,150,1.17 [0.92-1.50],0.1956174540761024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB8,Serpin B8,23917,149,0.90 [0.69-1.16],0.419561740416478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINB9,Serpin B9,23436,150,1.30 [0.83-2.03],0.2522137397616232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINC1,Antithrombin-III,20477,132,2.34 [0.76-7.18],0.1375921047301261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPIND1,Heparin cofactor 2,20477,132,1.57 [0.88-2.80],0.1245033239777451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINE1,Plasminogen activator inhibitor 1,23938,149,1.14 [0.92-1.42],0.2433839496983161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINE2,Glia-derived nexin,20484,132,1.23 [0.96-1.58],0.1076175131093743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINF1,Pigment epithelium-derived factor,20199,132,1.33 [0.71-2.51],0.372250145856137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINF2,Alpha-2-antiplasmin,20128,132,1.89 [0.55-6.47],0.3090066178541897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPING1,Plasma protease C1 inhibitor,20477,132,1.68 [0.69-4.14],0.2554514816199953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINH1,Serpin H1,20126,125,1.09 [0.95-1.25],0.2050539810958861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINI1,Neuroserpin,19991,132,0.87 [0.48-1.59],0.6515221875204433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SERPINI2,Serpin I2,20422,129,1.21 [0.91-1.61],0.1827644721834418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23119,148,0.93 [0.74-1.18],0.5627598939617708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SETMAR,Histone-lysine N-methyltransferase SETMAR,23350,148,0.75 [0.46-1.23],0.2500655250542424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEZ6,Seizure protein 6 homolog,19939,127,0.82 [0.46-1.45],0.4943719120088539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEZ6L,Seizure 6-like protein,23701,148,0.83 [0.49-1.41],0.4934122804096672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SEZ6L2,Seizure 6-like protein 2,23526,149,0.62 [0.33-1.16],0.1351619249976375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SF3B4,Splicing factor 3B subunit 4,23526,149,1.19 [0.98-1.43],0.0728450431332249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFRP1,Secreted frizzled-related protein 1,23350,149,0.93 [0.65-1.32],0.675072421059562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFRP4,Secreted frizzled-related protein 4,20023,132,0.82 [0.54-1.26],0.3759922775407615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFTPA1,Pulmonary surfactant-associated protein A1,23083,148,0.83 [0.61-1.12],0.2243058226806475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFTPA2,Pulmonary surfactant-associated protein A2,23083,148,0.70 [0.52-0.96],0.0250138467752683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SFTPD,Pulmonary surfactant-associated protein D,23640,150,0.94 [0.76-1.17],0.599520519194779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SGSH,N-sulphoglucosamine sulphohydrolase,20156,129,0.86 [0.63-1.18],0.344972062307522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH2B3,SH2B adapter protein 3,23083,148,1.11 [0.96-1.29],0.1639053114751682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH2D1A,SH2 domain-containing protein 1A,23613,149,1.06 [0.84-1.33],0.6264431601002631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19830,123,0.89 [0.64-1.22],0.4574720798638579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3BP1,SH3 domain-binding protein 1,20422,129,1.18 [0.88-1.58],0.2810988213576244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3GL3,Endophilin-A3,20006,125,1.02 [0.83-1.25],0.8501258316757263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SH3GLB2,Endophilin-B2,20438,131,1.40 [1.10-1.79],0.00609485456679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHBG,Sex hormone-binding globulin,20513,128,1.12 [0.78-1.63],0.5365870343278958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHC1,SHC-transforming protein 1,19767,126,0.94 [0.80-1.10],0.4413426957202441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHD,SH2 domain-containing adapter protein D,19755,124,1.06 [0.88-1.29],0.5423666190712026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHH,Sonic hedgehog protein,19884,122,1.15 [0.78-1.69],0.4741860004164506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHISA5,Protein shisa-5,20492,132,0.82 [0.41-1.63],0.5756070758513391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHMT1,"Serine hydroxymethyltransferase, cytosolic",23689,148,1.14 [0.96-1.36],0.1310742857992095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SHPK,Sedoheptulokinase,20126,125,0.93 [0.59-1.45],0.7349492489854634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIAE,Sialate O-acetylesterase,23660,148,1.34 [0.98-1.82],0.0629794850444614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC1,Sialoadhesin,23725,148,1.35 [0.95-1.90],0.0899676031692692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC10,Sialic acid-binding Ig-like lectin 10,23613,149,1.28 [0.85-1.92],0.232272229175929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC15,Sialic acid-binding Ig-like lectin 15,23119,148,0.88 [0.70-1.10],0.2585970103948798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC5,Sialic acid-binding Ig-like lectin 5,23652,147,0.96 [0.85-1.08],0.4682387825733156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC6,Sialic acid-binding Ig-like lectin 6,23846,151,1.29 [0.85-1.98],0.2359618998241335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC7,Sialic acid-binding Ig-like lectin 7,23640,150,2.14 [1.32-3.48],0.0020487761727335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19922,125,0.90 [0.62-1.32],0.5992314509528807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIGLEC9,Sialic acid-binding Ig-like lectin 9,23810,151,1.27 [0.79-2.04],0.320695627769495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIL1,Nucleotide exchange factor SIL1,19922,125,0.63 [0.31-1.25],0.183414500257819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23708,148,1.22 [0.94-1.59],0.1423418254265491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRPB1,Signal-regulatory protein beta-1,23561,148,1.51 [1.12-2.03],0.0068268734604575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19884,122,0.91 [0.73-1.15],0.4277023138010329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRT2,NAD-dependent protein deacetylase sirtuin-2,23526,149,1.26 [1.06-1.48],0.0075368026926282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23119,148,1.05 [0.80-1.36],0.7449588547962818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SIT1,Signaling threshold-regulating transmembrane adapter 1,23231,145,1.12 [0.86-1.47],0.3949228468997806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SKAP1,Src kinase-associated phosphoprotein 1,23403,150,1.05 [0.86-1.28],0.6613437529714683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SKAP2,Src kinase-associated phosphoprotein 2,23725,148,1.07 [0.93-1.23],0.3310411014934469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SKIV2L,Helicase SKI2W,19790,124,0.93 [0.58-1.48],0.7478220329303329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLA2,Src-like-adapter 2,20447,131,1.13 [0.96-1.32],0.1446609020396949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF1,Signaling lymphocytic activation molecule,23231,145,0.88 [0.69-1.12],0.2978475866271597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF6,SLAM family member 6,23083,148,1.42 [1.01-2.01],0.0454046279894746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF7,SLAM family member 7,23613,149,0.99 [0.78-1.27],0.9596798177222864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLAMF8,SLAM family member 8,23083,148,0.99 [0.75-1.30],0.9442537782924268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC12A2,Solute carrier family 12 member 2,19790,124,1.16 [0.63-2.17],0.6296701087999974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC13A1,Solute carrier family 13 member 1,20415,129,0.93 [0.68-1.26],0.6339143331597432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC16A1,Monocarboxylate transporter 1,23119,148,0.99 [0.75-1.29],0.9208285672945612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC1A4,Neutral amino acid transporter A,19939,127,0.87 [0.60-1.26],0.4472790904915785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC27A4,Long-chain fatty acid transport protein 4,23119,148,1.04 [0.84-1.28],0.7277011833704564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC28A1,Sodium/nucleoside cotransporter 1,19767,126,1.02 [0.77-1.36],0.8748092381377566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC34A3,Sodium-dependent phosphate transport protein 2C,19767,126,1.11 [0.79-1.55],0.5582166783845081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC39A14,Zinc transporter ZIP14,23119,148,1.22 [0.81-1.82],0.3390332787590048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC39A5,Zinc transporter ZIP5,23613,149,0.96 [0.73-1.27],0.77265614346606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC44A4,Choline transporter-like protein 4,19939,127,0.84 [0.62-1.13],0.2433388997604206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC4A1,Band 3 anion transport protein,20492,132,1.44 [1.04-1.99],0.0285915108914452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC51B,Organic solute transporter subunit beta,19790,124,0.96 [0.75-1.23],0.7466111342189199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20023,132,1.15 [0.95-1.39],0.150820127062553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,20422,129,0.92 [0.64-1.32],0.6498794967705729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19767,126,1.23 [0.96-1.59],0.0986534959081243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLIT2,Slit homolog 2 protein,23119,148,1.15 [0.89-1.48],0.2918316322535642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLITRK1,SLIT and NTRK-like protein 1,19884,122,0.77 [0.45-1.32],0.341209703205664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLITRK2,SLIT and NTRK-like protein 2,23846,151,1.31 [0.92-1.86],0.1322813355485996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLITRK6,SLIT and NTRK-like protein 6,23208,146,1.00 [0.65-1.52],0.9913673128329924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLK,STE20-like serine/threonine-protein kinase,20126,125,1.21 [1.02-1.43],0.0289216172436755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLMAP,Sarcolemmal membrane-associated protein,20422,129,1.04 [0.85-1.27],0.7190947654541813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SLURP1,Secreted Ly-6/uPAR-related protein 1,20348,132,0.76 [0.46-1.26],0.2908583209339233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD1,Mothers against decapentaplegic homolog 1,23083,148,1.10 [0.93-1.31],0.2578551587574945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD2,Mothers against decapentaplegic homolog 2,20415,129,1.20 [0.95-1.51],0.1270270886185453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD3,Mothers against decapentaplegic homolog 3,20415,129,0.87 [0.62-1.21],0.4005593714347585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMAD5,Mothers against decapentaplegic homolog 5,23526,149,0.89 [0.43-1.86],0.7614269315615857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMARCA2,Probable global transcription activator SNF2L2,23119,148,1.00 [0.81-1.22],0.969227496359534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMC3,Structural maintenance of chromosomes protein 3,19767,126,0.64 [0.43-0.96],0.0286788320356009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMNDC1,Survival of motor neuron-related-splicing factor 30,20422,129,1.21 [0.98-1.51],0.0760473948898557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMOC1,SPARC-related modular calcium-binding protein 1,23846,151,0.99 [0.64-1.54],0.9663448008225322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMOC2,SPARC-related modular calcium-binding protein 2,23725,148,0.88 [0.60-1.28],0.4939036367729926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPD1,Sphingomyelin phosphodiesterase,23738,149,1.06 [0.80-1.41],0.6705365787115807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPD3,Sphingomyelin phosphodiesterase 3,19884,122,0.82 [0.57-1.19],0.2916670708575679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,23680,148,0.96 [0.77-1.19],0.6811631863313021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,20415,129,0.99 [0.79-1.24],0.9313168334563352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMS,Spermine synthase,19830,123,1.13 [0.89-1.45],0.3136382440502535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SMTN,Smoothelin,20397,131,0.95 [0.79-1.15],0.5937745452961654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAP23,Synaptosomal-associated protein 23,23640,150,1.06 [0.90-1.26],0.4776182593264839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAP25,Synaptosomal-associated protein 25,19830,123,1.15 [0.80-1.65],0.4392912402695808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAP29,Synaptosomal-associated protein 29,23701,148,1.14 [0.97-1.33],0.1137735842341957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNAPIN,SNARE-associated protein Snapin,20447,131,0.93 [0.69-1.24],0.6170704655687267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNCA,Alpha-synuclein,20023,132,1.14 [0.99-1.32],0.072199015895817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNCG,Gamma-synuclein,23436,150,0.94 [0.75-1.17],0.5644469731173858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19922,125,0.68 [0.38-1.21],0.1873495164892983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNRPB2,U2 small nuclear ribonucleoprotein B'',20438,131,1.08 [0.79-1.48],0.6184100421372798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNU13,NHP2-like protein 1,19790,124,1.05 [0.80-1.36],0.729385300600949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX15,Sorting nexin-15,20023,132,1.61 [1.21-2.13],0.0009104252819935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX18,Sorting nexin-18,20422,129,1.29 [0.93-1.81],0.1293520855838439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX2,Sorting nexin-2,20415,129,0.98 [0.80-1.19],0.8328893249856146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX5,Sorting nexin-5,19922,125,1.60 [0.94-2.70],0.0811848162526194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SNX9,Sorting nexin-9,23640,150,1.24 [1.01-1.52],0.0418960033533122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOD1,Superoxide dismutase [Cu-Zn],23189,141,1.61 [1.21-2.14],0.001103280504829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOD2,"Superoxide dismutase [Mn], mitochondrial",23652,147,0.96 [0.65-1.43],0.8544437603681873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOD3,Extracellular superoxide dismutase,20513,128,1.09 [0.85-1.39],0.4816890937950069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORBS1,Sorbin and SH3 domain-containing protein 1,20447,131,1.22 [0.86-1.73],0.2660382431781777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORCS2,VPS10 domain-containing receptor SorCS2,23083,148,0.75 [0.49-1.15],0.1842495441727415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORD,Sorbitol dehydrogenase,23741,151,0.99 [0.80-1.22],0.8937404856257257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SORT1,Sortilin,23609,150,1.31 [0.90-1.90],0.1632885390059459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOST,Sclerostin,23609,150,1.06 [0.73-1.54],0.7626020458940069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19939,127,0.71 [0.46-1.11],0.1313404858386311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOX2,Transcription factor SOX-2,20403,131,0.91 [0.45-1.83],0.7883943839991756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SOX9,Transcription factor SOX-9,19939,127,1.09 [0.58-2.07],0.7833443623749103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,20447,131,0.94 [0.54-1.66],0.8423271056186481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPAG1,Sperm-associated antigen 1,20447,131,1.14 [0.88-1.47],0.3307374604337783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPARC,SPARC,23701,148,0.99 [0.81-1.22],0.9465289381554048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPARCL1,SPARC-like protein 1,23670,148,1.50 [0.97-2.31],0.0672021288174547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPART,Spartin,20023,132,1.11 [0.89-1.37],0.3496542289145733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPESP1,Sperm equatorial segment protein 1,20484,132,0.88 [0.54-1.46],0.6310351820356455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK1,Serine protease inhibitor Kazal-type 1,23652,147,1.17 [0.83-1.66],0.3656598760410817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK2,Serine protease inhibitor Kazal-type 2,20023,132,1.11 [0.70-1.76],0.6514115862600189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK4,Serine protease inhibitor Kazal-type 4,23613,149,1.18 [0.96-1.46],0.1229966632791534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK5,Serine protease inhibitor Kazal-type 5,23652,147,0.77 [0.50-1.17],0.2219476029167822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK6,Serine protease inhibitor Kazal-type 6,23846,151,0.75 [0.57-0.97],0.0312425239834516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINK8,Serine protease inhibitor Kazal-type 8,19790,124,0.74 [0.43-1.28],0.2847006113080779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINT1,Kunitz-type protease inhibitor 1,23563,147,0.92 [0.51-1.64],0.7665722374926799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINT2,Kunitz-type protease inhibitor 2,23725,148,1.54 [1.07-2.22],0.0195857366312978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPINT3,Kunitz-type protease inhibitor 3,20422,129,1.01 [0.92-1.12],0.7870602948056455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPOCK1,Testican-1,23436,150,0.50 [0.29-0.88],0.015361229384527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPON1,Spondin-1,23642,148,0.86 [0.55-1.37],0.534686688021087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPON2,Spondin-2,23526,150,1.33 [0.87-2.02],0.1908028189152857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPP1,Osteopontin,23903,149,0.85 [0.61-1.19],0.3479083674212896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19884,122,0.92 [0.60-1.39],0.6759500550702546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRING1,SREBP regulating gene protein,19767,126,0.85 [0.61-1.18],0.3246723065720175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRR1B,Cornifin-B,20126,125,0.79 [0.61-1.02],0.076533097148053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRR3,Small proline-rich protein 3,20438,131,0.84 [0.64-1.10],0.2109574040152965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPRY2,Protein sprouty homolog 2,23231,145,1.09 [0.93-1.28],0.268457197135893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19830,123,1.07 [0.62-1.82],0.8159249888579813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SPTLC1,Serine palmitoyltransferase 1,20438,131,1.23 [0.85-1.78],0.2642599971074562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRC,Proto-oncogene tyrosine-protein kinase Src,23663,148,1.05 [0.93-1.19],0.4002941727193602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRP14,Signal recognition particle 14 kDa protein,23526,149,1.31 [1.06-1.63],0.0140855661745437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRPK2,SRSF protein kinase 2,23613,149,1.09 [0.92-1.28],0.31015944448625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SRPX,Sushi repeat-containing protein SRPX,20484,132,1.03 [0.67-1.58],0.9053795814321676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSB,Lupus La protein,23119,148,1.20 [0.99-1.45],0.058284083641805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19884,122,1.11 [0.69-1.80],0.6715984215059451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,23609,150,1.00 [0.89-1.13],0.9689540718755004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23752,148,1.06 [0.76-1.49],0.7211706754783833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSH3,Protein phosphatase Slingshot homolog 3,19767,126,0.84 [0.45-1.56],0.5821573077600348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SSNA1,Sjoegren syndrome nuclear autoantigen 1,20422,129,1.53 [1.14-2.05],0.0045640200972308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST13,Hsc70-interacting protein,20023,132,1.69 [1.26-2.28],0.000529116037257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",23526,149,1.11 [0.80-1.53],0.5254100444242437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23938,149,1.25 [0.79-1.96],0.3421353549581067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19884,122,1.05 [0.75-1.46],0.7905042330990482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAB2,Stabilin-2,20492,132,1.13 [0.62-2.06],0.6938304069073922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAM,Signal transducing adapter molecule 1,20415,129,0.84 [0.51-1.37],0.4800275037318277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAMBP,STAM-binding protein,23403,150,1.27 [1.01-1.59],0.0383984868914548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAT2,Signal transducer and activator of transcription 2,19884,122,1.11 [0.89-1.38],0.3624522041841993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAT5B,Signal transducer and activator of transcription 5B,23526,149,1.12 [1.01-1.25],0.0351302136037476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19767,126,1.27 [1.03-1.58],0.0272492523992303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STC1,Stanniocalcin-1,23855,150,1.11 [0.81-1.51],0.5171281963499181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STC2,Stanniocalcin-2,23620,147,0.81 [0.44-1.49],0.4934895108505627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STEAP4,Metalloreductase STEAP4,19830,123,1.05 [0.83-1.32],0.7063375363309208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STIP1,Stress-induced-phosphoprotein 1,23606,147,1.36 [1.09-1.68],0.0052763248075342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STK11,Serine/threonine-protein kinase STK11,23208,146,1.25 [1.02-1.52],0.0298151350829067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STK24,Serine/threonine-protein kinase 24,23119,148,1.20 [0.95-1.51],0.1277267679773382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STK4,Serine/threonine-protein kinase 4,23640,150,1.13 [0.96-1.33],0.1400034902515518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STOML2,"Stomatin-like protein 2, mitochondrial",19767,126,0.90 [0.74-1.10],0.3064694770275959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX16,Syntaxin-16,23083,148,0.80 [0.60-1.07],0.1366470871385312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX1B,Syntaxin-1B,19939,127,0.84 [0.52-1.34],0.4590342100501672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX3,Syntaxin-3,20438,131,1.15 [0.77-1.71],0.502784075255375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX4,Syntaxin-4,23526,149,1.04 [0.82-1.32],0.7285385518381775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX5,Syntaxin-5,19884,122,1.14 [0.77-1.70],0.5128987744201019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX6,Syntaxin-6,23083,148,0.98 [0.78-1.23],0.8331856784659325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX7,Syntaxin-7,19884,122,1.21 [0.85-1.72],0.3009359364272876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STX8,Syntaxin-8,23613,149,1.15 [0.86-1.54],0.3411944431438453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STXBP1,Syntaxin-binding protein 1,20447,131,1.16 [0.93-1.44],0.178177531860503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,STXBP3,Syntaxin-binding protein 3,23083,148,1.11 [0.80-1.53],0.5329883790913126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUGP1,SURP and G-patch domain-containing protein 1,20422,129,1.12 [0.74-1.67],0.5955465176037948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUGT1,Protein SGT1 homolog,23083,148,1.22 [1.01-1.47],0.0369401428975604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SULT1A1,Sulfotransferase 1A1,23855,150,1.10 [0.98-1.24],0.1000870675044227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SULT2A1,Bile salt sulfotransferase,23613,149,0.92 [0.71-1.20],0.5578074869083042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUMF1,Formylglycine-generating enzyme,19884,122,1.02 [0.78-1.34],0.8780868300543213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23855,150,1.14 [0.86-1.51],0.3520546005265563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUOX,"Sulfite oxidase, mitochondrial",20447,131,1.09 [0.84-1.42],0.5102868720038293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD1,Sushi domain-containing protein 1,23208,146,1.33 [0.98-1.81],0.0653683049856264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD2,Sushi domain-containing protein 2,23652,147,1.10 [0.65-1.84],0.7266352282173512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD4,Sushi domain-containing protein 4,20415,129,0.87 [0.56-1.36],0.53899481510989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SUSD5,Sushi domain-containing protein 5,19923,132,1.02 [0.62-1.67],0.9362441713642116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SV2A,Synaptic vesicle glycoprotein 2A,19939,127,1.14 [0.88-1.47],0.3135182417712782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SWAP70,Switch-associated protein 70,20422,129,1.42 [0.97-2.09],0.0728214867023541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYAP1,Synapse-associated protein 1,20023,132,1.37 [1.04-1.79],0.023476643695371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19830,123,1.32 [1.04-1.66],0.0226388916781792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYT1,Synaptotagmin-1,20438,131,1.04 [0.70-1.56],0.8332151564485167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,SYTL4,Synaptotagmin-like protein 4,20484,132,1.19 [0.96-1.48],0.1147298190120545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20126,125,1.02 [0.86-1.20],0.8346547680591462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TACC3,Transforming acidic coiled-coil-containing protein 3,23526,149,1.09 [0.96-1.23],0.1867928272534147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TACSTD2,Tumor-associated calcium signal transducer 2,20928,131,0.88 [0.51-1.52],0.6451756886435618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TADA3,Transcriptional adapter 3,20415,129,1.31 [0.88-1.95],0.1907391264370067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAFA5,Chemokine-like protein TAFA-5,23526,149,1.01 [0.68-1.51],0.957143932530822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAGLN3,Transgelin-3,19767,126,1.12 [0.86-1.47],0.3983259902624791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TALDO1,Transaldolase,20422,132,1.54 [1.10-2.15],0.0122620761137665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TANK,TRAF family member-associated NF-kappa-B activator,23231,145,1.03 [0.84-1.27],0.7549211588572846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAP1,Antigen peptide transporter 1,20126,125,1.12 [0.86-1.46],0.3973870571087033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TARBP2,RISC-loading complex subunit TARBP2,23119,148,1.06 [0.88-1.27],0.5602459164374669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19939,127,0.91 [0.71-1.16],0.4355105543880994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",20415,129,0.98 [0.62-1.54],0.9375612764805944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TAX1BP1,Tax1-binding protein 1,20438,131,1.03 [0.79-1.35],0.8132093501448384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBC1D17,TBC1 domain family member 17,23119,148,1.25 [0.92-1.69],0.1523964010217955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBC1D23,TBC1 domain family member 23,23526,149,1.03 [0.87-1.20],0.758950537941929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBC1D5,TBC1 domain family member 5,23613,149,0.93 [0.77-1.12],0.4364223695208779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBCA,Tubulin-specific chaperone A,20023,132,1.33 [1.09-1.61],0.0041818813163812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBCB,Tubulin-folding cofactor B,23436,150,1.14 [0.98-1.33],0.0816727947092619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBCC,Tubulin-specific chaperone C,23436,150,1.15 [0.96-1.38],0.1226925048606812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBL1X,F-box-like/WD repeat-containing protein TBL1X,23083,148,1.08 [0.91-1.28],0.3885661752505354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TBR1,T-box brain protein 1,19939,127,0.75 [0.48-1.17],0.205294334359146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCL1A,T-cell leukemia/lymphoma protein 1A,23406,150,0.97 [0.84-1.12],0.6758559160155089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCL1B,T-cell leukemia/lymphoma protein 1B,23208,146,1.06 [0.89-1.26],0.497136574031557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCN1,Transcobalamin-1,20112,127,1.23 [0.80-1.89],0.3554629902425034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCN2,Transcobalamin-2,23903,149,1.47 [0.94-2.30],0.0887456460350442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCOF1,Treacle protein,20484,132,1.07 [0.64-1.78],0.7984758378472221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCP11,T-complex protein 11 homolog,20126,125,1.03 [0.76-1.39],0.8662985907067253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TCTN3,Tectonic-3,20484,132,0.76 [0.44-1.32],0.3386445667450313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDGF1,Teratocarcinoma-derived growth factor 1,23119,148,1.03 [0.93-1.13],0.6013942801890526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDO2,"Tryptophan 2,3-dioxygenase",19939,127,0.81 [0.49-1.32],0.396052885528381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDP1,Tyrosyl-DNA phosphodiesterase 1,20415,129,0.97 [0.77-1.23],0.8113543937747203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TDRKH,Tudor and KH domain-containing protein,23119,148,1.04 [0.88-1.24],0.6508606243616843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEF,Thyrotroph embryonic factor,19790,124,1.30 [0.93-1.84],0.129323503286867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEK,Angiopoietin-1 receptor,23701,148,1.00 [0.52-1.94],0.9927924926956168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TERF1,Telomeric repeat-binding factor 1,19884,122,1.02 [0.56-1.87],0.9492542325572256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TET2,Methylcytosine dioxygenase TET2,20090,125,1.00 [0.85-1.18],0.9792360352096106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEX101,Testis-expressed protein 101,19939,127,0.98 [0.74-1.29],0.869630259005177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TEX33,Testis-expressed protein 33,20126,125,1.02 [0.65-1.59],0.9418753159667448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TF,Serotransferrin,20510,132,0.97 [0.45-2.09],0.9327134561908637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFAP2A,Transcription factor AP-2-alpha,19830,123,1.07 [0.81-1.41],0.6449239922411913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFF1,Trefoil factor 1,23538,147,1.00 [0.83-1.20],0.9886959720152269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFF2,Trefoil factor 2,23689,148,1.05 [0.82-1.36],0.6811780624382333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFF3,Trefoil factor 3,23636,147,1.52 [1.14-2.02],0.0041264252266071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFPI,Tissue factor pathway inhibitor,23602,148,1.31 [0.86-1.99],0.2143792272365428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFPI2,Tissue factor pathway inhibitor 2,23635,148,1.18 [0.85-1.62],0.3208991686716601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TFRC,Transferrin receptor protein 1,23746,148,1.42 [0.99-2.06],0.0597421828659014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TG,Thyroglobulin,20415,129,0.87 [0.74-1.04],0.1214014671055429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFA,Protransforming growth factor alpha,23613,149,1.35 [1.00-1.82],0.0527062359094738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFB1,Transforming growth factor beta-1 proprotein,23878,149,1.18 [0.82-1.69],0.3786093762155432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFB2,Transforming growth factor beta-2 proprotein,20415,129,1.09 [0.80-1.49],0.5871712903291324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBI,Transforming growth factor-beta-induced protein ig-h3,23524,147,0.37 [0.21-0.64],0.0003553807845519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBR1,TGF-beta receptor type-1,19884,122,0.89 [0.40-2.01],0.7868894647668567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBR2,TGF-beta receptor type-2,23701,148,1.34 [0.89-2.01],0.1551561082426419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGFBR3,Transforming growth factor beta receptor type 3,23938,149,1.16 [0.72-1.88],0.5361993814669768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGM2,Protein-glutamine gamma-glutamyltransferase 2,23598,150,1.05 [0.87-1.27],0.630213053769661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TGOLN2,Trans-Golgi network integral membrane protein 2,20513,128,1.24 [0.66-2.35],0.4984055496577626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THAP12,52 kDa repressor of the inhibitor of the protein kinase,19731,126,1.00 [0.81-1.22],0.9745581782123448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THBD,Thrombomodulin,23640,150,1.38 [0.86-2.20],0.1839934034792348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THBS2,Thrombospondin-2,23652,147,0.73 [0.48-1.10],0.1300177287631716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THBS4,Thrombospondin-4,23680,148,1.02 [0.74-1.41],0.88005238785314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THOP1,Thimet oligopeptidase,23529,149,1.36 [0.88-2.10],0.1681792514659457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THPO,Thrombopoietin,23208,146,0.90 [0.62-1.32],0.5914949021104967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THRAP3,Thyroid hormone receptor-associated protein 3,19790,124,0.95 [0.79-1.14],0.5693631670757179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THSD1,Thrombospondin type-1 domain-containing protein 1,19740,122,0.92 [0.54-1.55],0.7418793781843114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THTPA,Thiamine-triphosphatase,20368,129,1.25 [1.03-1.51],0.0251373656429443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,THY1,Thy-1 membrane glycoprotein,23855,150,1.15 [0.69-1.90],0.5910748353442561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIA1,Nucleolysin TIA-1 isoform p40,22951,145,1.16 [1.03-1.30],0.0151086086512974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIE1,Tyrosine-protein kinase receptor Tie-1,23938,149,0.88 [0.64-1.21],0.4341995404277373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23086,148,1.01 [0.74-1.38],0.9448721499744014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20126,125,1.05 [0.67-1.65],0.835203639187432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,23752,148,1.18 [0.84-1.65],0.3425293152936839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20484,132,1.49 [1.02-2.19],0.0412676329504618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,20438,131,1.09 [0.90-1.32],0.3693440024891329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP1,Metalloproteinase inhibitor 1,23412,146,1.60 [0.98-2.59],0.0591189476076305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP2,Metalloproteinase inhibitor 2,20484,132,1.10 [0.63-1.94],0.7278484016273443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP3,Metalloproteinase inhibitor 3,23725,148,1.13 [1.01-1.25],0.0319653874885611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TIMP4,Metalloproteinase inhibitor 4,23652,147,1.15 [0.80-1.66],0.4395450613913721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TINAGL1,Tubulointerstitial nephritis antigen-like,23573,150,1.04 [0.54-2.01],0.9155635814329536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TJAP1,Tight junction-associated protein 1,23701,148,1.03 [0.87-1.23],0.7002178383369648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TJP3,Tight junction protein ZO-3,19830,123,0.96 [0.62-1.47],0.8403553438650336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TK1,"Thymidine kinase, cytosolic",20126,125,0.86 [0.57-1.30],0.4777644165923769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR1,Toll-like receptor 1,19884,122,1.70 [0.94-3.07],0.0807881832068403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR2,Toll-like receptor 2,20126,125,1.52 [0.76-3.04],0.2414743115906404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR3,Toll-like receptor 3,23917,149,1.02 [0.80-1.29],0.898334187815568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TLR4,Toll-like receptor 4,19884,122,1.01 [0.55-1.86],0.9826551448782758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19939,127,1.18 [0.89-1.58],0.2577187284220089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED1,Transmembrane emp24 domain-containing protein 1,20126,125,1.11 [0.83-1.49],0.4725476398612096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED10,Transmembrane emp24 domain-containing protein 10,19790,124,0.71 [0.42-1.20],0.2037342862015942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED4,Transmembrane emp24 domain-containing protein 4,19790,124,0.99 [0.72-1.35],0.9345765599750346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMED8,Protein TMED8,20422,129,1.11 [0.94-1.31],0.2216782020483732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMEM106A,Transmembrane protein 106A,20415,129,1.25 [1.00-1.55],0.0471765695853466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMEM132A,Transmembrane protein 132A,19922,125,0.92 [0.69-1.21],0.5411941522591002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMEM25,Transmembrane protein 25,20447,131,1.04 [0.73-1.48],0.842367243801758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMOD4,Tropomodulin-4,19767,126,1.16 [0.76-1.77],0.477219498070929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS11B,Transmembrane protease serine 11B,19830,123,0.94 [0.74-1.20],0.623941806491591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS11D,Transmembrane protease serine 11D,20400,131,1.18 [0.77-1.80],0.4430203003014484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS15,Enteropeptidase,23526,149,1.21 [1.03-1.43],0.0190229228614471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMPRSS5,Transmembrane protease serine 5,23320,149,0.97 [0.66-1.42],0.8701877439267485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TMSB10,Thymosin beta-10,23652,147,1.21 [1.00-1.47],0.0448866450178956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNC,Tenascin,23752,148,1.19 [0.89-1.61],0.2415572820814404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNF,Tumor necrosis factor,23176,145,1.34 [0.96-1.87],0.0815108610334121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,20422,129,1.30 [0.96-1.76],0.0864848828977762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,23231,145,1.09 [0.73-1.61],0.6759481665502729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20023,132,1.26 [0.98-1.62],0.0707443265694313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23436,150,1.29 [0.86-1.94],0.219501437246691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23436,150,1.02 [0.72-1.45],0.9172613975397674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,23717,146,1.24 [0.91-1.68],0.1730719581733853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23917,149,1.36 [0.95-1.95],0.0900095346732087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23606,148,1.18 [0.72-1.94],0.5037940508941509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23701,148,1.07 [0.72-1.60],0.7396662087716114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23642,148,1.37 [0.96-1.97],0.0864440105889207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,23231,145,1.24 [0.89-1.72],0.202767691871221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23642,148,1.65 [1.06-2.55],0.0254861092792421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20023,132,0.98 [0.65-1.47],0.91278623926117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23846,151,1.25 [0.82-1.90],0.3096367758055673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23652,147,1.49 [0.95-2.35],0.0821547758407846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23652,147,1.27 [0.90-1.80],0.1759738006184261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23855,150,1.25 [0.75-2.09],0.387787303734444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23878,149,1.37 [0.95-1.98],0.088890619007503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23436,150,1.09 [0.85-1.40],0.4780014145417802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23855,150,1.04 [0.75-1.44],0.8091889200411889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,23436,150,1.13 [0.81-1.58],0.473290219179181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF10,Tumor necrosis factor ligand superfamily member 10,23917,149,1.23 [0.69-2.17],0.4813133639259843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF11,Tumor necrosis factor ligand superfamily member 11,23613,149,0.98 [0.77-1.24],0.8516407617754531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF12,Tumor necrosis factor ligand superfamily member 12,23917,149,1.31 [0.79-2.19],0.2974235060962194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF13,Tumor necrosis factor ligand superfamily member 13,23725,148,1.16 [0.68-1.97],0.5893593221431519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23900,148,1.10 [0.65-1.86],0.7204473203218408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF14,Tumor necrosis factor ligand superfamily member 14,23436,150,1.35 [1.06-1.71],0.0142917354842301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNFSF8,Tumor necrosis factor ligand superfamily member 8,20492,132,0.96 [0.60-1.52],0.8548859379576239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNIP1,TNFAIP3-interacting protein 1,20438,131,1.07 [0.88-1.29],0.502690820119552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNN,Tenascin-N,20492,132,0.67 [0.45-0.98],0.0397806712914648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNNI3,"Troponin I, cardiac muscle",23208,146,1.02 [0.86-1.22],0.8185605607268241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNPO1,Transportin-1,20126,125,0.90 [0.55-1.48],0.6877957124429923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNR,Tenascin-R,23436,150,1.06 [0.75-1.50],0.7270286488928513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TNXB,Tenascin-X,23652,147,0.75 [0.43-1.32],0.3217288995298009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20484,132,1.20 [0.98-1.47],0.0852718595748601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOP1,DNA topoisomerase 1,20422,129,0.92 [0.80-1.06],0.2376723025962519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOP1MT,"DNA topoisomerase I, mitochondrial",19767,126,0.83 [0.56-1.23],0.3521749911417119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOP2B,DNA topoisomerase 2-beta,19884,122,1.14 [0.92-1.41],0.2379624182775725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TOR1AIP1,Torsin-1A-interacting protein 1,19922,125,1.31 [1.01-1.69],0.0401442101680765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53,Cellular tumor antigen p53,23083,148,1.20 [0.87-1.65],0.26709361624351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53BP1,TP53-binding protein 1,19884,122,1.01 [0.82-1.23],0.9535993714077006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53I3,Quinone oxidoreductase PIG3,19589,131,1.51 [1.12-2.05],0.0071005641959118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP53INP1,Tumor protein p53-inducible nuclear protein 1,23208,146,0.84 [0.49-1.45],0.5268073629955645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TP73,Tumor protein p73,19939,127,1.03 [0.62-1.71],0.9067376014552854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPBGL,Trophoblast glycoprotein-like,19939,127,0.85 [0.55-1.33],0.4874748579331823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPD52L2,Tumor protein D54,20023,132,1.16 [0.99-1.36],0.0669258410094741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPK1,Thiamin pyrophosphokinase 1,20484,132,0.93 [0.51-1.71],0.8246180118969141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPM3,Tropomyosin alpha-3 chain,19790,124,1.01 [0.69-1.46],0.9792646946120525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPMT,Thiopurine S-methyltransferase,23083,148,1.11 [0.92-1.35],0.2733759918114077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPP1,Tripeptidyl-peptidase 1,23452,148,1.33 [1.00-1.77],0.0511327934802105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPPP2,Tubulin polymerization-promoting protein family member 2,20126,125,0.79 [0.61-1.03],0.082578993875237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPPP3,Tubulin polymerization-promoting protein family member 3,23119,148,0.69 [0.45-1.08],0.1037957362536656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPR,Nucleoprotein TPR,19790,124,1.09 [0.79-1.49],0.6085153725894714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPRKB,EKC/KEOPS complex subunit TPRKB,19767,126,0.98 [0.75-1.28],0.904245608443984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPSAB1,Tryptase alpha/beta-1,23879,149,1.10 [0.83-1.45],0.5101351318378379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPSD1,Tryptase delta,20447,131,0.96 [0.61-1.53],0.8684191451940884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPSG1,Tryptase gamma,19884,122,1.79 [1.08-2.98],0.0240066417414237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TPT1,Translationally-controlled tumor protein,23231,145,0.83 [0.63-1.09],0.1777700644549114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRAF2,TNF receptor-associated factor 2,23613,149,1.03 [0.84-1.27],0.7688156263486028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19884,122,1.22 [0.82-1.83],0.3322930847968123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19790,124,0.60 [0.37-0.97],0.0374258899642581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20126,125,1.09 [0.90-1.31],0.3896724777111038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREH,Trehalase,20492,132,1.07 [0.85-1.34],0.5584522277361555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREM2,Triggering receptor expressed on myeloid cells 2,23606,148,0.79 [0.60-1.05],0.1045144279877656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREML1,Trem-like transcript 1 protein,20513,128,1.32 [0.97-1.80],0.0737874477141642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TREML2,Trem-like transcript 2 protein,23652,147,1.57 [1.05-2.33],0.0264963753381483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIAP1,TP53-regulated inhibitor of apoptosis 1,23846,151,1.23 [0.98-1.54],0.0692727704895388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM21,E3 ubiquitin-protein ligase TRIM21,23613,149,1.15 [0.94-1.40],0.1775967084333152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM24,Transcription intermediary factor 1-alpha,20089,125,1.10 [0.85-1.42],0.4742611554381208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,20422,129,1.08 [0.92-1.26],0.3271459828938659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM26,Tripartite motif-containing protein 26,19767,126,1.23 [0.96-1.57],0.105192659540848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM40,E3 ubiquitin ligase TRIM40,19939,127,0.98 [0.78-1.24],0.8873249572430779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM5,Tripartite motif-containing protein 5,23613,149,1.03 [0.87-1.22],0.7251669434232214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRIM58,E3 ubiquitin-protein ligase TRIM58,20415,129,1.14 [0.94-1.38],0.1912475395638194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TRPV3,Transient receptor potential cation channel subfamily V member 3,19790,124,0.96 [0.67-1.36],0.8008722693985559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSC1,Hamartin,19884,122,0.86 [0.65-1.13],0.2671382765877519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSC22D1,TSC22 domain family protein 1,20447,131,1.04 [0.80-1.34],0.7871454184059563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSHB,Thyrotropin subunit beta,23640,150,0.77 [0.62-0.95],0.0133788265145086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSLP,Thymic stromal lymphopoietin,23208,146,0.99 [0.77-1.27],0.941778593821723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSNAX,Translin-associated protein X,19790,124,1.42 [0.94-2.13],0.0948232326180177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN1,Tetraspanin-1,23208,146,0.93 [0.77-1.12],0.4273498011891382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN15,Tetraspanin-15,19790,124,0.97 [0.68-1.38],0.8696773581448073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN7,Tetraspanin-7,19830,123,1.00 [0.83-1.19],0.9651050068132652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPAN8,Tetraspanin-8,20422,129,0.98 [0.82-1.18],0.8654641522139102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TSPYL1,Testis-specific Y-encoded-like protein 1,19884,122,1.35 [0.91-2.00],0.1340608442225954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TST,Thiosulfate sulfurtransferase,23083,148,1.06 [0.87-1.29],0.5594865187265363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TTF2,Transcription termination factor 2,19939,127,1.28 [0.92-1.78],0.1375042394979525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TTN,Titin,19790,124,1.00 [0.78-1.29],0.9873762614406226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TTR,Transthyretin,20293,132,1.16 [0.59-2.30],0.6677810320677775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TUBB3,Tubulin beta-3 chain,19830,123,1.05 [0.57-1.93],0.8711810571221391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TWF2,Twinfilin-2,20492,132,1.16 [0.96-1.40],0.1348466140460835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXK,Tyrosine-protein kinase TXK,20126,125,0.98 [0.77-1.25],0.8774599353514744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXLNA,Alpha-taxilin,23436,150,1.13 [0.96-1.33],0.1477627071602842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXN,Thioredoxin,20187,127,1.38 [1.00-1.90],0.0506225783077366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNDC15,Thioredoxin domain-containing protein 15,23701,148,0.57 [0.33-0.96],0.0361410759694659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNDC5,Thioredoxin domain-containing protein 5,23855,150,1.20 [0.98-1.48],0.0754761168937259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNDC9,Thioredoxin domain-containing protein 9,20438,131,1.28 [0.96-1.71],0.098709949603398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNL1,Thioredoxin-like protein 1,19796,122,0.97 [0.82-1.16],0.7748325114033737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",23652,147,1.20 [0.88-1.64],0.2405505449023083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TYMP,Thymidine phosphorylase,23493,148,1.21 [0.97-1.50],0.0919990076965374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TYRO3,Tyrosine-protein kinase receptor TYRO3,23640,150,1.35 [0.81-2.25],0.2542441936810038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19884,122,0.97 [0.73-1.28],0.8170608760197704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBAC1,Ubiquitin-associated domain-containing protein 1,23526,149,1.51 [0.99-2.31],0.0563364907471302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBE2B,Ubiquitin-conjugating enzyme E2 B,20415,129,1.22 [0.69-2.13],0.4936071098588878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20484,132,1.37 [1.06-1.78],0.0174662815652472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19884,122,1.16 [0.89-1.51],0.2843520536327932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBQLN3,Ubiquilin-3,19790,124,1.02 [0.76-1.38],0.8806099297221934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UBXN1,UBX domain-containing protein 1,20023,132,1.33 [1.06-1.68],0.0146530888217694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,20422,129,1.11 [0.98-1.25],0.0879116162836207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UGDH,UDP-glucose 6-dehydrogenase,19790,124,1.10 [0.94-1.27],0.22760092128725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UHRF2,E3 ubiquitin-protein ligase UHRF2,19790,124,1.20 [0.76-1.88],0.4333457753808187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ULBP2,UL16-binding protein 2,23436,150,1.05 [0.73-1.52],0.7971978148064716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UMOD,Uromodulin,23856,149,0.78 [0.61-1.01],0.0631090313451726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UNC5D,Netrin receptor UNC5D,19884,122,1.20 [0.64-2.28],0.5686463623040868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UNC79,Protein unc-79 homolog,19767,126,1.07 [0.78-1.45],0.6820403705638306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UNG,Uracil-DNA glycosylase,20415,129,1.08 [0.67-1.72],0.7585025441937459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UPB1,Beta-ureidopropionase,20484,132,1.00 [0.83-1.21],0.9903417589501042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UPK3A,Uroplakin-3a,19830,123,1.00 [0.70-1.43],0.981167000849578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UPK3BL1,Uroplakin-3b-like protein 1,20082,125,0.92 [0.64-1.31],0.6291845995773306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UROD,Uroporphyrinogen decarboxylase,20023,132,1.46 [1.14-1.85],0.0022357567780565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UROS,Uroporphyrinogen-III synthase,19939,127,0.95 [0.73-1.24],0.709470109116928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USO1,General vesicular transport factor p115,23526,149,1.13 [0.96-1.33],0.1458333841346361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP25,Ubiquitin carboxyl-terminal hydrolase 25,20415,129,1.12 [0.89-1.41],0.346820263278802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP28,Ubiquitin carboxyl-terminal hydrolase 28,20438,131,1.07 [0.68-1.68],0.7648265565766881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19790,124,0.95 [0.77-1.18],0.6601031617767557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,USP8,Ubiquitin carboxyl-terminal hydrolase 8,23208,146,1.17 [1.00-1.35],0.0456714004925806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,UXS1,UDP-glucuronic acid decarboxylase 1,23083,148,1.01 [0.76-1.35],0.919444362495334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAMP5,Vesicle-associated membrane protein 5,23208,146,1.10 [0.84-1.43],0.4923398122498732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAMP8,Vesicle-associated membrane protein 8,19884,122,1.12 [0.92-1.36],0.2593712178771493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VASH1,Tubulinyl-Tyr carboxypeptidase 1,23613,149,1.21 [1.02-1.43],0.0310241276970067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VASN,Vasorin,23288,142,1.70 [0.99-2.90],0.0527985639738776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VASP,Vasodilator-stimulated phosphoprotein,20513,128,1.16 [0.92-1.46],0.1977017603648613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,23526,149,0.67 [0.32-1.44],0.3066182755417967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VAV3,Guanine nucleotide exchange factor VAV3,19830,123,1.18 [0.99-1.40],0.0688386959764584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VCAM1,Vascular cell adhesion protein 1,23717,148,1.53 [0.92-2.57],0.1038969583561684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VCAN,Versican core protein,23855,150,1.20 [0.74-1.93],0.4580628894314135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VCPKMT,Protein-lysine methyltransferase METTL21D,19767,126,0.98 [0.79-1.20],0.8158561511189565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFA,Vascular endothelial growth factor A,23843,149,1.38 [1.09-1.75],0.0072447084160978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFB,Vascular endothelial growth factor B,19884,122,0.90 [0.50-1.63],0.7264479895050229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFC,Vascular endothelial growth factor C,23701,148,1.21 [0.93-1.57],0.1540311966576531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VEGFD,Vascular endothelial growth factor D,23883,149,0.93 [0.65-1.35],0.7155715089210188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VGF,Neurosecretory protein VGF,20447,131,0.79 [0.45-1.38],0.4019829995155255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VIM,Vimentin,23208,146,1.04 [0.91-1.18],0.5946191307188657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VIPR1,Vasoactive intestinal polypeptide receptor 1,19922,125,0.96 [0.46-1.98],0.9045940852139572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VIT,Vitrin,20484,132,1.01 [0.65-1.56],0.9629910166223874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VMO1,Vitelline membrane outer layer protein 1 homolog,23526,149,1.07 [0.86-1.33],0.5511120640247839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VNN1,Pantetheinase,20513,128,0.86 [0.69-1.08],0.187202334914894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VNN2,Vascular non-inflammatory molecule 2,23526,149,1.28 [0.93-1.77],0.1287969629421614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS28,Vacuolar protein sorting-associated protein 28 homolog,20126,125,1.20 [0.93-1.53],0.1556044028004179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS37A,Vacuolar protein sorting-associated protein 37A,23526,149,1.05 [0.87-1.25],0.6169745447714483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS4B,Vacuolar protein sorting-associated protein 4B,20415,129,1.16 [0.97-1.38],0.0951213039165508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VPS53,Vacuolar protein sorting-associated protein 53 homolog,23526,149,1.14 [0.95-1.37],0.1565170066641166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG10,V-set and immunoglobulin domain-containing protein 10,20415,129,1.32 [0.87-2.01],0.1967810426932464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19790,124,1.12 [0.68-1.86],0.650466150590024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG2,V-set and immunoglobulin domain-containing protein 2,20415,129,1.08 [0.83-1.41],0.5561592564858556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIG4,V-set and immunoglobulin domain-containing protein 4,23620,147,1.27 [0.90-1.80],0.1693359033871839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,23603,150,1.25 [1.00-1.56],0.0460412229143993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSNL1,Visinin-like protein 1,20438,131,0.46 [0.29-0.74],0.0013356086548419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSTM1,V-set and transmembrane domain-containing protein 1,23119,148,1.41 [1.09-1.81],0.0076868827807196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSTM2B,V-set and transmembrane domain-containing protein 2B,20126,125,0.86 [0.55-1.36],0.5285829758575669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,23208,146,0.83 [0.63-1.09],0.1746395754058427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23855,150,1.26 [1.03-1.54],0.0251103700388149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VTCN1,V-set domain-containing T-cell activation inhibitor 1,23083,148,1.05 [0.66-1.68],0.8254593986467553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20023,132,1.19 [0.90-1.58],0.2130820983727828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWA1,von Willebrand factor A domain-containing protein 1,23818,151,1.30 [0.93-1.83],0.1264018620953515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWA5A,von Willebrand factor A domain-containing protein 5A,19767,126,1.05 [0.85-1.30],0.627530266263455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWC2,Brorin,23360,149,0.85 [0.59-1.22],0.3718116185217969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWC2L,von Willebrand factor C domain-containing protein 2-like,20447,131,0.72 [0.45-1.15],0.1705246223539185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,VWF,von Willebrand factor,23938,149,0.99 [0.82-1.20],0.92821787096843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WARS,"Tryptophan--tRNA ligase, cytoplasmic",23652,147,0.93 [0.63-1.36],0.7077104872343043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WAS,Wiskott-Aldrich syndrome protein,23231,145,0.79 [0.62-1.00],0.0453823492638528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASF1,Wiskott-Aldrich syndrome protein family member 1,23208,146,1.11 [0.95-1.29],0.1814079300520719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASF3,Wiskott-Aldrich syndrome protein family member 3,23119,148,1.19 [1.00-1.41],0.0486637071215174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASHC3,WASH complex subunit 3,20438,131,1.03 [0.83-1.29],0.7725716745539551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WASL,Neural Wiskott-Aldrich syndrome protein,19884,122,1.05 [0.78-1.40],0.7549233033411104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WDR46,WD repeat-containing protein 46,20415,129,1.31 [0.89-1.93],0.1654274389058591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFDC1,WAP four-disulfide core domain protein 1,19992,127,1.08 [0.80-1.45],0.6142312614145993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFDC12,WAP four-disulfide core domain protein 12,23798,151,0.88 [0.70-1.11],0.2964547667416352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFDC2,WAP four-disulfide core domain protein 2,22452,141,0.97 [0.66-1.44],0.8812618315911842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",23350,148,0.64 [0.45-0.92],0.0152671308188867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",23642,148,0.99 [0.64-1.55],0.9795663734265142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WIF1,Wnt inhibitory factor 1,23846,151,0.67 [0.44-1.03],0.0702411978925776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WNT9A,Protein Wnt-9a,23231,145,1.01 [0.60-1.69],0.983620732687844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,23436,150,1.15 [0.87-1.50],0.3231206690742568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XCL1,Lymphotactin,23846,151,0.87 [0.65-1.14],0.3112485682677451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XG,Glycoprotein Xg,23828,148,0.95 [0.63-1.44],0.8072644727828008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XIAP,E3 ubiquitin-protein ligase XIAP,19884,122,1.11 [0.82-1.49],0.4949458610265924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XPNPEP2,Xaa-Pro aminopeptidase 2,23701,148,0.93 [0.81-1.05],0.2425271700659555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,XRCC4,DNA repair protein XRCC4,23119,148,0.94 [0.63-1.40],0.7640627752515519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YAP1,Transcriptional coactivator YAP1,20438,131,0.61 [0.32-1.17],0.1351632127408997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",20422,129,1.14 [1.01-1.29],0.0298537764441305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YES1,Tyrosine-protein kinase Yes,23526,149,1.07 [0.95-1.22],0.2772983736365583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YJU2,Splicing factor YJU2,20415,129,1.35 [0.83-2.19],0.2231313299118102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YOD1,Ubiquitin thioesterase OTU1,19790,124,1.27 [0.97-1.67],0.0858802774134373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YTHDF3,YTH domain-containing family protein 3,23231,145,1.13 [0.95-1.35],0.1514336860632737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YWHAQ,14-3-3 protein theta,20023,132,1.25 [1.00-1.56],0.0464838913827857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,YY1,Transcriptional repressor protein YY1,19884,122,1.48 [0.84-2.62],0.175227759670079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZBP1,Z-DNA-binding protein 1,19884,122,1.02 [0.67-1.56],0.9255154456306512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZBTB16,Zinc finger and BTB domain-containing protein 16,23083,148,1.10 [0.91-1.34],0.3277298443646242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZBTB17,Zinc finger and BTB domain-containing protein 17,23208,146,1.16 [0.85-1.58],0.355499229587736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19790,124,1.02 [0.77-1.36],0.8871481085814777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZFYVE19,Abscission/NoCut checkpoint regulator,20422,129,1.24 [1.03-1.50],0.0233640675446883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZHX2,Zinc fingers and homeoboxes protein 2,20438,131,1.13 [0.74-1.72],0.5741660984710566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNF174,Zinc finger protein 174,19884,122,1.19 [0.79-1.81],0.4017108872615814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNF75D,Zinc finger protein 75D,20126,125,1.06 [0.81-1.38],0.6709848764081687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNF830,Zinc finger protein 830,20415,129,1.05 [0.85-1.29],0.6803537577294316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNRD2,Protein ZNRD2,20422,129,1.05 [0.83-1.34],0.6780644231097368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20415,129,1.32 [1.00-1.74],0.0491181190347083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZP3,Zona pellucida sperm-binding protein 3,19922,125,1.00 [0.94-1.07],0.911441937077638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZP4,Zona pellucida sperm-binding protein 4,19767,126,0.74 [0.39-1.40],0.3593683003509664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,ZPR1,Zinc finger protein ZPR1,19830,123,0.88 [0.71-1.09],0.2425095175481883
